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ด้วยรีพอร์ตเตอร์ยีน ลูซิเฟอร์เรส (IL-6 promoter-reporter construct, pmIL-6.Luc(-231) luciferase 
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reporter) ในเซลล์ RAW264.7 ท่ีไดรั้บการปลูกถ่ายยีนดงักล่าว  ทั้งน้ีฤทธ์ิการยบัย ั้งของ 95EE-FLP เป็น
ปฏิภาคโดยตรงกบัความเขม้ขน้ท่ีใช ้โดยภาพรวมสารสกดัจากใบฮวา่นง็อกมีศกัยภาพควรค่าต่อการพฒันา
ในอนาคตเพื่อใช้ประโยชน์ในเชิงป้องกนั หรือรักษาโรคต่าง ๆ อนัมีสาเหตุจากอนุมูลอิสระ และ
กระบวนการอกัเสบ  
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INFLAMMATORY CYTOKINE ACTIVITY BY EXTRACTS FROM HOAN-
NGOC (PSEUDERANTHEMUM PALATIFERUM (NEES) RADLK.).  THESIS 
ADVISOR : ASST. PROF. BENJAMART  CHITSOMBOON, Ph.D. 169 PP. 
 
PHENOLIC/FLAVONOID/ANTIOXIDANT/CELL VIABILITY/ 
ANTI-INFLAMMATORY 
 
Extracts of Pseuderanthemum palatiferum (PP) leaves have been demonstrated to 
possess antioxidant activities, but their anti-inflammatory effects have not yet been 
reported.  The present study aimed to further investigate the phytochemicals and explore the 
antioxidant and anti-inflammatory activities of [1] 95% ethanol extract of fresh leaves of PP 
(95EE-FLP), [2] 80% ethanol extract of fresh leaves of PP (80EE-FLP), [3] 80% ethanol 
extract of dried leaves of PP (80EE-DLP), [4] water extract of fresh leaves of PP (WE-FLP), 
or [5] water extract of dried leaves of PP (WE-DLP).  The results suggested that all fresh 
leaf extracts significantly exhibited higher phenolic and flavonoid contents than those of 
dried leaf extracts (p<0.001).  Concordantly, the antioxidant activity, assessed by DPPH and 
FRAP assays, was also more prominent in fresh leaf extracts than that of dried leaf extracts.  
Both 95EE-FLP and WE-FLP could also effectively attenuate intracellular reactive oxygen 
species (ROSs) generation in tBuOOH-induced oxidative stress in macrophage RAW264.7 
cells as monitored by using DCFH-DA fluorescent probe.  Both 95EE-FLP and WE-FLP 
also possess anti-inflammatory properties.  At non-cytotoxic concentrations (50-250 
µg/mL), 95EE-FLP and WE-FLP effectively diminished the up regulation of nitric oxide 
and protein levels of inducible NO synthase (iNOS) and cyclooxygenase (COX-2) enzymes 
in 1 µg/mL LPS plus 25 U/mL IFN-γ-stimulated RAW264.7 cells.  95EE-FLP, the most 
potent extract, was selected for further investigation of its immune modulation on critical 
  
 
 
 
 
 
 
 
IV 
proinflammatory cytokines, TNF-α and IL-6.  The results showed that 95EE-FLP induced a 
dose-dependent suppression of LPS (100 ng/mL)-induced TNF-α and IL-6 secretion in 
mouse (C57BL/6) peritoneal macrophages.  In addition, 95EE-FLP also suppressed LPS-
induced TNF-α and IL-6 protein synthesis and mRNA expression in RAW264.7 cells.  The 
study of the molecular mechanism of 95EE-FLP-mediated immune modulation of TNF-α 
and IL-6 revealed that the suppression in RAW264.7 cells was mediated, at least in part, 
through decreasing the binding activity of NF-ҡB to the response element in mTNF-α 
promoter and the binding activities of NF-ҡB, C/EBP and AP-1 in mIL-6 promoters.  
Furthermore, the LPS activation of pmIL-6.Luc(-231) promoter/luciferase reporter gene in 
transfected RAW264.7 cells was also suppressed by 95EE-FLP in a dose-dependent 
manner.  Collectively, the extracts from PP leaves exhibit a high potential for future 
development to be exploited in prevention or treatment of diseases caused by over 
production of ROSs and inflammatory disorders. 
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CHAPTER I 
INTRODUCTION 
 
1.1 Introduction 
Reactive oxygen species (ROSs) are produced by exposure to environmental factors 
and by activated neutrophils and macrophages during mitochondria catalyzed electron 
transport reactions, and other mechanisms (Gülcin, Bursal, Şehitoğlu, Bilsel, and Gӧren, 
2010).  Excessive release of ROSs has been implicated in the pathogenesis of tissue injury 
and development of several degenerative and inflammatory diseases, including cancers, 
cardiovascular diseases, diabetes, neural disorders, and other chronic inflammations 
(Gutteridge, 1995; Valko, Rhodes, Moncol, Izakovic, and Mazur, 2006).  ROS propagate 
inflammation by stimulating the release of several proinflammatory mediators such as nitric 
oxide (NO) and proinflammatory cytokines, which in turn mediated the recruitment of 
additional neutrophils and macrophages.  Therefore, ROSs are prime mediators provoking 
or sustaining inflammatory processes, and, consequently, their neutralization by 
antioxidants and radical scavengers can attenuate inflammation (Geronikaki and Gavalas, 
2006).  Consumption of foods rich in antioxidants has been shown to play an essential role 
in the prevention of cancers (Ames, Gold, and Willett, 1995), neurodegenerative diseases 
(Christen, 2000), and inflammations (Kaur and Kapoor, 2001).  Therefore, it is possible to 
reduce the risk of chronic diseases and prevent disease progression by using natural 
antioxidants. 
Inflammation is a complex biological response to the harmful stimuli and is 
associated with many pathological conditions.  Macrophages play a key role in 
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inflammatory and immune reactions by releasing a variety of inflammatory mediators such 
as proinflammatory cytokines (IL-1, TNF-α, and IL-6), ROSs, NO, chemokines, growth 
factors, and inducible enzymes (iNOS and COX-2) (Adams and Hamilton, 1984; Ramana et 
al., 2006).  These inflammatory mediators can be stimulated by a variety of agents such as 
TNF, IFN-γ, and microbial products including lipopolysaccharide (LPS) (Lowenstein et al., 
1993; Xie, Whisnant, and Nathan, 1993).  After LPS stimulation of macrophage, inducible 
isoforms of NOS and COX-2 are responsible for the production of large amounts of NO and 
prostaglandin E2 (PGE2), respectively (Senthil Kumar and Wang, 2009; Yoon et al., 2009).  
There are indications that activation of nuclear factor kappaB (NF-ҡB) is involved in iNOS 
and COX-2 expression as suggested by the presence of NF-ҡB consensus site in the 
upstream promoter region of both the iNOS and COX-2 genes (Park et al., 2006; Chung et 
al., 2008).  Hence, suppression of NF-ҡB leading to decreased activity of NO, iNOS, and 
COX-2 have been used as screening tools for substances with anti-inflammatory activity. 
Cytokines are important in recruitment of immune cells and in regulation of 
inflammatory responses (Gonzalo et al., 1996).  NF-ҡB, CCAAT/enhancer binding protein 
(C/EBP), and activator protein-1 (AP-1) are common transcription factors involved in the 
regulation of many proinflammatory cytokines.  The transcriptional promoters of 
proinflammatory genes TNF-α and IL-6 contain typical binding sites for NF-ҡB, AP-1, and 
C/EBP (Zagariya et al., 1998; Kuprash et al., 1999; Baccam, Woo, Vinson, and Bishop, 
2003).  NF-ҡB plays a critical role in the expression of many genes (TNF-α, IL-1β, IL-6,  
IL-8, and COX-2) involved in immune and inflammatory responses.  It is regarded as one 
of the most important transcription factors that regulate inflammation and play a key role in 
several inflammatory diseases, such as rheumatoid arthritis (RA) synovia fibroblasts, 
asthma, inflammatory bowel disease, sepsis, neurodegeneration, and ischemia/reperfusion 
injury (Tak and Firestein, 2001; Prajapati, singhal, Yashwant, and Gupta, 2010).  Among 
many transcription factors, AP-1 is one of the most important transcription factors that has 
  
 
 
 
 
 
 
 
3 
been implicated as a critical regulator of gene expression in the setting of inflammation.  
Like NF-ҡB, activation of AP-1 complexes, composed of Jun and Fos family members, 
contributes to RA-associated inflammation (Firestein and Manning, 1999).  C/EBP is a 
transcription factor that is involved in multiple biological functions including a role in 
inflammation (Ramji and Foka, 2002).  Therefore, modulation of NF-ҡB, AP-1, and/or 
C/EBP activations might serve as an effective strategy for suppressing the levels of 
proinflammatory mediators implicated in inflammatory diseases. 
There has been increasing interest in the discovery and development of novel 
pharmaceuticals from medicinal plants possessing antioxidant and anti-inflammatory 
activity with minimal side effects.  Natural products and herbal remedies used in traditional 
folk medicine have been the sources of many medicinally beneficial drugs.  In some 
countries, government encourages the use of indigenous forms of medicine rather than 
expensive imported drugs.  In Thailand, a large percentage of the population is dependent 
on herbal medicines because the international commercial medicines are becoming 
increasingly expensive and out of reach.  Among several medicinal plants in Thailand, 
Pseuderanthemum palatiferum Nees Radlk. (PP) is widely used.  PP leaves have been long 
used among the native population of Thailand and Vietnam as remedies against different 
diseases such as hypertension, diabetes, cancers, and inflammatory diseases (Dieu, Loc, 
Yamasaki, and Hirata, 2005; Padee, Nualkaew, Talubmook, and Sakuljaitrong, 2010).  
Recently, this plant has been reported to possess phenolics and flavonoids as well as 
antioxidant properties (Nguyen and Eun, 2011).  Phenolic compounds in plants are known 
to exhibit a wide range of biological activities, including anticancer, antibacterial, 
antioxidant, and anti-inflammatory properties (Lu and Foo, 2002).  Therefore, the aim of 
this study was to investigate the effect of the extracts of PP leaves on antioxidant activity, 
RAW264.7 macrophage cell viability, anti-inflammatory activity as well as in vitro 
production and transcriptional regulation of inflammatory mediators in order to gain             
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a further insight into the molecular mechanisms whereby this plant leaf extract may mediate 
its immunosuppressive action in vitro. 
 
1.2 Research objectives 
 The main objectives of this study are as following : 
1.2.1 To investigate the phytochemicals and antioxidant properties of PP leaf 
extracts. 
1.2.2 To investigate the effect of PP leaf extracts on RAW264.7 cell viability. 
1.2.3 To investigate the cellular antioxidant activity (CAA) of PP leaf extracts in 
RAW264.7 cells. 
1.2.4 To investigate anti-inflammatory effect of PP leaf extracts by modulation of 
NO, iNOS, and COX-2 protein expressions in LPS plus IFN-γ-stimulated 
RAW264.7 cells. 
1.2.5 To investigate immunomodulation of PP leaf extract on protein synthesis and 
mRNA expressions of proinflammatory cytokines TNF-α and IL-6. 
1.2.6 To explore whether the anti-inflammatory mechanism of PP leaf extract was 
mediated by suppression of NF-ҡB, C/EBP, or AP-1 activation. 
 
1.3. Research hypothesis 
 1.3.1 PP leaf extracts contain high contents of total phenolic and flavonoid. 
 1.3.2 PP leaf extracts have high antioxidant activities as compared to standard 
antioxidants. 
 1.3.3 PP leaf extracts are not toxic on RAW264.7 macrophage cells, but appear to 
have biological activity. 
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 1.3.4 PP leaf extracts suppress COX-2 protein expression and NO levels by 
modulation of iNOS protein. 
 1.3.5 PP leaf extracts suppress TNF-α and IL-6 proinflammatory cytokines by 
regulation of NF-ҡB, AP-1, or C/EBP transcription factors. 
 
1.4 Scope and limitations of the study 
 Phytochemicals of various extracts of PP leaves were evaluated for total phenolic and 
flavonoid contents.  Antioxidant properties of the extracts were determined in vitro by both 
chemical and cell-based assays.  RAW264.7 macrophage cells were used to investigate the 
effects of extracts of PP leaves on in vitro cytotoxic studies.  The anti-inflammatory 
properties of extracts of PP leaves were investigated in vitro using LPS and/or IFN-γ-
activated RAW264.7 macrophage cell line.  The inflammatory parameters measured were 
NO production, iNOS and COX-2 protein expressions, TNF-α and IL-6 productions and 
mRNA expressions.  Anti-inflammatory-mediated modulation was examined by 
determination of activation of NF-ҡB located in mouse TNF-α promoter, and NF-ҡB, 
C/EBP, and AP-1 located in mouse IL-6 promoters using the electrophoretic mobility shift 
assay.  The effect of extract from PP leaves on activation of pmIL-6.Luc(-231) 
promoter/luciferase reporter gene in transfected RAW264.7 cells activated with LPS was 
also examined using transient transfection followed by luciferase assays.  The limitation of 
this study was antioxidant and anti-inflammatory cytokine activity of PP.  It was only 
investigated in vitro and mainly focused on RAW264.7 cells.  The overviews of the studies 
were summarized in Figure 1.1. 
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Figure 1.1 Scope and limitation of the studies. 
95EE-FLP, 95% ethanol extract of fresh leaves of PP; 80EE-FLP, 80% ethanol extract of 
fresh leaves of PP; 80EE-DLP, 80% ethanol extract of dried leaves of PP; WE-FLP, water 
extract of fresh leaves of PP; WE-DLP, water extract of dried leaves of PP; CAA, cellular 
antioxidant activity. 
(1) PP extracts preparation : 95EE-FLP, 80EE-FLP, 80EE-DLP, WE-FLP, or WE-DLP 
(2) Determination of phytochemical compounds from all extracts of PP leaves : 
total phenolic and flavonoid contents 
 
(3) Determination of antioxidant activities : 
     - DPPH and FRAP assays (all extracts of PP leaves) 
     - CAA in RAW264.7 cells (95EE-FLP and WE-FLP) 
(4) Cytotoxicity test of 95EE-FLP and WE-FLP on RAW264.7 cells : 
     - Trypan blue exclusion method, MTT assay and PI staining 
(5) Anti-inflammatory activities 
(5.1) - Suppression of 95EE-FLP and WE-FLP on NO production by Griess reagent in 
LPS plus IFN-γ-stimulated RAW264.7 cells 
         - Suppression of 95EE-FLP and WE-FLP on iNOS and COX-2 proteins by 
Western blot analysis in LPS plus IFN-γ stimulated RAW264.7 cells 
(5.2) - Suppression of 95EE-FLP on TNF-α and IL-6 proinflammatory cytokines by 
ELISA in LPS-activated peritoneal murine macrophages and RAW264.7 cells 
         - Suppression of 95EE-FLP on TNF-α and IL-6 mRNA expressions by qRT-PCR 
in LPS-activated RAW264.7 cells 
(5.3) Suppression of 95EE-FLP on DNA binding transcription factor activity in  
         LPS-stimulated RAW264.7 cells using gel mobility shift assay 
         - NF-ҡB located in mouse TNF-α promoter 
         - NF-ҡB, C/EBP, and AP-1 located in mouse IL-6 promoters 
(5.4) Suppression of 95EE-FLP on pmIL-6.Luc(-231) luciferase activity in transfected  
         RAW264.7 cells induced with LPS using transient transfection and luciferase 
         assay. 
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1.5 Expected results 
 1.5.1 The outcomes from the study of phytochemical and antioxidative properties of 
PP leaf extracts can be used as basic pharmacological data for future research. 
 1.5.2 Scientific data obtained from PP leaf extracts will help to support and 
strengthen the knowledges and practices of using leaves of PP which has 
already gained popularity in Thailand. 
 1.5.3 Information on anti-inflammatory activity of PP leaf extracts can be used to 
develop anti-inflammatory drugs in the future. 
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CHAPTER II 
LITERATURE REVIEW 
 
2.1 Pseuderanthemum palatiferum 
 Pseuderanthemum palatiferum (Nees) Radlk. (PP) or Eranthemum palatiferun Nees, 
known as Hoan-Ngoc, is a native plant of Vietnam belonging to the Acanthaceae family.  
During the latter half of the 1990‟s, the plant was found in Cuc Phuong forest in Northern 
Vietnam.  After the discovery, the plant has been cultivated throughout the country (Figure 2.1) 
as a medicinal and ornamental plant including the Mekong Delta region, the most southern 
region in the country.  The Vietnamese people believe that PP is a miracle-medicinal plant.  
Chewing its fresh leaves, or drinking its juice prepared fresh or boiled is supposed to cure 
many diseases such as wounds, trauma, stomachache, colitis, blood pressure, nephritis, and 
diarrhea (Dieu, Loc, Yamasaki, and Hirata, 2005, 2006).  In addition, PP leaves have also 
been used for prevention and treatment of piglet diarrhea (Dieu et al., 2006).  PP was taken 
through the northeast of Thailand, Surin, Buriram, and Sisaket provinces, about 25-30 years 
ago by a Vietnam Era veteran.  Its Thai name is “Wan Ling” or “Payawanorn”.  PP can be 
widely grow in Thailand and Thai people have used PP leaves for prevention and treatment 
of many diseases, such as chronic pain in older adults, trauma, nerve disease, influenza, 
allergy, high or low blood pressure, digestive disorder, diarrhea, bone fracture, 
stomachache, nephritis, hepatitis, diabetes, and cancer.  Therefore, commercial products 
made from PP leaves including powder decoctions, herbal tea bags and capsules have been 
developed (Figure 2.2).  These products are available in markets both in Thailand and 
Vietnam, but without quality control. 
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Figure 2.1 PP (Hoan-Ngoc) has been cultivated in various regions throughout Vietnam 
country (Sinh, 2010; Trần, 2013). 
 
 
Figure 2.2 Commercial products from PP leaves (Thaiza, www, 2013). 
 
 At present, there are very limited published studies of PP and most of them are 
written in Vietnamese.  The showed that PP leaves contain n-pentacosan-1-ol, β-sitosterol, 
stigmasterol, β-sitosterol 3-O-β-glucoside, stigmasterol 3-O-β-glucoside, kaempferol 3-
methyl ether 7-O-β-glucoside, apigenin 7-O-β-glucoside, 1-triacontanol, and salicylic acid 
(Phan, Ha, and Phan, 2003; Dieu et al., 2005, 2006).  The leaves also contain pseuderantin, 
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a proteinase with high thermal stability and proteolytic activity.  Moreover, the leaves of PP 
contain crude proteins, minerals such as Ca, Mg, Fe and Cu, and amino acids such as lysine, 
methionine, and threonine (Dieu et al., 2005) as demonstrated in Table 2.1.  Flavonoids, 
phenol carboxylic acids, and terpenoids were also detected in dried leaf extract of PP by 
80% ethanol maceration with thin-layer chromatography fingerprinting (Chayarop et al., 
2011).  Dried leaf extracts of PP macerated with different solvents (methanol, acetone, 
ethanol, and water) showed phenolic content determined by the Folin-Cioculteu method, 
flavonoid content determined by aluminium trichloride colorimetric assay, and antioxidant 
activities with reducing power (FRAP), metal chelating activity, and 2, 2-diphenyl-2-
picrylhydrazyl hydrate (DPPH) radical scavenging activity (Nguyen and Eun, 2011).  The 
ethyl acetate and n-butanol fractions of PP leaves contained high flavonoid contents and 
have antioxidant activity in human blood peroxidase model.  Moreover, PP leaf extract had 
antibacterial activity against Salmonella typhi 158, Shigella flexneri, and Escherichia coli, 
and antifungal activity against Candida albicans and Candida stellatoides (Phan, Ha, and 
Phan, 2005).  Dieu et al. (2006) reported that the dried and fresh-leaves had comparable 
effect in the treatment of diarrhea in piglets, and the efficacy was almost equivalent to Coli-
norgent and Co-trimoxazold which are the best prevalent drugs in treating diarrhea.  Nam, 
Kim, Bae, and Ahn (2003) reported that methanol extract from PP leaves was toxic to B16 
melanoma and could inhibit new blood vessel growth in human umbilical venous.  Aqueous 
and ethanol crude extracts from PP leaves had anti-mutagenic effect with Ames test.  In 
addition, two extracts from PP had anti-proliferative activity against 3 types of colon cancer 
cell lines; HCT15, SW48, and SW480 with 3‟-(4,5 dimethylthiazol-2-yl)-2,5 diphenyl 
tetrazolium bromide (MTT) assay (Pamok, Saenphet, Vinitketkumnuen, and Saenphet, 
2012).  Moreover, crude extract of PP with 80% ethanol showed hypoglycemic effect on 
streptozotozin-induced diabetic rats (Padee, Nualkaew, Talubmook, and Sakuljaitrong, 
2010). 
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Table 2.1 Chemical composition, dry matter yield and crude protein, and amino acid 
contents of PP leaves. 
 
Isolation and identification of compounds from PP leaves 
 
     n-Pentacosan-1-ol 
     β-Sitosterol 
      Stigmasterol 
     β-Sitosterol 3-O-β-glucoside 
     Stigmasterol 3-O-β-glucoside 
    Kaempferol 3-methyl ether 7-O-β-glucoside 
      Apigenin 7-O-β-glucoside 
     1-Triacontanol 
     Salicylic acid 
 
Minerals (mg/100 g fresh leaves) 
 
      Ca        875.5 
      Mg        837.6 
      Fe        38.8 
     Cu        0.43 
 
Amino acids (mg/100 g fresh leaves) 
 
      Lysine        30.6 
      Methionine       29.7 
      Threonine       61.0 
 
Dry matter (%)       13.4 
 
 
Crude protein (% dry matter)     30.8 
 
Source: Phan et al., 2003; Dieu et al., 2005, 2006. 
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2.2 Free radicals (ROSs and RNSs) and antioxidants 
 In recent years, there has been considerable interest in free radicals and related 
species.  They are mainly derived from oxygen (reactive oxygen species/ROSs), including 
not only the oxygen radicals (superoxide anion O2˙ˉ, hydroxyl radicals ˙OH etc.) but also 
some non-radical derivatives.  In addition, they are also derived from nitrogen (reactive 
nitrogen species/RNSs) such as nitric oxide (NO) and RNSs, which play also important 
roles in biology similar to ROS (Hallwell, 2006; Fang, Seki, and Maeda, 2009).  Free 
radicals are very small highly reactive molecules due to the presence of unpaired valence 
shell electrons.  They are very short lived, with half-lifes in milli-, micro- or nanoseconds.  
The well-regulated levels of ROS and RNS are produced to maintain cellular homeostasis 
in the normal healthy tissue and they play important roles as signaling molecules that 
regulate cell growth and reduction-oxidation (redox) status (Devasagagam et al., 2004). 
 Free radicals are normally generated in our body by various endogenous systems.  
They are generated from the autoxidation and consequent inactivation of small molecules 
such as reduced thiols and flavins, and from the activity of certain oxidases, lipoxygenases, 
cyclooxygenases, peroxidases, and dehydrogenases.  (Machlin and Bendich, 1987; Nicholis 
and Budd, 2000).  Other sources of free radicals also include redox cycling of xenobiotics, 
exposure to environmental (atmospheric pollutants and cigarette smoking etc.) or 
physicochemical agents (ultraviolet rays and radiation etc.), or toxic chemicals, 
overnutrition, or pathophysiological state (Machlin and Bendich, 1987; Cadenas and 
Davies, 2000; Devasagayam and Kamat, 2002) (Figure 2.3).  However, during time of 
environmental stress, free radicals can adversely alter lipids, proteins, and DNA, resulting 
in significant damage to cell structure and functions.  Membrane lipids present in 
subcellular organelles are highly prone to free radical damage resulting in lipid peroxidation 
that can lead to adverse alterations (Devasagayam, Boloor, and Ramasarma, 2003).  
Oxidation of proteins by ROSs/RNSs can result in loss of enzyme activity (Stadtman, 1992, 
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2001).  Free radical damage to DNA can result in mutagenesis and carcinogenesis.  The 
hydroxyl radical is known to react with all components of the DNA molecule.  Hydroxyl 
radicals can cause damage to purine and pyrimidine bases and also the deoxyribose 
backbone (Halliwell and Gutteridge, 1999). 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Sources of free radicals (Symmetry, www, 2013). 
 
 Oxidative stress or overproduction of ROSs and RNSs have been implicated in aging 
and a number of human diseases such as atherosclerosis, malaria, rheumatoid arthritis, 
neurodegenerative diseases, ischemia-reperfusion (I/R) injury, cardiovascular diseases, viral 
pathogenesis, hypertension, formation of drug resistant mutant, drug-induced tissue injury, 
and inflammation  (Aroma, 1998; Fang et al., 2009).  Antioxidants are known as substances 
or nutrients that neutralize free radicals in various stages (Sies, 1997).  Nature has endowed 
each cell with adequate protective mechanisms against any harmful effects of free radicals.  
As shown in Figure 2.4, these defense systems include intracellular superoxide dismutase 
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(SOD), glutathione peroxidase, and glutathione reductase.  Other non-enzymatic 
antioxidants include essential nutrient such as vitamin E and C.  Vitamin E acts as a chain-
breaking antioxidant which prevents the propagation of free radical reactions in all cell 
membranes in our body.  Vitamin E is also considered as the standard antioxidant to which 
other compounds with antioxidant activities are compared.  Ascorbic acid or vitamin C is 
also part of the normal protecting mechanism (Buettner, 1993; Mahadik and Mukherjee, 
1996; Kagan et al., 2002).  Other non-enzymatic antioxidants also include carotenoids, 
flavonoids, and related polyphenols such as α-lipoic acid, glutathione.  Carotenoids, such as 
beta-carotene, lycopene, lutein and other carotenoids, function as important antioxidants to 
quench O2 and ROO˙ (Stahl and Sies, 2003).  Flavonoids, mainly present as coloring 
pigments in plants also function as potent antioxidants at various levels.  Antioxidant can 
act at the levels of prevention, interception, and repair.  Preventive antioxidants attempt to 
stop the formation of ROS like intracellular SOD.  Interception of free radicals is mainly 
mediated by radical scavengers such as vitamin C and E, glutathaione, other thiol 
compounds, carotenoids, flavonoids etc.  Repair enzymes are involved at the repair and 
reconstitution level of antioxidants (Devasagagam et al., 2004). 
 Natural products from dietary components such as Indian spices, Thai spices, 
traditional Chinese spices as well as medicinal plants are known to possess antioxidant 
activity.  They have important roles in bioprospecting of new medicines from medicinal 
plants, which are also rich sources of antioxidants.  Current estimate indicates that about 
80% of people in developing countries still rely on traditional medicine from medicinal 
plants and animals for various diseases prevention and treatment (Devasagagam et al., 
2004). 
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Figure 2.4 Antioxidant defense system (Lewrockwell, www, 2010). 
 
2.3 Phenolic compounds and flavonoids 
 Phenolic compounds have been associated with the health benefits derived from 
consuming high levels of fruits, vegetables, and medicinal plants (Hertog, Hollman, Katan, 
and Kromhout, 1993; Parr and Bolwell, 2000; Barros, Dueñas, Carvalho, Ferreira, and 
Santos-Buelga, 2012).  The beneﬁcial eﬀects derived from plant phenols have been 
attributed to their antioxidant properties (Heim, Tagliaferro, and Bobilya, 2002).  They are 
also considered to possess anti-atherogenic, anti-allergenic, anti-inﬂammatory, anti-
microbial, anti-thrombotic, vasodilatory, and cardioprotective eﬀects.  Basic structures of 
phenolic compounds possess an aromatic ring bearing one or more hydroxyl groups and 
their structures may range from that of a simple phenolic molecule to that of a complex 
high-molecular weight polymer (Balasundram, Sundram, and Samman, 2006).  Phenolic 
phytochemicals are the largest category of phytochemicals and the most widely distributed 
in the plant kingdom.  More than 8,000 phenolic phytochemicals have been identified 
(Croft, 1998).  Phenolic compounds are plant secondary metabolites that are frequently 
Glutathione 
peroxidase 
Glutathione 
reductase Riboflavin 
Vitamin B2 
(Produced Naturally in The Body From Precursors Zinc, Manganese, Copper) 
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attached to sugars (glycosides).  Occasionally, phenolic compounds also occur in plants as 
aglycones.  Thus, these phenolics can be classified into non-soluble compounds (condensed 
tannin, lignins, and cell-wall bound hydroxycinnamic acids) and soluble compounds 
(phenolic acids, phenylpropanoids, flavonoid, and quinones) (Bravo, 1998).  Phenolic 
compounds can be divided into several classes based upon their chemical structures.  
Though such structural diversity results in the range of phenolic compounds that occur in 
nature, the three most important groups of dietary phenolics are phenolic acid, tannins, and 
flavonoids (King and Young, 1999).  Phenolic acids consist of two subgroups: the 
hydroxybenzoic and hydroxycinnamic acids.  The two major dietary hydroxybenzoic acids 
are ellagic (Figure 2.5A) and gallic acid (Figure 2.5B), which usually occur as hydrolyzable 
tannins and are found mainly in berries and nuts (Maas and Galletta, 1991).  Tannins, the 
relatively high molecular weight compounds, are divided into 2 groups.  Condensed tannins 
are the first group, which are polymers of catechins or epicatechins.  And the second group 
is hydrolyzable tannins which are polymers of gallic acid (Chang, Collins, Bailey, and 
Coffey, 1994; King and Young, 1999).  Flavonoids are the largest group of plant phenolics, 
accounting for over half of the eight thousand naturally occurring phenolic compounds 
(Baxter, Harborne, and Moss, eds., 1999).  Flavonoids are low molecular weight 
compounds, consisting of fifteen carbon atoms which are arranged in a C6-C3-C6 
configuration.  Essentially, the structure consists of two aromatic rings A and B, joined by a 
3-carbon bridge usually in the form of heterocyclic ring, C (Bohm, 1998; Marken and 
Beecher, 2000) (Figure 2.6).  Flavonoids can be further subdivided into 6 major subclasses, 
based on the connection of an aromatic ring to the heterocyclic ring, as well as the oxidation 
state and functional groups of the heterocyclic ring.  In addition, within each subclass, 
individual compounds are characterized by specific hydroxylation and conjugation patterns 
(Beecher, 2003).  The six major subclasses of flavonoids include flavones, flavonols, 
flavanones, catechins or flavanols, isoflavones, and anthocyanidins (Ross and Kasum, 
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2002).  Chemical structures and major food sources of flavonoid subclasses are shown in 
Figure 2.7. 
 
 
 
 
 
 
 
Figure 2.5 Structure of (A) ellagic acid (King and Young, 1999), and (B) gallic acid 
(Balasundram et al., 2006). 
 
 
 
Figure 2.6 Generic structure of a flavonoid molecule (Balasundram et al., 2006). 
 
A B 
Ellagic acid Gallic acid 
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Figure 2.7 Chemical structures and major food sources of flavonoid subclasses (Ross and 
Kasum, 2002). 
 
2.4 Inflammation 
 Inflammation is the reaction of vascularized tissue to local injury.  The causes of 
inflammation are many and varied but most commonly result from an immune response to 
infectious microorganisms (Sommer, 2005) as shown in Figure 2.8.  Inflammation can be 
classified into acute and chronic.  Though the temporal profiles differ, both acute and 
chronic inflammation share common mechanisms with different timescales and amplitudes 
of the biological response (Cheng et al., 2010).  Acute inflammation is the early or 
immediate response to vascular changes where the widespread effects of inflammatory 
mediators produce pain, heat, and swelling, usually of short duration (Sommer, 2005).  
Subacute or chronic phase is characterized by the development of specific humoral and 
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cellular immune responses to the pathogen present at the site of tissue injury (Faghali and 
Wright, 1997).  Chronic inflammation is self-perpetuating and may be present for weeks, 
months, or even years.  It may develop as the result of a recurrent or progressive acute 
inflammatory process or from low-grade, smoldering responses that fail to evoke an acute 
attack (Sommer, 2005).  During both the acute and chronic inflammatory state, a variety of 
soluble factors are involved in leukocyte recruitment through increased expression of 
cellular adhesion molecules and chemoattraction.  In addition, a variety of these soluble 
mediators regulate resident cells and the newly recruited inflammatory cells and some of 
these mediators contribute to the systemic responses associated with the inflammatory state.  
The soluble factors that mediate these responses are divided into four main categories: (1) 
inflammatory lipid metabolites and the numerous derivatives from arachidonic acid such as 
prostaglandins and leukotrienes, (2) three cascades of soluble proteinase/substrates such as 
clotting and complement which generate numerous proinflammatory peptides, (3) NO, a 
potent endogenous vasodilator, (4) a group of cell-derived polypeptides, known as 
cytokines, which to a large extent orchestrate the inflammatory response (Faghali and 
Wright, 1997).  Thus, many inflammatory conditions are associated with many and varied 
factors including production of large amounts of NO (Liu and Hotchkiss, 1995), 
proinflammatory cytokines (TNF-α and IL-6) (Faghali and Wright, 1997), inducible 
enzymes (iNOS and COX-2) (Dannhardt and Kiefer, 2001; Calixto, Otuki, and Santos, 
2003), and numerous of genes are expressed in association with the inflammatory process 
by activating several types of transcription factors (NF-ҡB, C/EBP, and AP-1) (Koj, 1996).  
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Figure 2.8 Inflammatory response against pathogens (Inflammation relief guide, www, 
2011). 
 
 2.4.1 Role of nitric oxide in physiological function and inflammation 
  NO is an important bioregulatory molecule regulating numerous physiological 
functions such as blood pressure, neural signal transmission, and platelet functions, as well 
as playing critical roles in the anti-pathogen and tumoricidal response of the immune 
system.  Low concentrations of NO are sufficient, in most cases, to affect these functions 
(Liu and Hotchkiss, 1995; Wink et al., 1998).  However, during infection and inflammation, 
in vivo formation of NO is increased suggesting that NO concentrations are well above 
those found in normal physiological functions in infection of tissues.  Increased NO levels 
may bring about some adverse effects of NO such as formation of carcinogenic  N-nitroso 
compounds, deamination of DNA bases and mutagenesis, oxidation of DNA bases and 
tissue injury caused by potent oxidative agents (Liu and Hotchkiss, 1995).  It is likely that 
the release of NO via iNOS has also been implicated as a deleterious agent in various 
pathophysiological conditions and tissue damages (Moncada, Palmer, and Higgs, 1991; 
Wink et al., 1998).  Figure 2.9 shows physiological and pathological roles of NO. 
1 Bacteria and other pathogens enter 
would. 
 
2 Platelets from blood release blood-
clotting proteins at would site. 
 
3. Mast cells secrete factors that mediate 
vasodilation and vascular constriction.  
Delivery of blood, plasma, and cells to 
injured area increases. 
 
4. Neutrophils secrete factors that kill 
and degrade pathogens 
 
5. Neutrophils and macrophages remove 
pathogens by phagocytosis. 
 
6. Macrophages secrete hormones called 
cytokines that attract immune system 
cells to the site and activate cells 
involved in tissue repair. 
 
7. Inflammatory response continues until 
the foreign material is eliminated and the 
wound is repaired.  
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 2.4.2 Inducible nitric oxide synthase (iNOS) 
  The molecular NO is synthesized from the guanidino group of L-arginine by 
three isoforms of the enzyme NO synthase (NOS).  Each isoform has been described and 
cloned: endothelial cell NOS (ecNOS or type 3), brain NOS (bNOS, nNOS, or type 1), and 
inducible macrophage-type NOS (iNOS or type 2) (Cuzzocrea, Riley, Caputi, and 
Salvemini, 2001).  Historically, NOS have been classified into two distinct categories, 
constitutive (nNOS and ecNOS) and inducible (iNOS).  Each isoform is the product of        
a distinct gene (Wink et al., 1998).  As shown in Figure 2.10, biosynthesis of NO, generally, 
nNOS and ecNOS are present continuously in neurons and endothelial cells, respectively, 
and require elevation in intracellular Ca
2+
 and attendant activation of calmodulin 
(Ca
2+
/calmodulin dependent) to produce NO.  These isoforms are regulated primarily by 
calcium influx and generate low levels of NO for brief periods of time in response to 
receptor or physiological stimulation.  Therefore, when NO is formed by vascular 
endothelial, it diffuses into the vascular smooth muscle cells adjacent to the endothelium 
where it binds to and activates guanylyl cyclase.  This enzyme catalyzes the 
dephosphorylation of GTP to cGMP, which serves as a second messenger for many 
important cellular functions, particularly for signaling smooth muscle relaxation (Moncada 
et al., 1991; Wink et al., 1998).  Another enzyme, iNOS needs to be induced by cytokines 
primarily by cells of the myeloid lineage, macrophages, enthothelial cells, and a number of 
other cells and can generate locally high concentration of NO for prolonged periods of time 
(Wink et al., 1998).  iNOS is expressed typically in response to immunological stimuli, 
bacteria lipopolysaccharide (LPS), and a variety of proinflammatory cytokines, and 
produces nanomoles, rather than picomoles of NO (Cuzzocrea et al., 2001).  iNOS is a 
cytosolic Ca
2+
-independent enzyme.  It requires tetrahydrobiopterin as well as other 
cofactors, and its induction is suppressed by glucocorticoids (Moncada et al., 1991).  
Induction of iNOS can also be suppressed by numerous agents, including thrombin, 
  
 
 
 
 
 
 
 
25 
macrophage deactivation factor, transforming growth factor-β, platelet-derived growth 
factor, interleukin (IL)-4, IL-8, IL-10, and IL-13 (Cuzzocrea et al., 2001).  Macrophages are 
capable of producing wide ranges of NO concentrations depending on the source of 
stimulus such as LPS, proinflammatory cytokines, or LPS plus proinflammatory cytokines.  
Interestingly, macrophages are stimulated by LPS plus IFN-γ.  The amount of NO 
generation is higher when compared to stimulation with LPS alone or LPS plus TNF-α or 
IL-1β (Cheng et al., 2010). 
 
 
Figure 2.9 Physiological and pathological roles of NO (Liu and Hotchkiss, 1995). 
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Figure 2.10 Biosynthesis of NO (Cardiovascular physiology concepts, www, 2008). 
 
 2.4.3 Direct and indirect effects of NO 
  The biological effects of NO can be divided into two types, direct and indirect.  
The direct effects of NO generally occur at low concentrations, whereas indirect effects 
occur at much higher concentration.  Direct effects are those chemical reactions in which 
NO reacts directly with given biological targets.  Low levels of NO can react directly with 
heme-containing proteins such as guanylate cyclase, oxyhemoglobin, and cytochrome P450, 
and thereby may account for the neuromodulatory effects of nNOS and the vasodilatory 
effects of ecNOS.  In contrast, the indirect effects require the reaction of NO with oxygen 
(O2) or superoxide (O2
-
) to generate RNS which subsequently react with the biological 
targets and change their downstream functions.  These reactions require high local 
concentrations of NO of which iNOS may be the sole biological source (Wink et al., 1998; 
Thomas et al., 2008; Cheng et al., 2010).  Figure 2.11 shows the overview of the chemistry 
of direct and indirect reactions of NO. 
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Figure 2.11 The chemistry of direct and indirect reactions of NO (adapted from Thomas et 
al., 2008). 
 
 2.4.4 Inducible cyclooxygenase-2 (COX-2) 
  Cyclooxygenase (COX) or prostaglandin H2 synthase (PGHS), first purified in 
1976 and cloned in 1988, is the key enzyme in the synthesis of prostaglandins (PGs) from 
arachidonic acid (AA) (DeWitt and Smith, 1988; Merlie, Fagan, Mudd, and Needleman, 
1988; Yokoyama, Takai, and Tanabe, 1988).  Two closely related forms of COX known as 
COX-1 and COX-2 have been identified.  Both isoforms are almost identical in structure 
but have important differences in substrate and inhibitor selectivity and in their intracellular 
locations.  Both isoenzymes transform AA to PGs, but they differ in their distribution and 
their physiological roles.  Thus, rather than classifying PG biosynthesis into physiological 
and pathological, it may be better to classify based on COX isoforms: either constitutive or 
induced.  COX-1 activity is constitutive and is present in nearly all cell types at a constant 
level, whereas COX-2 activity is normally absent from cells, and when induced, the protein 
  
 
 
 
 
 
 
 
28 
level can increase or decrease in a matter of hours after a single stimulus (Vane, Bakhle, 
and Botting, 1998). 
  It is now known that under basal conditions the constitutive enzyme COX-1 is 
expressed in nearly all tissues including the kidney, colon, stomach, liver, spleen, heart, 
lung, and brain (Vane et al., 1998; Dannhardt and Kiefer, 2001).  In contrast, COX-2 
expression is largely undetectable unless it is induced by inflammatory stimuli in cells such 
as macrophages, endothelial cells, and synoviocytes.  Such stimuli are proinflammatory 
cytokines (IL-1α/β, IL-2, IFN-γ, and TNF-α), endotoxin, mitogens, oncogenes (phorbolic 
ester), growth factors (fibroblast growth factor, FGF; platelet derived growth factor, PDGF; 
epidermal growth factor, EGF), hormones (luteinizing hormone, LH) and disorders of 
water-electrolyte homeostasis.  The anti-inflammatory cytokines, IL-4, IL-10, and IL-13, 
and glucocorticoids can decrease induction of COX-2 (Dannhardt and Kiefer, 2001; Wang 
and Dubois, 2010).  In addition, COX-2 expression is regulated at both transcriptional and 
post-transcriptional levels.  It is well established that the COX-2 transcription can be 
regulated by various transcription factors such as NF-ҡB, C/EBP, CREB, NFAT, AP-1, and 
PPAR (Wang and Dubois, 2010). 
  Induction of COX-2 by several stimuli associated with cell activation and 
inflammation assured the relationship of this particular isoform to inflammatory disease in 
general.  Apart from its involvement in inflammatory process, COX-2 seems to play a role 
in angiogenesis, colon cancer, and Alzheimer‟s disease, based on the fact that it is 
expressed during these diseases.  The discovery of the COX-2 has made possible the design 
of new drugs that can reduce inflammation without removing the protective PGs in the 
stomach and kidney made by COX-1 (Vane et al., 1998).  Therfore, the selective COX-2 
inhibitors have offered a new perspective for anti-inflammatory treatment. 
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 2.4.5 LPS and toll-like receptor 
  LPS is a principal outer membrane component of Gram-negative bacteria, 
which potently activates the innate immune system.  The known components of LPS 
recognition complex in macrophages is summarized in Figure 2.12.   
 
 
Figure 2.12 Schematic illustration of the LPS receptor complex on macrophages.  LPS is 
recognized by a complex of three proteins: CD14, TLR4, and MD-2.  A serum LBP 
transfers LPS to CD14.  CD14 concentrates LPS and presents it to TLR4-MD-2.  MD-2 
plays a role in LPS recognition and regulates the cellular distribution of TLR4.  TLR4 is a 
transmembrane protein characterized by an extracellular domain containing multiple LRR, 
a transmembrane domain, and an intracellular TIR domain.  TLR4 also plays a role in LPS 
recognition and functions as the signal-transducing receptor for LPS.  Three adaptor 
proteins including MyD88, TIRAP (also known as Mal), and TRIF (also known as 
TICAM-1) are responsible for the TLR4-mediated signaling (Fujihara et al., 2003). 
 
  CD14 serves as a ligand-binding component of the LPS sensing complex, 
having a role in concentration and presentation of LPS to the downstream 
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recognition/signaling components.  It is Toll-like receptor 4 (TLR4) that works downstream 
of CD14 and is responsible for delivering an LPS signal.  Although TLR4 is indispensable 
for LPS signaling, MD-2 is required for recognition of LPS that involves physical 
association of MD-2 with TLR4.  Therefore, in macrophages and dendritic cells, TLR4-
MD-2 and CD-14 are important for LPS recognition (Miyake, 2003). 
 2.4.6 Role of cytokines in inflammation 
  Inflammation is mediated by many and a variety of soluble factors including   
a group of secreted polypeptides known as cytokines.  They are major determinants leading 
to cellular infiltrate, the state of cellular activation, and the systemic responses to 
inflammation.  Cytokines are multifunctional and pleiotropic molecules that elicit their 
effects locally or systemically in an autocrine or paracrine manner.  They are associated in 
extensive networks that involve synergistic as well as antagonistic interactions.  In addition, 
these cytokines exhibit both negative and positive regulatory effects on various target cells.  
Cytokines can be divided into two major groups that mediate acute and chronic 
inflammation (Faghali and Wright, 1997).  Figure 2.13 shows the types of multiple 
cytokines that play key roles in mediating acute and chronic inflammatory reactions. 
 
Figure 2.13 Cytokines involved in acute and chronic inflammatory responses (Faghali and 
Wright, 1997). 
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  2.4.6.1 Tumor necrosis factor alpha 
   Tumor necrosis factor (TNF, also known as TNF-α) was identified in 
1975.  TNF has since been implicated in common biological properties, and in a diverse 
range of inflammatory infectious and malignant conditions.  The importance of TNF in 
inflammation has been highlighted by the efficacy of anti-TNF antibodies or administration 
of soluble TNF receptor (TNFRs) in controlling disease activity in rheumatoid arthritis and 
other inflammatory conditions.  TNF is one of the products which is produced 
predominantly by activated monocyte/macrophage.  Although these cells are the main 
source of TNF in inflammatory disease, a wide range of cells types can produce TNF, 
including mast cells, T and B lymphocytes, natural killer (NK) cells, neutrophils, 
endothelial cells, smooth and cardiac muscle cells, fibroblasts, and osteoclasts (Bradley, 
2008). 
   Regulation of the transcription factor NF-ҡB is a key component of 
TNF signal transduction.  All known responses to TNF are triggered by binding to one of 
two distinct receptors as shown in Figure 2.14.  Designated TNFR1 (also known as 
TNFRSF1A, CD120a, p55) and TNFR2 (also known as TNFRSF1B, CD120b, p75) are 
differentially regulated on various cell types in normal and diseased tissue.  Both the 
proinflammatory and the programmed cell death pathways activated by TNF, and 
associated with tissue injury, are largely mediated through TNFR1.  In addition to 
mediating cell survival and proinflammatory signals through NF-ҡB and AP-1, TNFR1 can 
also initiate cell death signaling pathways.  Moreover, both TRAF1 and TRAF2 can 
contribute to NF-ҡB activation, through binding of the IKK complex and through 
recruitment of inhibitor of cellular apoptosis associated proteins.  However, the utilization 
of different signaling mechanisms by TNFR1 and TNFR2 is consistent with the ability of 
each receptor to signal distinct biological responses in cultured cells (Bradley, 2008). 
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Figure 2.14 Signaling pathways leading to the main cellular responses of TNF.  Soluble 
TNF receptors or monoclonal anti-TNF antibodies, which prevent TNF interacting with its 
receptors to activate the pathways, can be used to treat inﬂammatory disease (Bradley, 
2008). 
 
   In response to TNF, endothelial cells promote inflammation by 
displaying in distinct temporal, spatial, and anatomical patterns including different 
combinations of adhesion molecules (Bradley, 2008).  Many of the classical features of 
inflammation can be produced by local effects of TNF on endothelial cells.  In addition, 
TNF can induce the expression of COX-2 leading to vasodilation, thus causing „rubor‟ and 
 
 
Soluble TNF receptors bind to 
TNF preventing interaction with 
cellular TNF receptors 
Membrane bound TNF may 
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„color‟ through increased local blood flow (Mark, Trickler, and Miller, 2001).  TNF-α 
exhibits several proinflammatory properties and can share these properties with IL-1.    
TNF-α and IL-1 can induce fever directly via stimulation of PGE2 production by 
hypothalamic vascular endothelium.  For indirect effects, TNF-α and IL-1 induce release of 
IL-1 (Faghali and Wright, 1997).  Furthermore, TNF-α shares similar inflammatory activity 
with IL-6 and IL-1.  Both TNF-α and IL-6 proinflammatory cytokines exhibit secondary 
inflammatory effects by stimulating IL-6 synthesis in many cell types (Warren, 1990). 
  2.4.6.2 Interleukin-6 
   IL-6 has many synonyms with some of its biological activities such 
as interferon-β2 (IFN-β2), hybridoma/plasmacytoma growth factor, hepatocyte-stimulating 
factor, B cell stimulatory factor (BSF-2), and B cell differentiation factor (BCDF) (Van 
Snick, 1990).  IL-6, a cytokine featuring redundancy and pleiotropic activity, contributes to 
host defense against acute environmental stress.  In addition, dysregulated persistent IL-6 
production has been demonstrated to play a pathological role in various autoimmune and 
chronic inflammatory diseases.  The proinflammatory cytokine, IL-6 is produced by a 
variety of cell types, including mononuclear phagocytes, T cells, and fibroblasts (Hirano et 
al., 1990; Van Snick, 1990; Hirano, 1992a).  In the early phase of infectious inflammation, 
IL-6 is produced by monocytes/macrophages immediately after the stimulation of toll-like 
receptors (TLRs) with distinct pathogen-associated molecular patterns (PAMPs).  This 
acute IL-6 expression plays a central role in host defense by stimulating various cell 
populations.  When acting on hepatocytes, IL-6 strongly induces a broad spectrum of acute-
phase proteins such as C-reactive protein (CRP), serum amyloid A (SAA), fibrinogen, 
hepcidin, haptoglobin, and antichymotrypsin, whereas it reduces albumin, cytochrome 
P450, fibronectin, and transferrin (Figure 2.15).  CRP is the best biomarker of inflammation 
and its expression mainly depends on IL-6.  IL-6 combined with TGF-β preferentially 
induces the differentiation of naïve CD4 positive T cells into Th17 cells, whereas IL-6 
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inhibits TGF-β induced regulatory T cell (Treg) development.  Consequently, Th17/Treg 
imbalance may cause the onset and progression of autoimmune and chronic inflammatory 
diseases.  In bone marrow, IL-6 induces maturation of megakaryocytes into platelets and 
activation of hematopoietic stem cells.  IL-6 also promotes the differentiation of osteoclasts 
and angiogenesis, the proliferation of keratinocytes and mesangial cells, and the growth of 
myeloma and plasmacytoma cells (Tanaka and Kishimoto, 2012). 
 
 
 
Figure 2.15 IL-6 has a pleiotropic effect but its dysregulated persistent production causes 
the onset and development of various autoimmune and chronic inflammatory diseases 
(Tanaka and Kishimoto, 2012). 
 
   IL-6 acts as a growth factor for mature B cells and induces their final 
maturation into antibody-producing plasma cells.  IL-6 is also involved in T cell activation 
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and differentiation, and participates in the induction of IL-2 and IL-2 receptor expression.  
Some regulatory effects of IL-6 involve inhibition of TNF production and provide negative 
feedback for limiting the acute inflammatory response (Feghali, Bost, Boulware, and Levy, 
1992).  An increase in IL-6 production has been observed in a variety of chronic 
inflammatory and autoimmune disorders such as type I diabetes, thyroiditis, RA (Tan, 
Farmiloe, Yeoman, and Watson, 1990; Hirano, 1992b), systemic sclerosis (Feghali et al., 
1992), mesangial proliferative glomerulonephritis and psoriasis, and neoplasms (Hirano, 
1992b). 
 2.4.7 Major transcription factors involved in cytokine gene expression 
  NF-ҡB, C/EBP, and AP-1 are a major family of transcription factors which 
participate in the basal and induced expression of proinflammatory cytokines, especially 
acute phase cytokines. 
  2.4.7.1 C/EBPs transcription factor 
   CCAAT/enhancer-binding proteins (C/EBPs) are a family of leucine 
zipper transcription factors involved in regulation of various aspects of normal cellular 
differentiation and function in multiple tissues.  In addition, C/EBPs act as pivotal 
regulators of response to inflammatory insults (Lekstrom-Himes and Xanthopoulos, 1998).  
Six different members of the family C/EBP, basic leucine zipper (bZIP) transcription 
factors, includes C/EBPα, -β, -γ, -δ, -ε, and –δ, which share related sequences and functions 
(Figure 2.16A).  Except for CEBP δ which lacks a canonical basic region, each protein 
contains similar basic region and leucine zipper sequences at its C-terminus, which mediate 
DNA binding and dimerization, respectively.  In addition, Figure 2.16B showed C/EBP 
bind to palindromic DNA sites as homo-or heterodimers.  The N-terminal portion of each 
protein contains effector domains that mediate transcriptional activation, repression, and 
autoregulatory functions (Johnson, 2005). 
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Figure 2.16 (A) Domain organization of C/EBP-family members.  Each C/EBP protein 
contains a functionally related leucine zipper dimerization domain (LZ) at its C-terminus.  
All family members, with the exception of C/EBPδ, share an adjacent highly conserved 
basic region (BR) that mediates sequence-specific DNA binding.  C/EBPα, C/EBPβ, 
C/EBPδ and C/EBPϵ each contain transactivation domains (TADs) and a regulatory domain 
(RD) located in their N-terminal regions.  A tripartite TAD at the N-terminus displays 
homology among several of the family members.  (B) The predicted structure of a C/EBP 
bZIP dimer bound to its cognate DNA site (Johnson, 2005). 
 
   Many target genes in a variety of tissues have been reported for 
C/EBP proteins.  In liver parenchymal cells, C/EBP proteins have been exhibited to form 
constitutive and inducible complexes on IL-6- and IL-1-responsive elements of acute phase 
protein genes.  Among C/EBP isoforms, C/EBPα and -β may be responsible for constitutive 
transcription of these genes.  C/EBPβ and –δ isoforms appear to predominate in the IL-6-
induced expression of such proteins as complement component 3 (C3) or mouse serum 
amyloid A3 in response to inflammation (Koj, 1996).  Furthermore, both C/EBPβ and –δ 
are strongly up-regulated at the transcription level by inflammatory stimuli such as LPS and 
A B 
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turpentine oil, and by recombinant cytokines such as IL-6, IL-1, and TNF-α (Poli, 1998).  
Both C/EBPβ and –δ isoforms participate in the induced expression of TNF-α, IL-6, IL-1β, 
IL-8, and other cytokines.  Interestingly, C/EBPβ and especially C/EBPδ are highly 
inducible or activated via several signaling pathways in multiple tissues including 
monocytes/macrophages during the acute phase response elicited by LPS (Koj, 1996).  
Constitutive expression of C/EBPβ was found in liver, intestine, lung, and adipose.  
Moreover, it is also detectable in kidney, heart, and spleen of mice.  Stimulation with LPS 
strongly induces C/EBPβ expression, suggesting a role in the mediation of the inflammatory 
response.  Constitutive expression of C/EBPδ is detected in intestines, adipose, and lung, 
with high levels of expression in all tissues following LPS stimulation (Lekstrom-Himes 
and Xanthopoulos, 1998). 
  2.4.7.2 AP-1 transcription factor 
   Activator protein 1 (AP-1) transcription factor complex which has     
a function in cell proliferation, differentiation, and cell transformation during development 
and in adult tissues, is also a key player in regulating inflammatory processes.  AP-1 is 
composed of homodimeric and heterodimeric complexes consisting of members of the Jun, 
Fos, or activating transcription factor (ATF) that bind to a common DNA site, the AP-1 
binding site (Karin, Liu, and Zandi, 1997; Schonthaler, Guinea-Viniegra, and Wangner, 
2011) (Figure 2.17).  It can be activated by bacterial endotoxin (LPS), growth factors, 
cytokines, chemokines, hormones, and multiple environmental stresses (Pocock et al., 2003; 
Schonthaler et al., 2011).  The leucine zipper is also a prominent feature of AP-1 
transcription factor like C/EBP, which was first identified in the human metallothionein 
gene.  AP-1 protein consists of either Jun homodimers or Fos/Jun heterodimeric complexes, 
which binds to palindromic sequence TRE (phorbol ester - TPA-responsive element) 
TGA(C/G)TCA.  TRE sequences are presented in numerous mammalian promoters, 
including genes that code for cellular growth factors, cytokines, and acute phase protein 
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(Koj, 1996).  AP-1 is usually composed of c-jun/c-fos subunits.  After stress-induced 
phosphorylation, AP-1 enters the nucleus and binds to a specific sequence in the promoter 
of numerous target genes (Karin et al., 1997).  The regulation of AP-1 complexes can occur 
at several levels, including transcription, mRNA translation, protein stability, or by 
interactions with other transcription factors (Schonthaler et al., 2011).  Two almost identical 
AP-1 sequences have been identified in the human and mouse promoters of IL-6 gene.    
AP-1 and NF-ҡB transcription factors differ in their structure and bind to distinct enhancer 
motifs.  AP-1, the heterodimer of c-Fos and c-Jun, are capable of physically reacting with 
NF-ҡB p65 subunit and the resulting heterodimer exhibits functional synergy (Koj, 1996).  
Current research has shown that AP-1 factors possess important roles in inflammatory state 
as well as in inflammatory diseases (e.g., psoriasis, fibrosis) (Schonthaler et al., 2011). 
 
 
 
 
 
 
Figure 2.17 AP-1/DNA complex.  Crystallographic structure of the AP-1 heterodimer is 
comprised of c-FOS (cyan) and c-Jun (green) complexed with DNA (Wikipedia, www, 
2013). 
 
  2.4.7.3 NF-ҡB transcription factor 
   Nuclear factor kappaB (NF-ҡB) is a ubiquitous and well-
characterized protein involved in physiological and pathological conditions, with a pivotal 
role in controlling cell signaling in the intact organism.  NF-ҡB controls the expression of 
encoding adhesion molecules (e.g., ICAM, VCAM, E-selectin), chemokines (e.g., IL-8, 
AP-1 binding site  
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MIP-1α, MCP1, RANTES, eotaxin, etc.), proinflammatory cytokines (e.g., IL-1, IL-2, IL-6, 
TNF-α, etc.), inducible enzymes (COX-2 and iNOS), growth factors, some of the acute 
phase proteins, and immune receptors, and all of which play a critical role in controlling 
inflammatory processes (Calixto et al., 2003).  The NF-ҡB family of transcription factors is 
composed of homo- and heterodimers of Rel proteins; NF-ҡB1 (p50), NF-ҡB2 (p52), RelA 
(p65), RelB, and c-Rel (Rel) (Hayden and Ghosh, 2012).  The most prevalent activated 
form of NF-ҡB is p50/p65 heterodimer.  In unstimulated cells, NF-ҡB is present in the 
cytoplasm as a heterodimer consisting of p50, p65, and IҡBα subunits.  In response to an 
activation signal with inflammatory agents such as LPS, IҡBα is degraded, leading to 
nuclear translocation and binding to a specific sequence in the promoter of numerous target 
genes (Calixto et al., 2003) (Figure 2.18).  The highest DNA binding affinity is exhibited by 
heterodimer recognizing sequent motif GGGACTTTCC; however, numerous variations 
exist (Koj, 1996).  Since NF-ҡB plays a central role in various inflammatory diseases, much 
research has been focused on the identification of compounds that selectively interfere with 
this pathway.  Currently, a great number of plant-derived substances has been evaluated as 
possible inhibitors of the NF-ҡB pathway (Calixto et al., 2003). 
   Regulatory promoter regions with NF-ҡB bindings are common in 
genes primarily involved in inflammation, immune reactions, and the acute phase response 
to external stimuli.  Activation of cytokine gene expression by NF-ҡB is probably the most 
important pathway, but additional factors are also required for the maximum response.  
Interaction of C/EBPα, C/EBPβ, NF-ҡB1 (p50), and NF-ҡB RelA (p65) was required for 
full IL-6 induction by LPS in differentiating bovine monocytes (Koj, 1996). 
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Figure 2.18 Mechanism of NF-ҡB activation.  In unstimulated cells, NF-ҡB is present in 
the cytoplasm as an inactive heterodimer composed of two sub-units, p50 and p65 (RelA).  
The heterodimer is complexed with an inhibitory protein IҡBα, preventing it from moving 
into the nucleus.  Through the intermediacy of integral membrane receptors, a variety of 
extracellular signals can activate the enzyme IҡB kinase (IKK).  IKK, inturn, 
phosphorylates the IҡBα protein, which results in ubiquitination, dissociation of IҡBα from 
NF-ҡB.  Phoshorylated IҡBα is then rapidly degraded by the proteasome, leading to the 
translocation of NF-ҡB to the nucleus, binding to its specific responsive element of DNA.  
The DNA/NF-ҡB complex then recruits other proteins such as coactivators and RNA 
polymerase, which transcribe downstream DNA into mRNA, which, inturn, is translated 
into protein, resulting in alteration of cellular functions (Prajapati, singhal, Yashwant, and 
Gupta, 2010). 
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CHAPTER III 
PHYTOCHEMICAL AND ANTIOXIDANT PROPERTIES 
OF EXTRACTS FROM PSEUDERANTHEMUM 
PALATIFERUM LEAVES 
 
3.1 Abstract 
 Beneficial antioxidant phytochemicals are found in many medicinal plants including 
the extracts from leaves of Pseuderanthemum palatiferum (PP).  However, reports on the 
phytochemical constituents and antioxidant activities of these extracts are still very limited.  
Therefore, the present study aimed to evaluate and compare phytochemical contents and 
antioxidant activities of [1] 95% ethanol extract of fresh leaves of PP (95EE-FLP), [2] 80% 
ethanol extract of fresh leaves of PP (80EE-FLP), [3] 80% ethanol extract of dried leaves of 
PP (80EE-DLP), [4] water extract of fresh leaves of PP (WE-FLP), or [5] water extract of 
dried leaves of PP (WE-DLP).  All extracts from PP were evaluated for total phenolic 
content (TPC) by Folin-Ciocalteu method, total flavonoid content (TFC) by aluminium 
trichloride colorimetric assay, free radical scavenging capacity by DPPH assay, and 
reducing capability by ferric reducing-antioxidant power (FRAP) method.  The present 
study showed that WE-FLP had significantly higher levels of TPC and TFC than 95EE-FLP 
and 80EE-FLP, followed by WE-DLP, and 80EE-DLP, respectively, at p<0.001.  The 
highest scavenging activity against DPPH radicals was found in WE-FLP, followed by 
95EE-ELP, 80EE-FLP, WE-DLP, and 80EE-DLP, respectively, at p<0.01.  The highest 
FRAP value was found in 95EE-FLP and 80EE-FLP, followed by WE-FLP, WE-DLP, and 
80EE-DLP, respectively, at p<0.001.  As a consequence, high levels of TPC and TFC, and 
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antioxidant activities were observed in extracts of fresh leaves of PP, whereas low levels of 
them were found in extracts of dried leaves of PP.  This study also indicated that there were 
no significant difference in the levels of phenolic and flavonoid as well as ferric reducing 
antioxidant ability between 95EE-FLP and 80EE-FLP.  Therefore, both 95EE-FLP and  
WE-FLP were employed to evaluate anti-oxidative stress in RAW264.7 cells using a 
fluorogenic dye marker, DCFH-DA.  The result showed that both 95EE-FLP and WE-FLP 
suppressed reactive oxygen species (ROSs) generation in RAW264.7 cells.  This study also 
indicated that 95EE-FLP more potently suppressed ROSs generation from RAW264.7 cells 
than did WE-FLP.  Collectively, the present study suggested that all extracts of PP had 
levels of TPC and TFC, and possess antioxidant properties in an in vitro assay, and both 
95EE-FLP and WE-FLP also displayed strong antioxidant properties when analyzed using a 
cell-based assay.  Therefore, increased medicinal plant consumption is an effective strategy 
to increase antioxidant intake and decrease oxidative stress, and may lead to reduced risk of 
many chronic diseases. 
 
3.2 Introduction 
 The balance between oxidants and antioxidants in humans is important for sustaining 
optimal physiological conditions.  Reactive oxygen species (ROSs) are continuously 
produced in the human body, being essential for energy supply, detoxiﬁcation, chemical 
signaling, and immune function (Dimitrios, 2006).  However, during oxidative stress, large 
amounts of ROSs can adversely alter lipids, proteins, and DNA, resulting in significant 
damage to cell structure and function (Devasagayam et al., 2004).  These types of damage 
have been implicated in increased risks of cancer, atherosclerosis, rheumatoid arthritis, and 
neurodegenerative diseases including inflammation (Fang, Seki, and Maeda, 2009).  
Although, the body can produce endogenous superoxide dismutase (SOD), glutathione 
peroxidase (GPx), and catalase that help prevent the damaging effects of ROSs, these 
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endogenous systems are often insufficient for fully scavenging ROSs (Dimitrios, 2006).  
Thus, finding exogenous sources of antioxidants is an important reason for discovery and 
synthesis of novel antioxidant compounds.  Potential sources of natural antioxidants have 
been found in fresh fruits and vegetables, leaves, oilseeds, grains, bark and roots, spices, 
and herbs (Ramarathnam, Ochi, and Takeuchi, 1997).  Natural antioxidants like flavonoids 
and other phenolics are free radical scavengers, and exhibit many biological activities 
(Rice-Evans, Miller, and Paganga, 1996).  The antioxidant activity of phenolics is mainly 
due to their redox properties, which allow them to act as reducing agents, hydrogen donors, 
singlet oxygen quenchers, and metal chelators (Rice-Evans, Miller, and Paganga, 1997; Parr 
and Bolwell, 2000). 
 Pseuderanthemum palatiferum (PP) is one of the most popular medicinal plants in 
both Thailand and Vietnam.  It is referred to as a miracle plant in folk medicine because it 
anecdotally cures or prevents various conditions such as wounds, trauma, stomachache, 
colitis, hypertension, nephritis, diarrhea, diabetes, and cancer (Dieu, Loc, Yamasaki, and 
Hirata, 2005; Padee, Nualkaew, Talubmook, and Sakuljaitrong, 2010).  Oxidative stress can 
contribute to the pathology of these diseases.  However, reports on the phytochemical 
constituents and antioxidant activity of extracts of PP leaves are still very limited.  
Therefore, the present study aimed to investigate and compare the phytochemical contents 
and the antioxidant activities of extracts of PP leaves. 
 
3.3 Materials and methods 
 3.3.1 Chemicals and reagents 
  (+)- Catechin hydrate and vitamin C were purchased from Fluka Chemine 
GmbH (Buchs, Switzerland).  2,2-Diphenyl-1-picryl-hydrazyl (DPPH), penicillin G, 
streptomycin sulfate, resveratrol, 2’,7’-dichlorofluorescin-diacetate (DCFH-DA), and tert-
butyl hydroperoxide (tBuOOH), were ordered from Sigma-Aldrich (St. Louis, MO).  RPMI 
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medium 1640 and Hank’s balanced salt solution (HBSS) were obtained from Gibco 
Invitrogen (Grand Island, NY).  Fetal bovine serum (FBS) was obtained from Hyclone 
(Logan, Utah).  Quercetin dihydrate was obtained from INDOFINE Chemical Company, 
Inc. (Hillsborough, NJ).  Finally, 6-Hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic 
acid (trolox) was purchased from Sigma-Aldrich Chemine Gmbh (Steinheim, Germany). 
 3.3.2 Cell lines 
  The mouse macrophage RAW264.7 cell line (CLS, Cell Lines Service, 
Eppelheim, Germany) was used to investigate effects of extracts of PP leaves on 
suppression of ROS generation in cells. 
  3.3.2.1 Maintenances of RAW264.7 cells 
   Cells were cultured at 37 °C, 5% CO2 in RPMI-1640 medium 
supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/mL penicillin, 
100 µg/mL streptomycin, and 15 mM HEPES.  Exponentially growing cells were used for 
the experiments when they reached approximately 80% confluence. 
 3.3.3 Plant materials 
  Fresh leaves of PP were purchased from producers in Yasothon province, 
Thailand (Figure 3.1).  The plant was identified and authenticated by Dr. Kongkanda 
Chayamarit, the Forest Herbarium, Royal Forest Department, Bangkok, Thailand.  A voucher 
specimen (BKF 174009) was deposited at the Forest Herbarium, Royal Forest Department, 
Bangkok, Thailand. 
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Figure 3.1 Pseuderanthenum palatiferum (PP) in Yasothon province, Thailand. 
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 3.3.4 Plant extract preparation 
  Extracts of PP leaves were prepared by two different methods.  In the first 
method, fresh leaves of PP were extracted by blending.  In the second method, air-dried leaf 
powder of PP was extracted by maceration. 
  Concerning the first method, fresh leaves (1.5 and 2.1 kg) were cut into small 
pieces and blended in 6 L 95% and 8.4 L 80% ethanol (100 g : 400 mL), respectively 
(Figure 3.2).  This suspension was then filtered through several layers of gauze.  The pooled 
extracts were centrifuged at 3,500 x g for 10 min at 4 °C and the supernatant was filtered 
through Whatman No. 1 filter paper (Whatman International Ltd., Maidstone, England).  
Next, the ethanolic filtrate was concentrated using a vacuum rotary evaporator (Buchi 
Labortechnik AG, Flawil, Switzerland) and dried by lyophilization (Freeze-Zone 12 plus, 
Labconco Corporation, Missouri) (Figure 3.3) to give crude dried extracts of 95% ethanol 
extract of fresh leaves of PP (95EE-FLP) and 80% ethanol extract of fresh leaves of PP 
(80EE-FLP), respectively.  Forty grams of 95EE-FLP was further partitioned between 
hexane and water (1:1, v/v) using a separatory funnel (Figure 3.4).  The water fraction was 
collected, centrifuged at 14,000 x g for 10 min at 4 °C, evaporated and lyophilized to obtain 
water extract of fresh leaves of PP (WE-FLP). 
 
 
 
 
 
 
 
 
Figure 3.2 Fresh leaves of PP were blended in ethanol. 
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Figure 3.3 The extract was concentrated using a vacuum rotary evaporator and dried using 
a lyophilizer. 
 
 
Figure 3.4 Crude dried extract was partitioned between hexane and water (1:1, v/v) using a 
separatory funnel. 
 
  For another method, air-dried leaves were ground into powder with an electric 
grinder (Figure 3.5).  Powder air-dried leaves (420 g and 300 g) were then extracted with 
12.6 L 95% and 9 L 80% ethanol, respectively (60 g : 1.8 L) by maceration for 72 h at room 
temperature (RT), with the used solvent being replaced with fresh solvent after every 24 h.  
The pooled extracts were centrifuged at 3,500 x g for 10 min at 4 °C, and the supernatant 
was filtered through Whatman No. 1 filter paper.  Then, the ethanolic filtrate was 
concentrated using a vacuum rotary evaporator and dried by lyophilization to give crude 
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dried extracts of 95% ethanol extract of dried leaves of PP (95EE-DLP) and 80% ethanol 
extract of dried leaves of PP (80EE-DLP), respectively.  Twenty grams of 95EE-DLP was 
further partitioned between hexane and water (1:1, v/v).  The water fraction was later 
collected, centrifuged at 14,000 x g for 10 min at 4 °C, evaporated and lyophilized to obtain 
water extract of dried leaves of PP (WE-DLP).  The summary of all extracts of PP leaves is 
shown in Figure 3.6. 
 
 
 
 
 
 
 
 
 
Figure 3.5 Air-dried leaves and their ground powder prepared from PP. 
   
  All crude dried extracts were stored at -20 °C until use.  When used in 
experiments, the ethanol and water crude dried extracts were dissolved in dimethyl 
sulfoxide (DMSO) and water, respectively.  For cell culture, WE-FLP was dissolved in 
phosphate buffered saline (PBS).  95EE-FLP was dissolved in DMSO and then diluted to 
0.25% (v/v) DMSO in cell culture medium when preparing the designated concentrations. 
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Figure 3.6 The flow chart of the process of PP leaf extracts. 
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 3.3.5 Determination of phytochemical compounds 
  3.3.5.1 Total phenolic content (TPC) 
   The total phenolic content of individual extract was determined by 
the method of Folin-Ciocalteu (Mariod, Matthäus, Eichner, and Hussein, 2006).  This 
method is based on the reduction of phosphotungstic acid in alkaline solution to 
phosphotungstic blue.  The absorbance of formed phosphotungstig blue is proportional to 
the number of aromatic phenolic groups (Singleton, Orthofer, and Lamuela-Raventos, 
1999).  Briefly, 100 µL of test solutions were added to 2.0 mL of 2% Na2CO3 and mixed 
thoroughly.  After 2 min, 100 µL of 50% Folin-Ciocalteu reagent were added, mixed, and 
allowed to stand at RT for 30 min.  The absorbance of extracts was measured at 750 nm by 
a Cecil 1000 series spectrophotometer (Cecil Instruments, Cambridge, UK) against a blank 
consisting of all reagents and solvents without the extract.  A gallic acid solution ranging 
from 0.05-0.3 mg/mL was used to prepare a standard curve.  The concentration of phenolic 
compounds in the extracts was expressed as milligrams of gallic acid equivalent (GAE) per 
gram of dry extract. 
  3.3.5.2 Total flavonoid content (TFC) 
   The total flavonoid content was determined using the aluminium 
trichloride colorimetric assay (Liu et al., 2002).  The reaction is based on aluminium 
trichloride forming acid stable complexes with the C-4 keto group and either the C-3 or C-5 
hydroxyl group of flavones and flavonols.  Moreover, it also forms acid labile complexes 
with the ortho-dihydroxyl groups in the A or B ring of flavonoids (Kiranmai, Kumar, and 
Ibrahim, 2011).  Briefly, 250 µL of samples were diluted with 1.25 mL of distilled water  
(DI water).  Then 75 µL of 5% NaNO2 solution were added to the mixture.  After 6 min, 
150 µL of a 10% AlCl3∙6H2O solution were added and the mixture was allowed to stand for 
another 5 min.  One half mL of 1 M NaOH were added, and the total was brought up to    
2.5 mL with DI water.  The solution was thoroughly mixed, and the absorbance was 
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measured immediately against the prepared blank at 510 nm using a spectrophotometer.     
A catechin standard solution (0.05-0.4 mg/mL) was used to prepare a standard curve.  The 
concentration of flavonoids in the extracts was expressed as milligrams of catechin 
equivalent (CE) per gram of dry extract. 
 3.3.6 Determination of antioxidant properties 
  3.3.6.1 DPPH assay 
   One of the most frequently used techniques for antiradical capacity 
measurements is DPPH free radical scavenging assay.  DPPH assay is based on the 
reduction of DPPH radicals in methanol which causes an absorbance drop at 515 nm.  
When the stable proton free radical DPPH encounters proton radical scavengers, its purple 
color fades rapidly (Figure 3.7) (Ndhlala, Moyo, and Staden, 2010).   
 
 
 
Figure 3.7 The mechanism of DPPH radical interact with antioxidant compound.              
R= antioxidant compound, DPPH= 2,2-diphenyl-1-picrylhydrazyl (Wikipedia, www, 2012). 
 
   This
·
 method was determined as described by Sánchez-Moreno, 
Larrauri, and Saura-Calixto (1999).  Briefly, 100 µL of the extracts at different 
concentrations were added to 3.9 mL of DPPH methanolic solution
·
 (63 mM).  The mixture 
was shaken vigorously and left to stand at RT for 45 min in the dark.  The mixture was 
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measured spectrophotometrically at 515 nm.  The free radical scavenging activity was 
calculated as shown below.  The IC50 of DPPH
˙ 
was determined from a dose response curve 
using linear regression analysis.  Decreasing DPPH solution absorption indicates an 
increase of DPPH radical scavenging activity. 
 
DPPH radical scavenging activity (%) = 
Acontrol Asample
Acontrol
  100 
 
Where Asample = absorbance of different concentrations of sample extracts 
   Acontrol  = The absorbance of control 
 
  3.3.6.2 FRAP assay 
   The ferric reducing ability of the extracts was measured 
colorimetrically according to the method developed by Benzie and Strain (1996).  The 
principle of this method is based on the reduction of a ferric-tripyridyl triazine complex to 
its ferrous colored form in the present of antioxidants.  Briefly, the FRAP reagent included 
0.1 M acetate buffer (pH 3.6), 10 mM 2,4,6-Tris(2-pyridyl)-1,3,5-triazine (TPTZ) solution 
in 40 mM HCl, and 20 mM FeCl3·6H2O solution.  The fresh working solution was prepared 
by mixing acetate buffer, TPTZ solution, and FeCl3·6H2O solution (10:1:1, v/v/v).  The 
FRAP reagent (3 mL) was added to 0.1 mL of the extract and mixed.  Readings were 
recorded on the spectrophotometer at 593 nm, and the reaction was monitored for 10 min.  
A vitamin C standard solution (10-90 µg/mL) was used to perform the calibration curve.  
The ferric reducing ability of the extracts was expressed as milligrams of vitamin C 
equivalent antioxidant capacity (VCEAC) per gram of dry extract. 
  3.3.6.3 Cellular antioxidant activity (CAA) 
   Though currently, there are many in vitro chemistry models for 
antioxidant evaluation; however, most of these assays have certain limitations.  ABTS and 
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FRAP assays are not conducted under physiological condition, DPPH radical does not exist 
in human body (Pérez-Jiménez et al., 2008; Alamed, Chaiyasit, McClements, and Decker, 
2009).  For these reasons, the results from in vitro chemical antioxidant assays might not 
necessarily correlate with biological responses.  Therefore, antioxidant activity of a 
compound should also be tested in a cellular system for a step closer to in vivo result.  The 
popular cell-based model use 2’,7’-dichlorofluorescin-diacetate (DCFH-DA) as the probe to 
reflex ROSs and oxidative stress in cells.  When the nonfluorescent DCFH-DA is uptaken 
into cells, its diacetate moiety will be hydrolyzed by cellular esterases to generate the more 
polar DCFH which is trapped inside the cells.  In the presence of ROSs, intracellular DCFH 
is oxidized to form the fluorescence DCF product (Wolfe and Liu, 2007) as illustrated in 
Figure 3.8. 
 
 
 
 
 
 
 
 
 
Figure 3.8 The proposed principle of the cellular antioxidant activity (CAA) assay.  Cells 
were pretreated with antioxidant compounds or plant extract (AOx) prior exposed to  
DCFH-DA.  The oxidant initiator (tBuOOH) can generate peroxyl radicals (ROO˙) which 
can oxidize the intracellular DCFH to the fluorescent DCF.  AOx antioxidant prevent 
oxidation of DCFH, of membrane lipids and reduce the formation of DCF (adapted from 
Wolfe and Liu, 2007). 
tBuOOH 
tBuOOH 
Cellular 
esterases 
  
 
 
 
 
 
 
 
63 
   Intracellular oxidative stress was detected using the 2’,7’-
dichlorofluorescin-diacetate as described by Kim, Kwon, and Jang (2011) with slight 
modification.  Briefly, RAW264.7 cells (4x10
4
 cells/well) were plated in a Costa
TM
 96-well 
black clear bottom plate (Corning Inc., Corning, NY) and incubated for 16-18 h at 37 °C 
and 5% CO2.  After incubation, cells were washed with PBS twice.  To assess antioxidant 
activity, cells were pre-exposed to different concentrations of 95EE-FLP or WE-FLP (50, 
150, or 250 μg/mL), or the antioxidant positive controls, catechin (250 μM), resveratrol   
(20 μM), or quercetin (10 μM), for 24 h.  After washing twice with PBS, cells were exposed 
to 20 µM DCFH-DA in HBSS and further incubated in the dark for another 30 min.  The 
DCFH-DA was removed by washing the cells with PBS twice, 500 μM tBuOOH were 
added.  The intensity of the fluorescence signal was detected time-dependently with an 
excitation wavelength of 485 nm and an emission wavelength of 535 nm using a Gemini 
EM fluorescence microplate reader (Molecular Devices, Sunnyvale, CA). 
 3.3.7 Statistical analysis 
  All statistical significances (GraphPad Prism 5, USA) were determined by 
performing a one-way analysis of variance (ANOVA) with a post-hoc Turkey’ s analysis to 
determine differences between treatments.  Values were considered statistically significant 
when p<0.05.  Data were presented as mean ± SEM (n=3).  The data from CAA were 
statistically analyzed by two-way analysis of variance followed by Bonferonni’s post-hoc 
test with p<0.05 as statistical significant.  Data of CAA experiment were presented as mean 
± SEM (n=4). 
 
3.4 Results 
 3.4.1 Percent yield of extracts from PP leaves 
  The percentage yields of crude extracts from fresh and dried leaves of PP are 
shown in Table 3.1.  It shows that the percentage yield of different extracts from PP leaves 
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ranged widely from 3.17 to 84.80%.  In addition, high percentage yield was found in the 
water extracts (WE-FLP and WE-DLP). 
 
Table 3.1 The percentage yields of crude extracts from fresh and dried leaves of PP. 
Extracts Amount and source  
of preparation 
Yield (g) % yield 
95EE-FLP 
80EE-FLP 
80EE-DLP 
WE-FLP 
WE-DLP 
1500 g of fresh leaves 
2100 g of fresh leaves 
300 g of dried leaves 
40 g of 95EE-FLP 
20 g of 95EE-DLP 
60.41 
66.65 
46.99 
32.71 
16.96 
4.03 
3.17 
15.66 
81.77 
84.80 
95EE-FLP, 95% ethanol extract of fresh leaves of PP 
80EE-FLP, 80% ethanol extract of fresh leaves of PP 
80EE-DLP, 80% ethanol extract of dried leaves of PP 
WE-FLP, Water extract of fresh leaves of PP 
WE-DLP, Water extract of dried leaves of PP 
 
 3.4.2 Phytochemical compounds of extracts from PP leaves 
  3.4.2.1 Total phenolic contents (TPC) 
   Various extracts of PP leaves were used to investigate the best 
sources of antioxidant properties.  Initial studies were conducted to investigate and 
determine the total phenolic contents (TPC) of extracts of PP leaves.  The content of total 
phenolic content was expressed as mg gallic acid equivalent per gram of dry extract        
(mg GAE/g dry extract).  TPC of 95EE-FLP, 80EE-FLP, 80EE-DLP, WE-FLP, and       
WE-DLP are shown in Figure 3.9.  WE-FLP had a significantly higher level (p<0.001) of 
TPC (212.47 ± 0.52 mg GAE/g dry extract) than 95EE-FLP (200.14 ± 0.77 mg GAE/g dry 
extract) and 80EE-FLP (201.32 ± 0.72 mg GAE/g dry extract), followed by WE-DLP 
(177.56 ± 0.43 mg GAE/g dry extract), and 80EE-DLP (98.63 ± 0.26 mg GAE/g dry 
extract), respectively.  There was no significant difference in the level of total phenolic 
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content between 95EE-FLP and 80EE-FLP.  This study also demonstrated that WE-FLP 
had the highest total phenolic content, while 80EE-DLP had the lowest value.  These results 
suggested that fresh leaves, rather than dried leaves, provide more extractable phenolic 
compounds. 
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Figure 3.9 Total phenolic contents of extracts of PP leaves.  The contents were expressed as 
mg of GAE/g dry extract.  Values are mean ± SEM (n=3) of representative of three 
independent experiments with similar results.  Bars marked with different letters are 
significantly different at p<0.001. 
 
  3.4.2.2 Total flavonoid content (TFC) 
   The content of flavonoid was expressed as mg catechin equivalent 
per gram of dry extract (mg CE/g dry extract).  Total flavonoid contents of 95EE-FLP,      
80EE-FLP, 80EE-DLP, WE-FLP, and WE-DLP are shown in Figure 3.10.  WE-FLP had a 
significantly higher level (p<0.05) of TFC (133.43 ± 11.27 mg CE/g dry extract) than  
95EE-FLP (100.19 ± 0.68 mg CE/g dry extract) and 80EE-FLP (99.80 ± 1.02 mg CE/g dry 
extract), followed by WE-DLP (68.95 ± 0.42 mg CE/g dry extract), and 80EE-DLP     
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(30.73 ± 0.30 mg CE/g dry extract), respectively.  Both 95EE-FLP and 80EE-FLP did not 
have significantly different level of total flavonoid.  Collectively, high levels of flavonoid 
were found in extracts of fresh leaves of PP (95EE-FLP, 80EE-FLP, and WE-FLP), while 
low levels of flavonoid were found in extracts of dried leaves of PP (80EE-DLP and      
WE-DLP). 
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Figure 3.10 Total flavonoid contents of extracts of PP leaves.  The contents were expressed 
as mg of CE/g dry extract.  Values are mean ± SEM (n=3) of representative of three 
independent experiments with similar results.  Bars marked with different letters are 
significantly different at p<0.05. 
 
 3.4.3 Antioxidant properties of extracts from PP leaves 
  3.4.3.1 DPPH free radical scavenging activity 
   DPPH assay is one of the most extensively used methods to evaluate 
in vitro antioxidant activity.  The free radical scavenging capacity of extracts of PP leaves 
are shown in Figure 3.11.  The result suggested that all extracts exhibited the capability to 
scavenge DPPH free radical.  The highest scavenging activity against DPPH radicals was 
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found in WE-FLP (IC50= 21.55 ± 0.06 µg/mL), followed by 95EE-FLP (IC50= 23.45 ± 0.12 
µg/mL), 80EE-FLP (IC50= 25.35 ± 0.03 µg/mL), WE-DLP (IC50= 31.08 ± 0.52 µg/mL), 
and 80EE-DLP (IC50= 64.38 ± 0.52 µg/mL), respectively, at p<0.01.  This study also 
exhibited that high level of scavenging activities against DPPH radicals was found in 
extracts of fresh leaves of PP, while low level of them were found in extracts of dried leaves 
of PP.  However, the scavenging capacity of all extracts of PP leaves was not as effective as 
that of other positive antioxidant controls.  In the present study, the scavenging ability of 
vitamin C (IC50= 3.94 ± 0.01 μg/mL) and catechin (IC50= 3.55 ± 0.01 μg/mL) was 
comparable, and was significantly higher than trolox (IC50= 5.90 ± 0.27 µg/mL), at 
p<0.001. 
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Figure 3.11 Comparison of DPPH radical scavenging activity of extracts of PP leaves with 
various antioxidants controls.  Values are mean ± SEM (n=3) of representative of three 
independent experiments with similar results.  Bars marked with different letters are 
significantly different at p<0.01. 
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  3.4.3.2 Ferric reducing antioxidant power 
   The reducing power of extracts of PP leaves, expressed as milligram 
vitamin C equivalent antioxidant capacity per gram dry extract (mg VCEAC/g of dry 
extract), are shown in Figure 3.12.  The highest FRAP value was found in 95EE-FLP 
(213.23 ± 1.09 mg VCEAC/g dry extract) and 80EE-FLP (216.73 ± 0.44 mg VCEAC/g 
dry extract), followed by WE-FLP (193.40 ± 2.65 mg VCEAC/g dry extract), WE-DLP 
(168.40 ± 2.63 mg VCEAC/g dry extract), and 80EE-DLP (91.53 ± 0.44 mg VCEAC/g dry 
extract), respectively, at p<0.001.  Degrees of electron donating capacity of 95EE-FLP and 
80EE-FLP were comparable.  This study also showed that high level of FRAP values were 
found in extracts of fresh leaves of PP, while low level of them were found in extracts of 
dried leaves of PP. 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 Total antioxidant (FRAP) activity of extracts of PP leaves.  The activity was 
expressed as mg of VCEAC/g dry extract.  Values are mean ± SEM (n=3) of representative 
of three independent experiments with similar results.  Bars marked with different letters 
are significantly different at p<0.001. 
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  3.4.3.3 Cellular antioxidant activity (CAA) of extracts from PP leaves 
The direct scavenging effect of extracts of PP leaves on intracellular 
free radical stress was investigated in RAW264.7 cells using the DCFH-DA assay.  The 
increment of DCF fluorescence emission following ROSs-mediated oxidation of DCFH was 
following for 240 min.  As shown in Figure 3.13A, standard antioxidants positive controls, 
catechin (250 μM), resveratrol (20 μM), and quercetin (10 μM), could scavenge ROSs 
significantly throughout the incubation time when compared to the vehicle control (VH) 
(p<0.05).  As early as 30 min of incubation, catechin, resveratrol, and quercetin showed a 
considerable radical scavenging activity.  95EE-FLP (Figure 3.13B) and WE-FLP (Figure 
3.13C) decreased the DCF fluorescent emission in a dose-and time-dependent manner.  As 
early as 30 min of incubation, both 95EE-FLP and WE-FLP at lower concentrations          
(50 µg/mL) showed a comparable radical scavenging activity to the antioxidant controls.  
Increasing concentrations of 95EE-FLP significantly decreased the DCF fluorescent 
emission throughout the incubation time when compared to the VH control (p<0.05).  At 
high concentration (150 µg/mL), 95EE-FLP exhibited a strong scavenging activity as 
suggested by the capability to reduce the fluorescent intensity to approximately basal level 
of unstimulated control or naïve (NA).  In addition, the highest concentration of 95EE-FLP 
(250 µg/mL) significantly decreased DCF fluorescent intensity to the level of less than 
basal unstimulated condition at all time points (p<0.05).  Similarly, 150 and 250 µg/mL of     
WE-FLP significantly decreased the DCF fluorescent emission throughout the incubation 
time when compared to tBuOOH control (p<0.05).  At the lowest concentration                
(50 µg/mL), WE-FLP significantly decreased the DCF fluorescent emission at time points 
from 30 to 210 min (p<0.05). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13 Time course of cellular radical scavenging activity in tBuOOH-activated RAW264.7 cells.  Intracellular ROSs level generated in 
cells was measured by the 2’,7’-dichlorofluorescin-diacetate (DCFH-DA).  RAW264.7 cells were pretreated with indicated concentrations of 
antioxidants (A), 95EE-FLP (B) or WE-FLP (C) for 24 h prior allowed to take up 20 µM DCFH-DA for 30 min.  Results are mean ± SEM 
(n=4) of representative of three independent experiments with similar results.  Points marked with different letters are significantly different at 
p<0.05 when compared at the same time point as determined by two-way ANOVA. 
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3.5 Discussion and conclusion 
 It is well known that the major components of plant leaf extracts that act as 
antioxidants are phytochemicals such as phenolic compounds and flavonoids.  Phan, Ha, 
and Phan (2003) found flavonoids in ethyl acetate, chloroform and n-butanol-soluble 
fractions of PP leaves.  Moreover, flavonoids from PP leaves displayed antioxidant activity 
(Phan, Ha, and Phan, 2005).  In addition, Nguyen and Eun (2011) reported that phenolics 
and flavonoids were found in PP leaf extracts when assessed with Folin-Ciocalteu and 
aluminum trichloride.  PP leaf extracts also had antioxidant activities when evaluated with 
DPPH and FRAP assays.  Similarly, the present study also suggested that flavonoids and 
phenolics could exhibit antioxidant activities in all extracts from PP leaves.  Several 
methods have been performed and developed to measure the total antioxidant activity of 
natural medicinal plants in vitro.  The antioxidant capacity of medicinal plant extracts 
cannot be investigated by using only one single method, due to the complex composition of 
phytochemicals and oxidative process (Bӧhm, Schlesier, Harwat, and Bitsch, 2001).  The 
use of at least two methods should be employed in order to evaluate the total antioxidant 
activity.  The secondary metabolites in plants, vitamin C, trolox, catechin, resveratrol, and 
quercetin were used as positive antioxidant controls in the present study as they are the 
most frequently used antioxidant standards for food samples.  DPPH assay is one of the 
most extensively used methods to evaluate antioxidant activity.  The present study revealed 
that DPPH radical scavenging capacity of WE-FLP was greater than that of 95EE-FLP,      
80EE-FLP, WE-DLP, and 80EE-DLP, respectively as shown in Figure 3.11.  In contrast, 
95EE-FLP and 80EE-FLP had higher ferric reducing power than that of WE-FLP,          
WE-DLP, and 80EE-DLP, respectively as shown in Figure 3.12.  These contradictory 
results between DPPH and FRAP assays are not unusual.  Though both assays are based on 
a single electron transfer reaction (Bunea et al., 2011), their characteristics, sensitivities, 
mechanisms of the reaction, and endpoints are totally different.  For instance, DPPH 
71 
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method is based on the free radical scavenging activity while FRAP measures the reduction 
ability of Fe
3+
 to Fe
2+
.  Depending on what specific phytochemical constituents present in 
the extract are providing the antioxidant activity, their discrete chemical structures, 
positions, numbers, and types of substitutions of features can influence their redox 
properties and hence their antioxidant potentials.  The structure antioxidant activity 
relationships of flavonoids have been studied, for example, multiple hydroxyl groups of 
flavan nucleus of flavonoid favor antioxidant and chelating activity, methoxy group has 
unfavorable steric effects and increase lipophilicity, a double bond and carbonyl group in 
the herterocycle of the nuclear structure offer a more stable radical and hence increase the 
activity (Heim, Tagliaferro, and Bobilya, 2002).  Phenolics may have hydroxyl or methoxyl 
groups; while flavones possess hydroxyl, keto, and free carboxylic groups; and flavonoids 
have flavan nucleus with different types of substitutions.  Typically, all of these compounds 
can provide different reducing properties. 
 The present study indicated that WE-DLP had higher levels of phenolic and flavonoid 
contents including free radical scavenging capacity and ferric reducing ability than those of 
80EE-DLP.  Notably, both WE-DLP and 80EE-DLP had lower levels of phenolic and 
flavonoid contents, including antioxidant activities by DPPH and FRAP assay, than those of 
95EE-FLP, 80EE-FLP, and WE-FLP.  This study also suggested that high levels of TPC 
and TFC as well as antioxidant properties of various extracts of PP leaves were found in 
fresh leaves (95EE-FLP, 80EE-FLP, and WE-FLP), while low level of them were found in 
dried leaves (80EE-DLP and WE-DLP).  The profile of phytochemicals, both TPC and 
TFC, and antioxidant properties of extracts of PP leaves between fresh leaves and dried 
leaves was remarkable.  It is possible that extracts of dried leaves of PP exhibited a decrease 
in TPC and TFC resulting in less antioxidant capacity.  Nguyen and Eun (2011) found high 
levels of phenolic and flavonoid contents as well as antioxidant activities of extracts of 
dried leaves of PP by DPPH and FRAP assay when macerated with different solvents 
  
 
 
 
 
 
 
 
73 
(methanol, acetone, ethanol, and water).  Using similar investigation methods, Nguyen and 
Eun (2011) also found comparable levels of TPC, TFC, free radical scavenging, and ferric 
reducing capability of 80% ethanol extract of PP dried leaves.  Therefore, regardless of their 
geographic differences, leaves of PP collected from Thailand and Vietnam share similar 
antioxidant properties. 
 Though both DPPH and FRAP assays are frequently used methods, they have some 
drawbacks for antioxidant activity measurement.  In DPPH assay, other compounds may 
have high absorbance or interference at the same wavelength at 515 nm.  In addition, DPPH 
radical is absent in living organisms.  The drawbacks of the FRAP method are that the 
compounds with low redox potential (lower than 0.77) still can reduce the Fe
3+
 even though 
they do not behave as antioxidants in vivo.  Interfering compounds may also absorb at the 
same wavelength, and this assay is also performed at a non-physiological pH (Pérez-
Jiménez et al., 2008).  Therefore, the present study also determined the scavenging activity 
in the cell-based assay using intracellular fluorescent probe DCFH-DA. 
 Among various extracts of PP leaves, WE-FLP had the highest levels of TPC and 
TFC, and DPPH free radical scavenging activity, while 95EE-FLP and 80EE-FLP had the 
highest FRAP value.  In addition, there seemed to be no differences in TPC and TFC levels 
as well as antioxidant activity of 95EE-FLP and 80EE-FLP.  Therefore, both 95EE-FLP and 
WE-FLP were selected for subsequent evaluation of cellular antioxidant activity.  The 
macrophage is usually the cell of choice in studying ROSs-mediated cellular events since 
they could generate high amount of ROSs following stimulation.  The present study 
demonstrated that all antioxidant standards, 250 µM catechin, 20 μM resveratrol, and        
10 μM quercetin, exerted a strong inhibition of ROSs generation induced by tBuOOH over 
a period of 30 to 240 min.  In addition to extracellular antioxidant capacity, 95EE-FLP and 
WE-FLP also possessed intracellular antioxidant activity in scavenging ROSs and 
decreasing the oxidation of DCFH (Figure 3.13B and C).  Both 95EE-FLP and WE-FLP 
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exhibited comparable efficiency of scavenging ROSs formation to the antioxidants 
standards.  Notably, the highest concentrations (250 µg/mL) of 95EE-FLP reduced DCFH 
oxidation better than those of WE-FLP.  Several studies showed that crude water and crude 
ethanol extracts of plant leaves contained phenolic compounds that act as antioxidants 
(Aiyegoro and Okoh, 2009, 2010; Shi, Xu, Hu, Na, and Wang, 2011; Shukla, Mehta, 
Mehta, and Bajpai, 2011).  In addition, polyphenols are known to support bioactive 
activities in medicinal plants.  Therefore, the antioxidant activity of PP might be attributed 
to the presence of high contents of phenolic and flavonoid in both ethanol and water crude 
extracts of PP. 
 In summary, all extracts from PP leaves had phenolic and flavonoid compounds and 
displayed antioxidant properties by chemical antioxidant assays (DPPH and FRAP).  High 
levels of TPC and TFC and antioxidant activities were found in extracts from fresh leaves 
of PP.  However, there were no significantly different levels of phenolic and flavonoid as 
well as ferric reducing antioxidant ability between 95EE-FLP and 80EE-FLP.  The 
antioxidant activity in cell-based study revealed that both 95EE-FLP and WE-FLP 
exhibited high potential to prevent ROS-induced oxidative stress in RAW264.7 cells, and 
95EE-FLP exerted more pronounced effects than that of WE-FLP. 
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CHAPTER IV 
CYTOTOXICITY AND SUPPRESSION OF NO, iNOS AND  
COX-2 EXPRESSION BY EXTRACTS FROM  
LEAVES OF PSEUDERANTHEMUM  
PALATIFERUM 
 
4.1 Abstract 
 Pseuderanthemum palatiferum (PP), a well-known Vietnamese traditional medicinal 
plant in Thailand, has long been used in folk medicine for curing inflammatory diseases.  
This study aimed to determine cytotoxicity and anti-inflammatory activities of 95% ethanol 
extract of fresh leaves of PP (95EE-FLP), and water extract of fresh leaves of PP          
(WE-FLP).  In an initial study, the cell viability of RAW264.7 cells exposed to various 
concentrations of 95EE-FLP (0.05, 0.25, 0.50, 1.00, or 1.50 mg/mL) or WE-FLP          
(0.10, 0.50, 1.00, 1.50, or 4.50 mg/mL) for 24 h were assessed by MTT, trypan blue 
methods, and propidium iodide staining.  Both 95EE-FLP and WE-FLP displayed low 
toxicity towards RAW264.7 cells as evidenced by no apparent effect on cell viability up to 
the concentration of 1.5 mg/mL of each extract was used as assessed by MTT and trypan 
blue methods.  However, cytotoxicity of RAW264.7 cells as assessed by PI staining showed 
that 95EE-FLP at concentrations ranging from 0.05-0.25 mg/mL do not alter the viability of 
RAW264.7 cells.  Similarly, WE-FLP at a concentration range from 0.1-0.5 mg/mL did not 
alter the viability of RAW264.7 cells.  Therefore, both 95EE-FLP and WE-FLP at the 
concentration range of 0-0.25 mg/mL were selected for RAW264.7 cell treatment in anti-
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inflammatory test.  Anti-inflammatory effects of 95EE-FLP and WE-FLP were evaluated 
on LPS plus IFN-γ-stimulated RAW264.7 macrophage cells.  Various concentrations (50, 
100, 150, 200, or 250 µg/mL) of 95EE-FLP and WE-FLP significantly suppressed LPS plus 
IFN--induced nitric oxide (NO) production.  However, 95EE-FLP more potently 
suppressed LPS plus IFN--induced NO production when compared to WE-FLP.  Both 
95EE-FLP and WE-FLP also suppressed LPS plus IFN--induced protein production of 
inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2).  Collectively, these 
results suggested that both 95EE-FLP and WE-FLP at the concentration range of 0-0.25 
mg/mL did not cause cell death in RAW264.7 cells and their certain concentrations also 
displayed the anti-inflammatory properties by suppressing the production of NO, iNOS, and 
COX-2 proteins.  Therefore, the findings of this study could provide the rational for future 
studies on the mechanism of anti-inflammatory properties of extracts from PP leaves. 
 
4.2 Introduction 
 Macrophages play an important role in inflammatory diseases through the release of 
proinflammatory cytokines and other proinflammatory molecules involved in the immune 
response such as nitric oxide (NO) and prostaglandins (PGE2) (MacMicking, Xie, and  
Nathan, 1997; Harris, Padilla, Koumas, Ray, and Phipps, 2002).  NO is a short lived free 
radical gas produced by the conversion of L-arginine to citrulline, catalyzed by nitric oxide 
synthase (NOS).  Under normal physiological functions, NO production is regulated by the 
constitutive isoform of NOS (cNOS).  At nanomolecular levels, NO plays important roles in 
vasodilation, neuron communication, and host defense.  However, under pathological 
conditions, NO level is increased by the inducible isoform of nitric oxide synthase (iNOS) 
leading to regulation of almost all stages of inflammation development, in particular, the 
early stages of inflammatory cell transmigration to the sites of inflammation (MacMicking 
et al., 1997; Bernstein, Bogerts, and Keilhoff, 2005; Korde (Choudhari), Sridharan, 
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Gadbail, and Poornima, 2012).  Among a variety of inflammatory mediators, PGE2 is also 
of central importance in the regulation of inflammation.  PGE2 is produced from 
arachidonic acid by prostaglandin synthase or cyclooxygenase (COX) enzymes.  COX 
exists in two isoforms: COX-1 and COX-2.  COX-1 is constitutively expressed, and is a 
housekeeping enzyme required for normal physiological functions, whereas COX-2 is only 
induced during inflammatory processes (Donnelly and Hawkey, 1997; Harris et al., 2002).  
Many reports have demonstrated that when NO was up-regulated in inflammatory cells, 
iNOS and COX-2 expression increased in parallel (Lin, Juan, Shen, Hsu, and Chen, 2003; 
Park et al., 2005; Kim et al., 2006).  Therefore, reduction of the levels of NO, iNOS, and 
COX-2 expression could be an effective strategy for suppressing inflammation. 
 Plants have been used medicinally all over the world for many centuries.  In Thailand, 
as well as in other parts of the world, traditional healers have prescribed herbal preparations 
for the treatment of different types of diseases.  Pseuderanthemum palatiferum (PP) leaves 
have long been used for health improvement and treatment for a variety of diseases 
especially inflammatory diseases associated with wound healing, general trauma, colitis, 
and nephritis (Dieu, Loc, Yamasaki, and Hirata, 2005).  Therefore, the objective of the 
present study was to assess the anti-inflammatory effect of extracts from PP leaves,             
a common herbal medicine used in Thailand, on LPS and IFN-γ-activated RAW264.7 
macrophage cells.  The effect of extracts from PP leaves on cell viability of RAW264.7 
cells was predetermined in order to identify the optimum concentration range of the extract 
for RAW264.7 cell treatment. 
 
4.3 Materials and methods 
 4.3.1 Chemicals and reagents 
  3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and 
propidium iodide (PI) were purchased from Invitrogen Molecular Probes (Eugene, OR).  
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Vitamin C was purchased from Fluka Chemine GmbH (Buchs, Switzerland).  Penicillin G, 
streptomycin sulfate, N-(1-Naphthyl) ethylenediamine dihydrochloride, sodium nitrite, and 
LPS (Escherichia coli O111:B4), were purchased from Sigma-Aldrich (St. Louis, MO).  
RPMI medium 1640 was obtained from Gibco Invitrogen (Grand Island, NY).  Fetal bovine 
serum (FBS) was obtained from Hyclone (Logan, Utah).  6-Hydroxy-2, 5, 7, 8-
tetramethylchroman-2-carboxylic acid (trolox) was purchased from Sigma-Aldrich 
Chemine Gmbh (Steinheim, Germany).  Mouse interferon gamma (mIFN-) was purchased 
from Piearce Protein Research Products (Rockford, IL). 
 4.3.2 Cell lines 
  The mouse macrophage RAW264.7 cell line was used to investigate the 
effects of 95% ethanol extract of fresh leaves of PP (95EE-FLP), and water extract of fresh 
leaves of PP (WE-FLP) on in vitro cytotoxic and anti-inflammatory studies.  Cells were 
cultured as previously described in Chapter III: Cell lines. 
 4.3.3 Plant materials 
  Fresh leaves of PP were purchased from producers in Yasothon province, 
Thailand.  The plant was identified and authenticated by Dr. Kongkanda  Chayamarit, the 
Forest Herbarium, Royal Forest Department, Bangkok, Thailand.  A voucher specimen 
(BKF 174009) was deposited at the Forest Herbarium, Royal Forest Department, Bangkok, 
Thailand. 
 4.3.4 Plant extract preparation 
  95EE-FLP and WE-FLP were prepared as previously described in Chapter III: 
Plant extract preparation.  95EE-FLP was dissolved in DMSO and then diluted to 0.25% 
(v/v) DMSO in cell culture medium when prepared at the indicated concentrations.  
Another extract, WE-FLP, was dissolved in PBS when used in experiments. 
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 4.3.5 Cytotoxicity 
  The effect of 95EE-FLP and WE-FLP on RAW264.7 cell viability was 
evaluated by using different methods.  For MTT and trypan blue exclusion methods, cells 
were plated at a density of 5x10
4
 cells/well in a 96-well plate and incubated overnight.  For 
the other methods, PI staining, cells were plated at a density of 2x10
6
 cells/well in a 6-well 
plate and incubated overnight.  Cells were then exposed to various concentrations of 95EE-FLP 
or WE-FLP at 37 °C under 5% CO2 for 24 h. 
  4.3.5.1 MTT method 
   MTT is a colorimetric assay that measures the reduction of yellow   
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tratrazolium bromide (MTT) by mitochondrial 
succinate dehydrogenase.  The MTT enters the cells and passes into the mitochondria.  
Then, mitochondrial dehydrogenases of viable cells cleave the tetrazolium ring yielding 
purple MTT formazan crystals (dark purple colure) which are insoluble in aqueous 
solutions (Figure 4.1).  The crystal formazan product can be dissolved in acidified 
isopropanol or DMSO and measured spectrophotometrically.  An increase in cell number 
results in increasing amount of formazan product which in turn, is proportional to the 
absorbance at 540 nm.  As reduction of MTT can only occur in metabolically active cells, 
the level of MTT formazan formed could be a measurement of cell viability (Byun et al., 
2008). 
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Figure 4.1 A yellow 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tratrazolium bromide (MTT) 
is reduced to purple formazan product by mitochondrial reductase in living cells 
(Wikipedia, www, 2012). 
 
   Cell viability was determined with MTT assay as described by Chun 
et al. (2007).  Briefly, MTT (0.5 mg/mL) dye solution was added in each well and incubated 
at 37 °C, 5% CO2 for 4 h.  The medium was removed and DMSO was added into each well 
to dissolve insoluble formazan crystals giving a uniform dark purple color before reading 
OD at 540 nm by Benchmark Plus Microplate Spectrophotometer System (Bio-Rad 
Laboratories, Inc., Hercules, CA).  The percentage of cell viability was calculated by the 
following equation :  
Percent cell viability  
Average OD for test group
Average OD for control group
  100 
 
  4.3.5.2 Trypan blue exclusion method 
   The trypan blue exclusion test is a rapid, simple, and inexpensive 
method to assess cell viability.  Trypan blue is a diazo dye that has been widely used to 
color dead tissues or cells selectively.  The reactivity of trypan blue is based on it being 
negatively charged and not interacting with cells unless the membrane is damaged.  
Undamaged cells are very selective concerning the compounds that pass through their 
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membrane, and thus should not take up trypan blue.  Therefore, all the cells that exclude the 
dye are considered viable.  In contrast, cells with damaged membranes are stained in           
a distinctive blue color readily observed under a microscope (Longo-Sorbello, Saydam, 
Banerjee, and Berniti, 2006). 
   Cell viability was determined with trypan blue exclusion method.  
Briefly, after incubation with 95EE-FLP and WE-FLP, cells were washed three times with 
PBS.  Then cells were harvested by trypsinization and stained with 0.4% (w/v) trypan blue.  
A small amount of this diluted sample was transferred to one or both chambers of the 
haemocytometer and these chambers were filled by capillary action.  The 10X objective 
lens was used to focus on the grid lines of the chamber.  The viable cells (exclude trypan 
blue) and non-viable cells (stained blue) were counted in the four 1 mm
2
 corner squares in 
one chamber.  Cells that lie on the lines should only be counted if they are touching the top 
and left hand lines of each corner squares.  The percentage of cell viability was calculated 
by the following equation: 
Percent cell viability  
Total cells   Dead cells
Total cells
  100 
 
  4.3.5.3 Propidium iodide staining 
   One method to assess cell viability is propidium iodide staining.  
Propidium iodide (PI) is a membrane impermeant dye that is generally excluded from 
viable cells.  PI cannot pass through intact cell membranes, but may freely enter cells with 
compromised cell membranes.  Upon entering a non-viable cell, these dyes bind to the 
double stranded DNA by intercalating between base pairs. 
   Cell viability was determined with PI staining as described by 
Düchler and Stepnik (2008) with slight modifications.  Briefly, after incubation with   
95EE-FLP or WE-FLP, cells were washed three times with PBS, trypsinized, and 
transferred to tube.  Then, PBS was removed, and cells were stained with 100 μL of PI 
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solution (1 mg/mL stock solution diluted to 1:200) for 10 min in the dark.  After staining, 
cells were washed in PBS and analyzed by flow cytometry (BD FACSCalibur flow 
cytometer, BD, San Diego, CA). 
 4.3.6 Nitrite assay 
  The Griess test is a chemical analysis test which detects the presence of 
organic nitrite compounds.  The Griess reaction was first described in 1879 and this assay 
has also been used extensively in analysis of numerous biological samples including cell 
culture media.  In this assay, nitrite is first treated with a diazotizing reagent, sulfanilamide 
(SA) in acidic media to form a transient diazonium salt.  This intermediate is then allowed 
to treat with a coupling reagent, naphthylethylenediamine dihydrochloride (NED) to form   
a stable azo compound.  This overall reaction is described in the Figure 4.2.  The 
absorbance of purple color of the product at 540 nm is in linear proportion to the nitrite 
concentration in the sample (Sun, Zhang, Broderick, and Fein, 2003). 
 
Figure 4.2 The overall of Griess reaction.  Nitrite is detected by formation of purple color 
upon treatment of NO2-containing sample with Greiss reagent.  When SA in acidic media is 
added, the nitrites form a diazodium salt.  When azo dye agent (NED) is added, a purple 
color of the product develops (Sun et al., 2003).  
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  Therefore, the level of NO in the culture media was detected as nitrite, a major 
stable product of NO, and was determined using Griess reagent (de Oliveira et al., 2012).  
Briefly, RAW264.7 cells were seeded at a density of 2x10
5
 cells/well in a 96-well plate.  
Cells were grown for 3 h to allow plate attachment prior treating with antioxidant positive 
control vitamin C (500 µM) or various concentrations (50, 100, 150, 200, or 250 µg/mL) of 
95EE-FLP or WE-FLP.  After 1 h incubation, RAW264.7 cells were stimulated with           
1 µg/mL plus 25 U/mL IFN-.  The activated cells were further incubated for 24 h.  Then 
100 µL of supernatant was mixed with an equal volume of Griess reagent                        
(1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride, and 3% phosphoric 
acid).  After 10 min of dark incubation, the absorbance of samples was measured at 540 nm 
using a microplate spectrophotometer.  Fresh culture medium was used as the blank in all 
experiments.  The amount of nitrite in the samples was derived from a standard curve of 
sodium nitrite. 
 4.3.7 Western blot analysis 
  4.3.7.1 Preparation for protein lysate 
   RAW264.7 cells were plated at a density of 2x10
6
 cells/well in a      
6-well plate.  After an attachment period of approximately 3 h, cells were treated with 
various concentrations (50, 100, 150, 200, or 250 µg/mL) of 95EE-FLP or WE-FLP for 1 h.  
50 µg/mL trolox and 500 µM vitamin C were used as antioxidant positive controls.  Cells 
were then stimulated with 1 µg/mL LPS plus 25 U/mL IFN-  for 18 h.  After incubation, 
cells were washed three times with PBS and placed in 150 µL of ice-cold lysis buffer (1 mL 
RIPA buffer supplemented with 2 mM PMSF, 2 µM leupeptin, and 1 µM E-64) for 20 min.  
Then the disrupted cells were transferred to microcentrifuge tubes and centrifuged at  
14,000 x g at 4 °C for 30 min.  The supernatant was collected and kept in -80 °C for further 
analysis.  The aliquot part was used for protein determination. 
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  4.3.7.2 Determination of protein concentration 
   The protein concentration was measured according to the Lowry 
method (Lowry, Rosebrough, Farr, and Randall, 1951).  The protein lysate was diluted in 
DI water (1:10).  Twenty microliters of diluted protein lysate was mixed with 200 μL of 
reagent D in a 96-well plate.  After 10 min, 20 μL of reagent C were added to 96-well 
plates.  The reaction was incubated at RT for 30 min and the absorbance at 750 nm was 
measured.  Bovine serum albumin (BSA) was used to prepare a standard curve for protein 
determination. 
  4.3.7.3 SDS-PAGE gel electrophoresis and Western blot 
   Denaturing polyacrylamide gel was performed according to the 
method of Laemmli (1970) with some modification.  Cell lysate was boiled for 5 min in 6X 
sample buffer (50 mM Tris-base, pH 7.4, 4% SDS, 10% glycerol, 4% 2-mercaptoethanol, 
and 0.05 mg/mL of bromophenol blue).  Thirty micrograms of cellular proteins were 
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
using 7.5% and 10% polyacrylamide gels for determination the expression of iNOS and 
COX-2, respectively (125 volts, 120 min).  The proteins in the gel were transferred onto 
nitrocellulose membrane (AMersham, Pittsburgh, PA) at 80 volts for 1 h.  The membrane 
was blocked overnight at 4 °C with 5% nonfat milk in 0.1% Tween-20 in PBS-buffer 
(TPBS).  Membranes were then incubated with 1:1,000 dilution of primary antibody anti-
iNOS mouse monoclonal (Santa Cruz Biotechnology Inc., Santa Cruz, CA) or 1:2,000 
dilution of primary antibody anti-COX-2 mouse polyclonal (Cayman Chemical, Ann Arbor, 
MI) at RT for 2 h.  After extensive washing with TPBS, the membranes were incubated 
with a 1:10,000 dilution of the secondary antibody goat-anti-mouse-HRP conjugate (Santa 
Cruz) for iNOS and goat-anti-rabbit IgG-HRP conjugate (Cayman) for COX-2 at RT for     
1 h.  To control the equal loading of total protein in all lanes, the same blots were also 
stained with primary antibody anti-tubulin mouse monoclonal (Santa Cruz) at a dilution of 
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1:2000 at RT for 2 h.  After washing, the membranes were incubated with a 1:10,000 
dilution of the secondary antibody goat-anti-mouse-HRP conjugate (Santa Cruz).  
Membranes were washed three times with TPBS, 10 min per wash.  Blots were incubated 
for 3 min in ECL Western Blotting Substrate (Piearce Protein Research Products) and 
exposed to film.  The relative expression of proteins was quantified densitometrically using 
the ImageJ software and calculated according the reference band of tubulin. 
 4.3.8 Statistical analysis 
  All parameters statistical significance (GraphPad Prism 5, USA) were 
determined by performing a one-way analysis of variance (ANOVA) with a post-hoc 
Turkey’ s analysis to determine differences between treatment and control groups.  Values 
were considered statistically significant when p<0.05.  Data were presented as mean ± SEM 
(n=3).  PI staining and western blotting analysis experiments were repeated at least twice. 
 
4.4 Results 
 4.4.1 Effect of extracts from PP leaves on RAW264.7 cell viability 
  The cell viability of RAW264.7 cells exposed to 95EE-FLP and WE-FLP was 
determined by MTT (Figure 4.3A and B), trypan blue exclusion assay (Figure 4.3C and D), 
and PI staining (Figure 4.4A and B).  Cells were incubated for 24 h with various 
concentrations of 95EE-FLP (0.05, 0.25, 0.50, 1.00, or 1.50 mg/mL) or WE-FLP          
(0.10, 0.50, 1.50, or 4.50 mg/mL).  As shown in Figure 4.3, both 95EE-FLP (Figure 4.3A 
and C) and WE-FLP (Figure 4.3B and D) displayed low toxicity towards RAW264.7 cells 
as evidenced by no apparent effect of each extract on cell viability only observed when the 
treatment concentration reached 1.5 mg/mL, as assessed by MTT (Figure 4.3A and B) and 
trypan blue exclusion methods (Figure 4.3C and D).  At 1.5 mg/mL, 95EE-FLP (Figure 
4.3A) and WE-FLP (Figure 4.3B) decreased the viability of RAW264.7 cell by 34.14 ± 
9.69% (p<0.05) and 21.58 ± 1.66% (p<0.05), respectively.  However, the cytotoxic effect 
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was more pronounced at higher concentration, WE-FLP at 4.50 mg/mL decreased the cell 
viability to 54.21 ± 1.74% (p<0.05).  The suppression of cell viability by 37.56 ± 14.37%, 
as assessed by trypan blue, (Figure 4.3C) was only observed in the highest treatment group 
of 1.50 mg/mL 95EE-FLP (p<0.05).  The cell viability of RAW264.7 (Figure 4.3D) 
decreased by 8.16 ± 1.79% (p<0.05) and 65.32 ± 0.38% (p<0.05) at 1.50 and 4.50 mg/mL 
WE-FLP, respectively. 
  Increasing concentrations of 95EE-FLP and WE-FLP also exhibited low 
toxicity towards RAW264.7 cell as evidenced by PI staining.  As shown in Figure 4.4A, 
95EE-FLP at concentrations ranging from 0.05 to 0.25 mg/mL did not alter the viability of 
RAW264.7 cells.  However, at higher concentrations, 95EE-FLP at 0.50, 1.00, and         
1.50 mg/mL decreased the viability of RAW264.7 cell by 8.57%, 20.57% and 32.89%, 
respectively.  As shown in Figure 4.4B, WE-FLP at concentration ranging 0.1-0.5 mg/mL 
did not alter the viability of RAW264.7 cells.  At 1.50 mg/mL, WE-FLP decreased the 
viability of RAW264.7 cells by 21.64%.  However, the cytotoxic effect was more 
pronounced at higher concentrations, WE-FLP at 4.50 mg/mL decreased the cell viability to 
60.6%.  Therefore, a non-toxic concentration range of 0-0.25 mg/mL of both 95EE-FLP and 
WE-FLP was selected for RAW264.7 cell treatment in the subsequent studies. 
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Figure 4.3 Effects of 95EE-FLP (A and C) and WE-FLP (B and D) on cell viability of 
RAW264.7 cells were assessed by MTT (A and B) and trypan blue (C and D).  Values were 
expressed as mean ± SEM of representative of three independent experiments with similar 
results.  Bars marked with different letters are significantly different at p<0.05 as 
determined by one-way ANOVA. 
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Figure 4.4 Effects of 95EE-FLP (A) and WE-FLP (B) on cell viability of RAW264.7 cells 
were assessed by PI staining.  Data were expressed as the percentage of viable cells and are 
representative of at least two independent experiments. 
 
 4.4.2 Suppression of NO product by extracts of PP leaves in LPS plus IFN-γ-
activated RAW264.7 cells 
RAW264.7 cells were pretreated with antioxidant, vitamin C, 95EE-FLP or 
WE-FLP for 1 h, then stimulated with LPS plus IFN-γ, and measured for NO production 
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using the Griess assay.  As shown in Figure 4.5, Naïve RAW264.7 cells (NA) secreted 
basal levels of NO, while the production of NO was increased to about 43 µM in LPS-
activated RAW264.7 cells.  The antioxidant control, 500 µM vitamin C, decreased the NO 
production by almost 35%.  Pretreated RAW264.7 cells with 95EE-FLP or WE-FLP 
significantly suppressed (p<0.05) the induction of NO production in a dose-dependent 
manner (Figure. 4.5A and B), and the suppression was observed in all 95EE-FLP- and   
WE-FLP-treated groups.  These results also clearly indicated that 95EE-FLP was more 
potent in suppressing NO production than WE-FLP.  The concentrations of 50 µg/mL 
95EE-FLP, and 150 and 200 µg/mL WE-FLP were required to exhibit about the same 
efficiency as 500 µM vitamin C in NO suppression. 
 
 
Figure 4.5 95EE-FLP (A) and WE-FLP (B) suppressed LPS plus IFN--induced nitrite 
production in RAW264.7 cells.  RAW264.7 cells were incubated for 24 h with LPS (1 μg/mL) 
plus IFN- (25 U/mL) in the presence or absence of indicated concentrations of vitamin C 
(500 μM), 95EE-FLP or WE-FLP.  Accumulated nitrite in the culture medium was 
determined by the Griess reaction.  The values are means ± SEM (n 3) of representative of 
three independent experiments with a similar results.  Bars marked with different letters are 
significantly different at p<0.05 as determined by one-way ANOVA. 
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 4.4.3 Suppression of iNOS and COX-2 protein expressions by extracts of PP 
leaves in LPS plus IFN-γ-activated RAW264.7 cells 
  To determine whether suppression of NO production by 95EE-FLP and     
WE-FLP was related to changes in iNOS as well as COX-2 protein levels, Western blotting 
analysis was performed.  RAW264.7 cells were pretreated with antioxidants, trolox          
(50 μg/mL) or vitamin C (500 μM), and PP extracts, 95EE-FLP or WE-FLP, at 50 to       
250 µg/mL for 1 h prior subsequently activated with LPS (1 μg/mL) plus IFN- (25 U/mL) 
for 18 h.  Total proteins were extracted and analyzed by Western blotting for the 
expressions of iNOS and COX-2.  LPS plus IFN--induced increases in iNOS (Figure 4.6A 
and B) and COX-2 (Figure 4.6C and D) expression compared to unstimulated naïve culture.  
Anti-oxidant controls (trolox and vitamin C) decreased LPS plus IFN--induced iNOS and  
COX-2 protein levels.  The data also suggested that the suppression of 500 µM vitamin C 
was more pronounced than 50 µg/mL trolox.  Compared to the corresponding controls, both       
95EE-FLP and WE-FLP produced a dose-dependent suppression of iNOS level in LPS plus 
IFN-γ activated RAW264.7 cells (Figure 4.6A and B) suggesting the suppression of NO 
production by 95EE-FLP and WE-FLP was mediated by decreasing the expression of 
iNOS.  In parallel to the result of NO suppression, 95EE-FLP at 50 to 200 µg/mL was more 
efficient than WE-FLP in iNOS suppression.  The iNOS expression was almost completely 
abolished at 200 µg/mL 95EE-FLP and was barely observed at 250 µg/mL WE-FLP.  The 
anti-inflammatory activity of 95EE-FLP and WE-FLP was also further supported by the 
dose-dependent suppression of COX-2 level by both 95EE-FLP and WE-FLP (Figure 4.6C 
and D) in the activated RAW264.7 cells.  Notably, 95EE-FLP and WE-FLP exhibited 
higher suppressive effect on iNOS than COX-2. 
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Figure 4.6 Effect of 95EE-FLP on LPS plus IFN-γ-induced iNOS (A) and COX-2 (C) and 
WE-FLP on LPS plus IFN-γ-induced iNOS (B) and COX-2 (D) protein levels in RAW26.7 
cells.  The relative expression of proteins was quantified densitometrically using ImageJ 
software and normalized according to tubulin reference bands.  Data are a representative of 
at least two independent experiments (NA = naïve, VH = vehicle, Trolox = 50 µg/mL, 
Vitamin C = 500 µM). 
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4.5 Discussion and conclusion 
 Although PP leaves have long been used in folk medicine for curing inflammatory 
diseases, their anti-inflammatory effect has not been reported until now.  To determine anti-
inflammatory effects of extracts from PP leaves using RAW264.7 in vitro model, 
RAW264.7 cell line toxicity test was conducted to investigate concentrations of 95EE-FLP 
and WE-FLP that cause no detrimental effects on cells or cell viability.  Therefore, the 
number of viable cells was estimated using different methods to ensure that these 
concentrations do not adversely affect RAW264.7 cells.  The number of viable cells showed 
a similar trend of decreased viability after RAW264.7 cell treatment for 24 h with       
95EE-FLP or WE-FLP as assessed by MTT, trypan blue, and PI staining.  Moreover, this 
study suggested that the concentration range of 0-0.25 mg/mL both of 95EE-FLP and    
WE-FLP does not affect cell viability.  Therefore, these concentrations were selected for 
RAW264.7 cell treatment in the anti-inflammatory test. 
 Inflammatory disorders are characterized, among other events, by the production of 
significant amounts of free radicals, nitrogen reactive species as well as proinflammatory 
cytokines (Martin et al., 1997).  Therefore, this study aimed to investigate the anti-
inflammatory effects of extracts from PP leaves on the suppression of NO production in 
LPS plus IFN-γ-activated RAW264.7 cells.  Both 95EE-FLP and WE-FLP at concentrations 
ranging from 50-250 µg/mL showed concentration-dependent suppression of NO 
production, and the suppression was also more pronounced in 95EE-FLP than WE-FLP 
(Figure 4.5).  These results are consistent with the observation that 95EE-FLP was also       
a better scavenger of intracellular ROS than WE-FLP (Chapter III).  To rule out the 
possibility that NO suppression by 95EE-FLP and WE-FLP was due to the direct 
scavenging effect on NO alone, the effect of 95EE-FLP and WE-FLP on the suppression of 
iNOS, the inducible isoform of nitric oxide synthase, was also investigated.  The result 
clearly indicated that the mechanism of NO suppression by 95EE-FLP and WE-FLP was 
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mediated through the suppression of iNOS expression (Figure 4.6A and B).  In agreement 
with the findings of NO suppression, the suppressive effect of 95EE-FLP (50-200 µg/mL) 
on iNOS was more remarkable than WE-FLP.  Excess ROSs have been implicated in 
causing extensive oxidative damage to cells leading to tissue damage, cell death or 
degenerative processes, including aspects of cancer, atherosclerosis, diabetes, aging and 
other chronic inflammatory diseases (Valko, Rhodes, Moncol, Izakovic, and Mazur, 2006; 
Fang, Seki, and Maeda, 2009).  High NO concentrations can combine with superoxide to 
form peroxynitrite ion (OONO
-
)
 
which is responsible for cell and tissue damages in 
inﬂammation (Valko et al., 2006).  The present result strongly suggested that 95EE-FLP 
and WE-FLP could play an important role in attenuating cell damage through suppression 
of NO production by macrophages in response to inflammatory stimuli of LPS plus IFN-γ.  
Increased level of COX-2 expression has been detected in various tumor types, and may 
account for the excessive production of inflammatory PGH2 (Subbaramaiah and 
Dannenberg, 2003).  This study showed that COX-2 production induced by LPS plus    
IFN-γ-activated RAW264.7 cells was suppressed by increasing concentrations of both 
95EE-FLP and WE-FLP (Figure 4.6C and D).  Therefore, 95EE-FLP and WE-FLP can also 
exhibit anti-inflammatory effects by suppression of high COX-2 protein level.  It is well 
known that there is a link between the overproduction of NO, iNOS, and COX-2 in 
response to inflammatory stimuli.  Many inflammatory conditions are associated with 
production of large amounts of NO (Liu and Hotchkiss, 1995) in parallel with increased 
expression of inducible enzymes of both iNOS and COX-2 (Dannhardt and Kiefer, 2001; 
Calixto, Otuki, and Santos, 2003).  Therefore, extracts of PP leaves might exert their anti-
inflammatory effects by decreasing NO production, iNOS and COX-2 protein expression in 
LPS plus IFN-γ-stimulated RAW264.7 cells. 
 Several natural compounds derived from plants have been demonstrated to directly 
suppress the expression of NO, iNOS and COX-2.  For example, phenolic compounds from 
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the roots of Ulmus macroparpa (Kwon, Kim, Park, and Lee, 2011), certain flavonols (Wang 
et al., 2006), and arctigenin (Kou, Qi, Dai, Luo, and Yin, 2011) displayed antioxidant 
activity and directly suppressed the expression of NO, iNOS, and/or COX-2.  PP as part of 
the Acanthaceae plant family like Andrographis paniculata (AP) and the extract of AP 
displayed a wide spectrum of bioactive including anti-inflammatory.  For example, ethyl 
acetate extract (EtOAc) from AP suppressed NO production in LPS plus IFN-γ-stimulated 
RAW264.7 macrophages (Chao, Kuo, Hsieh, and Lin, 2011).  A mixture of β-sitosterol and 
stigmasterol isolated from EtOAc fraction of AP also significantly decreased NO 
production in LPS plus IFN-γ-stimulated RAW264.7 cells (Chao, Kuo, and Lin, 2010).  
Andrograpanin, isolated from AP also suppresed NO production in LPS-activated 
macrophage cells (Liu, Wang, and Ge, 2008).  In addition, neoandrographolind, one of the 
bioactive components isolated from AP, suppressed the production of NO, iNOS, and   
COX-2 proteins in LPS-stimulated murine macrophages (Liu, Wang, Ji, and Ge, 2007).  
Thus, NO, iNOS, and COX-2 expression were suppressed by AP, mirroring the suppression 
by PP in LPS plus IFN-γ-activated RAW264.7 macrophages.  Liang and coworkers 
demonstrated that pretreatement of RAW264.7 cells with flavonoids such as apigenin, 
genistein, and kaempherol suppressed LPS-induced expressions of NO secretion, and iNOS 
and COX-2 protein productions (Liang et al., 1999).  Major chemical constituents of PP 
leaves consist of β-sitosterol, stigmasterol, kaempferol 3-methyl ether 7-O-β-glucoside and 
apigenin 7-O-β-glucoside (Phan, Ha, and Phan, 2003) including flavonoids (Nguyen and 
Eun, 2011).  These chemical constituents have been shown to possess anti-inflammatory 
properties.  Both kaempferol 3-methyl ether 7-O-β-glucoside and apigenin-7-O-β-glucoside 
may be metabolized into kaempferol and apigenin which also have antioxidant and anti-
inflammatory activities.  Thus, considering their long historic use in folk medicine and their 
chemical composition, PP leaves have a high potential for treatment of inflammatory 
diseases.  Results from this study also supported the anti-inflammatory roles of PP leaves.  
  
 
 
 
 
 
 
 
99 
Whether the regulation of crucial proinflammatory cytokines is the underlying mechanism 
of anti-inflammation of PP needs further investigation. 
 In summary, non-cytotoxic concentrations (0-250 µg/mL) of 95EE-FLP and WE-FLP 
exerted anti-inflammatory effects by suppressing the expressions of NO production, iNOS, 
and COX-2 protein levels in LPS plus IFN-γ activated RAW264.7 cells.  Therefore,    
95EE-FLP and WE-FLP could play an anti-inflammatory role in response to endotoxin.     
In addition, increasing concentrations of 95EE-FLP also decreased NO production and 
iNOS protein levels in LPS plus IFN-γ-activated RAW264.7 cells better than that of      
WE-FLP.  These novel findings provide addition support for the anti-inflammatory action 
of PP leaves. 
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CHAPTER V 
IMMUNE MODULATION OF PROINFLAMMATORY  
CYTOKINES TNF-α AND IL-6 BY ETHANOL  
EXTRACT FROM FRESH LEAVES OF 
PSEUDERANTHEMUM  
PALATIFERUM  
 
5.1 Abstract 
 Extracts of Pseuderanthemum palatiferum (PP) leaves have been reported to possess 
immune modulatory properties.  In the present study, the anti-inflammatory potential and 
underlying mechanisms of 95% ethanol extract of fresh leaves of PP (95EE-FLP) was 
investigated using LPS-activated macrophages.  Specifically, the suppressive effect of 
95EE-FLP was examined on the production of proinflammatory mediators, TNF-α and    
IL-6.  The results showed a concentration-dependent suppression by 95EE-FLP of LPS-
induced TNF-α and IL-6 secretion by mouse peritoneal macrophages.  95EE-FLP also 
suppressed LPS-induced TNF- and IL-6 protein and mRNA levels in the RAW264.7 
murine macrophage cell line.  To further elucidate the molecular mechanisms responsible 
for impaired TNF- and IL-6 regulation, the activation of the transcription factors, nuclear 
factor-kappaB (NF-ҡB), CCAAT/enhancer-binding protein (C/EBP), and activator   
protein-1 (AP-1), was monitored by the gel mobility shift assay.  95EE-FLP suppressed 
LPS-induced NF-ҡB DNA binding activity within both the TNF-α and IL-6 promoters in 
RAW264.7 cells with impairment being more pronounced in the IL-6 promoter.  In 
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addition, 95EE-FLP exhibited a concentration-dependent suppression of C/EBP, and AP-1 
DNA binding activity within the IL-6 promoter.  Concordantly, IL-6 luciferase promoter 
reporter activity was also suppressed by 95EE-FLP in transiently transfected RAW264.7 
cells upon LPS activation.  Collectively, these results suggest that the anti-inflammatory 
effects of 95EE-FLP are mediated, at least in part, by modulating TNF-α and IL-6 
expression through down regulation of NF-ҡB, C/EBP, and AP-1 activity. 
 
5.2 Introduction 
 In both Vietnam and Thailand, Pseuderanthemum palatiferum (PP) leaves have been 
traditionally used for the prevention or treatment of hypertension, diabetes, cancer, as well 
as inflammation associated with wound healing, general trauma, colitis, and nephritis (Dieu, 
Loc, Yamasaki, and Hirata, 2006; Padee, Nualkaew, Talubmook, and Sakuljaitrong, 2010).  
Phan, Ha, and Phan (2003) found that fractional extracts of PP leaves contain several 
compounds, such as phytosterols, lipids, saponins, and flavonoids.  Additionally, flavonoids 
from PP display antioxidant activity (Phan, Ha, and Phan, 2005).  Likewise, previous study 
have also found that ethanolic extract of PP leaves which contain phenols and flavonoids 
exhibited potent antioxidant activity as assessed by various in vitro models (chapter III).  
Many investigators have demonstrated that numerous antioxidant medicinal plants also 
possess anti-inflammatory property (Heras et al., 1998; Sheeja, Shihab, and Kuttan, 2006; 
Dufour et al., 2007).  For example, green tea polyphenols are potent antioxidants and have 
anti-inflammatory effects.  Specifically, these polyphenols can suppress lipopolysaccharide 
(LPS)-induced proinflammatory tumor necrosis factor alpha (TNF-α) mRNA expression, its 
protein synthesis, and nuclear factor-kappaB (NF-ҡB)-binding activation in RAW264.7 
cells (Yang, ᴅᴇ Villiers, McClain, and Varilek, 1998). 
 LPS is an endotoxin that activates a variety of mammalian cells types including 
macrophages to produce proinflammatory cytokines (Guha and Mackman, 2001).  TNF-α 
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and IL-6 are among the most important cytokines released by activated macrophages.  TNF 
is a pleiotropic and multifunctional proinflammatory cytokine.  It can mediate both growth 
promotion and inhibitory activities in many cell types (Liu and Han, 2001), and exerts a 
wide spectrum of biological effects, including inflammation, lipid metabolism, coagulation, 
insulin resistance, and endothelial functions (Founds et al., 2008).  TNF-α is a prime 
mediator involved in many inflammatory mediated diseases, such as septic shock, cancer, 
multiple sclerosis, diabetes, and rheumatoid arthritis (Vassalli, 1992).  Several studies have 
shown the rapid elevation of TNF-α level with inflammation, which, if specifically blocked 
either through release or receptor binding, can alleviate severity of inflammatory response 
(Mohler et al., 1993; Colón et al., 2001; Scallon et al., 2002).  Similarly, IL-6 is a cytokine 
that is also induced by a variety of stimuli, including LPS, and is also a major initiating 
stimuli of the acute phase response.  In addition, IL-6 plays important roles in the immune 
response during chronic inflammation.  Elevated IL-6 levels have also been identified in 
many inflammatory diseases including rheumatoid arthritis (RA), systemic juvenile 
idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis, and 
Crohn’s disease (Gabay, 2006; Kishimoto, 2010). 
 LPS induces the expression of numerous genes involved in the inflammatory process 
by activating several types of transcription factors (Van Miert, 2002).  NF-ҡB is an 
important transcription factor playing crucial roles in the inflammatory response by 
regulating the gene expressions of proinflammatory cytokines (e.g., IL-1, IL-2, IL-6,    
TNF-α, etc), chemokines, adhesion molecules, inducible enzymes (COX-2 and iNOS), 
growth factors, some acute phase proteins, and immune receptors (Calixto, Otuki, and 
Santos, 2003).  The mouse TNF promoter contains several LPS-inducible NF-ҡB binding 
sites (Kuprash et al., 1999).  Recently, numerous plant-derived substances have been 
investigated for their potential to impair NF-ҡB binding with the intent to identify their 
therapeutic benefits in treating various inflammatory diseases (Calixto et al., 2003).  Also 
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involved in the regulation of inflammatory responses are CCAAT/enhancer binding 
proteins (C/EBPs), which are a family of six proteins containing basic leucine Zipper (bzip) 
motifs.  The C/EBPs are critical regulators of cellular differentiation and functions in 
multiple tissues.  Among these proteins, C/EBP β and C/EBP δ are involved in the 
regulation of gene expression during inflammation (Poli, 1998).  A third transcription factor 
also critically involved in regulating the inflammatory response is activator protein-1     
(AP-1).  AP-1 consists of either Jun homodimers or Fos/Jun heterodimeric complexes.  This 
transcription factor binds to the TPA DNA response element (TRE) appearing in various 
mammalian promoters, including those of acute phase proteins and cytokines involved in 
the inflammatory state (Koj, 1996).  Furthermore, NF-ҡB, C/EBP, and AP-1 are critical for 
transcriptional regulation of the mouse IL-6 promoter (Baccam, Woo, Vinson, and Bishop, 
2003).  Mouse IL-6 promoter also contained the same DNA biding sequences for NF-ҡB 
and AP-1 as human IL-6 promoter (Allen et al., 2010). 
 Currently, natural substances derived from plants are of potential interest for 
therapeutic interventions in the treatment of a variety of inflammatory diseases.  To date, 
the molecular mechanisms responsible for the anti-inflammatory properties of PP leaves 
ethanolic extract remains unknown.  The objective of the present study was to investigate 
the anti-inflammatory effects of PP by examining its modulation of macrophage-derived 
TNF-α and IL-6.  Here the present study demonstrated for the first time that 95EE-FLP 
decreases the levels of TNF-α and IL-6 at the protein and mRNA level in LPS-activated 
macrophage as well as provides a partial mechanism for the observed immunumodulatory 
activity. 
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5.3 Materials and methods 
 5.3.1 Chemicals and reagents 
  LPS (Escherichia coli O111:B4), streptavidin peroxidase, Phenylmethanesulfonyl 
fluoride (PMSF), Igepal, HEPES, bicinchoninic acid (BCA) solution, and copper (II) sulfate 
solution, were purchased from Sigma-Aldrich (St. Louis, MO).  RPMI medium 1640, 
Dulbecco’s Modified Eagle Medium (DMEM), high glucose, Hank’s balanced salt solution 
(HBSS), penicillin-streptomycin, 0.25% trypsin-EDTA, UltraPure
TM
 Trist, and UltraPure
TM
 
TEMED (N, N, Nˊ, Nˊ-tetramethylethylenediamine), were obtained from Gibco Invitrogen 
(Grand Island, NY).  Fetal bovine serum (FBS) was obtained from Hyclone (Logan, Utah).  
Ammonium persulfate, boric acid, MgCl2, NaCl, and glycerol, were purchased from Baker 
Analyzed Reagent (Phillipsburg, NJ).  Autoradiography film was purchased from Denville 
Scientific Inc. (Metuchen, NJ).  DNA binding sequences of transcription factors, NF-ҡB, 
AP-1, and C/EBP, were purchased from Integrated DNA Technologies (Coralville, IA).  
Bovine serum albumin (BSA) was obtained from Calbiochem (La Jolla, CA).  Poly dI-dC 
was obtained from Roche (Indianapolis, IN). 
 5.3.2 Cell lines 
  The mouse macrophage RAW264.7 cell line was used to investigate the 
effects of 95% ethanol extract of fresh leaves of PP (95EE-FLP) on anti-inflammatory 
mechanism.  Cells were cultured as previously described in Chapter III: Cell lines. 
 5.3.3 Animals 
  Pathogen-free female C57BL/6 mice, 5-8 weeks of age, were purchased from 
Charles River Breeding Laboratories (Portage, MI).  On arrival, mice were randomized, 
transferred to plastic cages containing sawdust bedding (5 animals/cage), and acclimatized 
for at least 1 week prior experiments.  Mice were provided food (Purina Certified 
Laboratory Chow) and water ad libitum and were not used for experimentation until their 
body weight was 17-20 g.  Animal holding rooms were kept at 21-24 °C and 40-60% 
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relative humidity with a 12-h light/dark cycle.  All procedures involving mice were in 
accordance with the Michigan State University Institutional Animal Care and Use 
Committee. 
 5.3.4 Plant material 
  Fresh leaves of PP were purchased from Yasothon province, Thailand.  The 
plant was identified and authenticated by Dr. Kongkanda Chayamarit, the Forest 
Herbarium, Royal Forest Department, Bangkok, Thailand.  A voucher specimen (BKF 
174009) was deposited at the Forest Herbarium, Royal Forest Department, Bangkok, 
Thailand. 
 5.3.5 Plant extract preparation 
  95EE-FLP was prepared as previously described in Chapter III: Plant extract 
preparation.  95EE-FLP was dissolved in DMSO, and then diluted to 0.125% (v/v) DMSO 
in cell culture medium when preparing the indicated concentrations. 
 5.3.6 Sample preparations for mRNA and ELISA studies 
  To determine the effects of 95EE-FLP on LPS induced proinflammatory 
cytokine gene and protein expression from RAW264.7 cells.  RAW264.7 cells were seeded 
in a 6-well culture plate at 2x10
6 
cells/well overnight.  After incubation, cells were 
pretreated with various concentrations of 95EE-FLP (50, 150, or 250 µg/mL) or DMSO 
vehicle control (0.125%) for 1 h.  RAW264.7 cells were activated with 100 ng/mL of LPS 
for 8 h.  The supernatants were then collected by centrifugation at 300 x g for 5 min and 
stored at -80 °C for further analysis of TNF-α and IL-6 by ELISA.  For RNA isolation, the 
adherent cells were lysed with 175 µL lysis buffer from SV Total RNA Isolation kit 
(Promega, Madison, WI) in a 6-well plate and stored at -80 °C until further use. 
 5.3.7 Isolation and culture of mouse peritoneal macrophages 
  To determine the effects of 95EE-FLP on LPS induced proinflammatory 
cytokine production from murine peritoneal macrophages, murine peritoneal macrophages 
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were obtained as described previously (Kaminski, Roberts, and Guthrie, 1982).  In brief, 10 
mL of HBSS were injected into the peritoneal cavity of C57BL/6 mice.  The abdominal 
area was gently massaged for 1 min to ensure uniform distribution of free cells in the HBSS 
and peritoneal cells were harvested by inserting a 16-gauge (B-D, Becton-Dickinson, 
Franklin Lakes, NJ), 1-inch needle into the lower right quadrant of the peritoneum.  A 
polyethylene tube, i.d. 0.58 mL, o.d. 0.965 mL, (Clay Adam Division Becton Dickinson Co, 
Parsippany, NJ) was then passed through a 16-gauge needle into the cavity.  The end of the 
tubing inserted into the cavity contained multiple perforations while the other end was 
attached to a 5 mL syringe (B-D) with a 23-gauge needle (B-D).  A 4 mL aliquot of 
collected peritoneal cell suspension was aspirated into the syringe and immediately 
transferred to a 50 mL tube on ice.  The isolated cells were then washed and resuspended in 
complete culture medium.  Cells were seeded in a 96-well culture plate at 2.5x10
5
 cells/well 
in a final volume of 200 µL.  The cells were cultured at 37 °C for 2 h to allow macrophages 
to adhere to the plate.  Non-adherent cells were removed by washing once with warm HBSS 
and the adherent cells were cultured in complete RPMI 1640 medium.  After an overnight 
culture at 37 °C, 5% CO2 in a humidified incubator, culture medium was removed, replaced 
with fresh medium, and then the adhered peritoneal macrophages were exposed to various 
concentrations of 95EE-FLP or vehicle control for 1 h before stimulation with 100 ng/mL 
LPS.  After 8 h incubation, the supernatants were isolated and stored at -80 °C for 
quantification the levels of TNF-α, and IL-6 cytokines. 
 5.3.8 Enzyme-linked immunosorbent assay (ELISA) 
  ELISA is a very popular technique in clinical diagnosis, biological, and 
medical scientific research.  ELISA can be used to detect and quantify the antigens, 
antibodies, hormones or cytokines presented in the sample.  Figure 5.1 shows the principle 
of an ELISA assay.  A specific monoclonal antibody (mAb) against the specific cytokine of 
interest is coated on a microtiterplate.  After adding samples, a second mAb which binds     
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a different epitope on the cytokine is added.  Commonly, the second mAb is labeled with 
biotin, which allows subsequent binding of a streptavidin-conjugated enzyme.  Unbound 
reagents are washed away in each step.  When substrate is added, a color reaction, which is 
proportional to the amount of cytokine bound, will develop.  The concentration of cytokine 
is determined from a standard curve prepared from the known amount of standard cytokine 
of interest (Mabtech, www, 2012). 
 
 
Figure 5.1 ELISA assay procedure.  After coating with monoclonal antibody (mAb), 
unknown sample or standard are added to the plate.  Biotinylated detection mAb and 
streptavidin-enzyme are added, respectively.  When substrate is added, a color reaction will 
be developed (Mabtech, www, 2012). 
 
  Cytokine levels were quantified by ELISA as previously described (Condie, 
Herring, Koh, Lee, and Kaminski, 1996).  Briefly, Immunolon strip plates (Thermo, York, 
PA) were coated with 50 µL/well of 1 µg/mL purified anti-mouse/rat TNF-α (clone#TN3-
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19.12, eBioscience, San Diego, CA) or purified anti-mouse IL-6 (clone#MP5-20F3, 
eBioscience) and incubated overnight at 4 °C.  Wells were then washed three times with  
250 µL PBST (0.02% Tween 20 in phosphate buffered saline, pH 7.4) to remove excess 
unbound antibody.  The non-specific sites were blocked with 300 µL/well of 3% BSA in 
PBST for 1 h at room temperature followed by three additional washes.  Fifty µL/well of 
sample or standard, mouse TNF-α recombinant protein (eBioscience) or mouse IL-6 
recombinant protein (eBioscience), were added to respective wells.  After washing,             
1 µg/mL biotinylated anti-mouse/rat TNF-α (Polyclonal Ab, eBioscience) or biotinylated 
anti-mouse IL-6 (clone#MP5-32C11, eBioscience) diluted in 3% BSA-PBST, was added to 
the corresponding wells and allowed to incubate at room temperature for 1 h.  After 
washing, 50 µL of streptavidin peroxidase diluted 333.3-fold was added followed by 
incubation at room temperature for 1 h.  After washing, TMB substrate [12.5 mL citric-
phosphate buffer pH 5.0 + 200 µL of 3, 3’, 5, 5’-tetramethyl-benzidine stock solution         
(6 mg/mL in DMSO) + 50 µL 1% H2O2] was added.  The reaction was terminated by the 
addition of 100 µL 6 N H2SO4.  Optical density was determined at 450 nm using an EL-808 
microplate reader (Bio-Tek Instruments, Winooski, VT). 
 5.3.9 Quantitative reverse transcription PCR (qRT-PCR) 
  Real-Time qRT-PCR (Real Time quantitative Reverse Transcrtiption 
Polymerase Chain Reaction) is a major development of PCR technology that enables 
reliable detection and quantification of product generated during each cycle using SYBR 
Green or TaqMan probes for detection.  TaqMan Gene Expression Assay reaction steps are 
shown in Figure 5.2.  At the start of the RT-PCR reaction, the temperature is increased to 
denature the double stranded cDNA.  The signal from the fluorescent dye on the 5ˊ end of 
TaqMan probe is quenched by the non-fluorescent quencher on the 3ˊ end of the probe.  
The reaction temperature is decreased to allow the primers and probe to anneal to their 
specific target sequences.  In the next step, Taq polymerase synthesizes a complementary 
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DNA strand using the unlabeled primers and template as a guide.  When the polymerase 
reaches the TaqMan probe, its endogenouse 5ˊ nuclease activity cleaves the probe, 
separating the dye from the quencher.  When more dye molecules are released in each cycle 
of PCR, these accumulated dye molecules lead to increased fluorescence intensity, which in 
turn, is proportional to the synthesis amount of amplicons (NCBI, www, 2012). 
 
 
 
Figure 5.2 TaqMan gene expression assay reaction steps (NCBI, www, 2012).  
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  Total RNA was isolated from RAW264.7 cells using SV Total RNA Isolation 
kits (Promega) according to the manufacturer’s instructions.  The isolated RNA was 
quantified using a Nanodrop ND-1000 spectrophotometer (NanoDrop, Wilmington, DE).  
qRT-PCR was performed on an Applied Biosystems 7900 PRISM Thermocycler (ABI, 
Foster City, CA) using a Taqman assay system.  Briefly, total RNA (250 ng) in a total 
reaction volume of 25 µL was reverse transcribed using High Capacity cDNA Reverse 
Transcription kit (AB Applied Biosystems) as described by the manufacturer’s instructions.  
Two µL of the generated cDNA were used as a template in a 20 µL PCR reaction 
containing 1 µL of the target gene primers (TNF-α, and IL-6 AB Applied Biosystems),       
1 µL of endogenous reference primers (18S ribosomal RNA, Applied Biosystem), 10 µL of 
TaqMan Universal PCR Master Mix (Applied Biosystems), and 6 µL of water to bring final 
volume to 20 µL.  The amount of target gene mRNA was normalized to 18S ribosomal 
RNA and relative to the calibrator was calculated by using the formula 2
-∆∆CT
 and was 
expressed as fold change compared to naïve control. 
 5.3.10 Electrophoretic mobility shift assay (EMSA) 
  The electrophoretic mobility shift assay (EMSA) is a powerful, widely used 
method that tests the capacity of purified proteins or proteins in cell extracts to bind 
selectively to specific double stranded DNA sequences.  Electrophoretic separation of         
a protein-DNA mixture on a polyacrylamide gel was indicated in Figure 5.3.  If specific 
protein-DNA adducts form, they will migrate more slowly than an unbound radioactive 
probe and are thus visualized by discrete bands of radioactivity near the top of an 
acrylamide gel image (Kothinti, Tabatabai, and Petering, 2011). 
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Figure 5.3 Electrophoretic separation of a protein-DNA mixture on a polyacrylamide gel 
for a short period of time.  Lane 1 is a negative control containing only DNA.  Lane 2 
contains protein as well as a DNA fragment that, based on its sequence, does not interact.  
Lane 3 contains protein and a DNA fragment that does react.  The resulting protein-DNA 
complex is larger, heavier, and slower-moving than the unbound probe, and these appear as 
a shifted up band in the autoradiographic film (Molecular station, www, 2008). 
 
  5.3.10.1 Preparation for protein lysate 
   Nuclear extracts from RAW264.7 cells were prepared as described 
previously (Condie et al., 1996).  Briefly, cells were seeded at 1x10
7
 cells/mL in a 150 mm
2
 
petri dish and cultured for 48 h.  Culture medium was removed at the end of 48 h and 
replaced with fresh media.  Cells were pretreated with 95EE-FLP (50, 150, or 250 µg/mL) 
or vehicle for 1 h and then stimulated with 100 ng/mL of LPS for 30 min (for NF-ҡB in 
mTNF-α, NF-ҡB in mIL-6 and AP-1 in mIL-6 promoters) or 1 h (for C/EBP in mIL-6 
promoter).  Cells were then isolated by scraping, resuspended in fresh media, transferred to 
50 mL tubes, and centrifuged at 300 x g for 5 min.  Cell pellets were resuspended in cold 
1X PBS, centrifuged at 300 x g for 5 min, and resuspended in 500 µL of hypotonic buffer 
(10 mM HEPES, and 1.5 mM MgCl2) supplemented with 1 mM dithiothreitol, 0.1 mM 
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phenylmethylsulfonyl, 0.2 µg/mL aprotinin, and 0.2 µg/mL leupeptin, and transferred to a 
1.5 mL eppendorf tube.  After 15 min on ice, cell pellets were centrifuged at 1,000 x g for 5 
min at 4 °C.  The cell pellets were vortex mixed in 100 µL of ice cold buffer C (30 mM 
HEPES, 1.5 mM MgCl2, 450 mM NaCl, 0.3 mM EDTA, 10% glycerol, and 0.1% Igepal) 
added with 1 mM DTT, 0.1 mM PMSF, and 0.2 µg/mL of leupeptin and aprotinin, and 
incubated on ice for 30 min.  Cellular debris was removed by centrifugation at 14,500 rpm, 
15 min at 4 °C.  Then, 100 μL supernatant was transferred and combined with 100 μL 
buffer D (30 mM HEPES, 1.5 mM MgCl2, 0.3 mM EDTA, and 10% glycerol).  These 
supernatant combined with buffer D was collected and kept in -80 °C for further analysis.  
The aliquot part was used for protein determination. 
  5.3.10.2 Determination of protein concentration 
   The protein concentration of the supernatant was quantified using the 
BCA assay (Stoscheck, 1990).  The protein lysate was diluted in nuclease free water (1:12).  
Thirty microliters of diluted protein lysate was mixed with 200 μL of copper BCA solution 
in a 96-well plate.  The reaction was incubated at 37 °C for 30 min and measured the 
absorbance of 562 nm.  BSA was used as a standard curve for protein determination. 
  5.3.10.3 Electrophoretic mobility shift assay 
   The binding reaction was performed by adjusting the final NaCl 
concentration to 50 mM (for NF-ҡB in mTNF-, and NF-ҡB and C/EBP in mIL-6 
promotors) and 100 mM (for AP-1 in mIL-6 promoter) followed by incubation on ice for  
10 min with nuclear protein (1 µg for NF-ҡB, C/EBP and AP-1 in mIL-6 promoters, and       
0.5 µg for NF-ҡB in mTNF-α promoter) and poly dI-dC (1 μg for NF-ҡB in mTNF-α and 
mIL-6 promoters and 0.2 μg for AP-1 and C/EBP in mIL-6 promoters).  After incubation 
with poly dI-dC, 45,000 cpm of the double-stranded 
32
P-labeled probes were added to the 
reaction and incubated at room temperature for another 20 min.  Pairs of complementary 
oligonucleotides with 2 nucleotide overhangs were used to generate double-stranded DNA 
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probes (Table 5.1).  To assess the specificity of DNA binding activity, the nuclear extracts 
were incubated with a 25-fold excess of unlabeled probe (NF-ҡB in mTNF-α and AP-1 in 
mIL-6 promoters), or a 10-, 25-, 50-, 100- and 250-fold excess of unlabeled probe (NF-ҡB 
and C/EBP in mIL-6 promoters) prior to addition of the radiolabeled probe.  The resulting 
protein-DNA complexes were resolved on a 5% polyacrylamide gel in 0.5X TBE buffer 
(1X = 89 mM Tris, 89 mM borate, and 2 mM EDTA).  The gel was then dried on 3 mm 
filter paper (Whatman, Hillsboro, OR) and autoradiographed. 
 
Table 5.1 Sequences of oligonucleotide probes used in the EMSA assay. 
Transcription 
factors 
Mouse 
promoter 
Oligonucleotide probes 
Position relative 
to transcription 
start 
NF-B 
 
NF-B 
 
C/EBP 
 
AP-1 
TNF- 
 
IL-6 
 
IL-6 
 
IL-6 
5’-GT AAA CAGGGGGCT TTCCCT CCT CAA-3’ 
5’-GT TTG AGG AGGGAAAGCCCC CTG TTT-3’ 
5’-TC AAA TGTGGG ATT TTCCCA TGA G-3’ 
5’-GA CTC ATGGGA AAA TCCCAC ATT T-3’ 
5’-AG CACATT GTG CAA TCT TAA-3’ 
5’-TA TTA AGA TTG CAC AATGTG-3’ 
5’-TT CCC ATG AGT CTC AAA ATT-3’ 
5’-CT AAT TTT GAGACTCAT GGG-3’ 
-510 
 
-64 
 
-147 
 
-55 
The putative transcription factor binding sequence is in bold for each probe. 
 
 5.3.11 Transient transfection and luciferase assay 
  5.3.11.1 Preparation of competent cells and their transformation with plasmid 
DNA 
   A genetically engineered highly transformable strain E. coli DH5α, 
pGL2-basic luciferase reporter gene vector, pmIL-6.Luc(-231) plasmid, and RAW264.7 cell 
were used in this study.  Two plasmids DNA were obtained as a kind gift from Dr. Gail 
Bishop from the University of Iowa.  Competent E. coli cells for DNA uptake were 
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prepared using the standard method of calcium chloride (CaCl2) treatment (Sharma, Singh, 
and Gill, 2007) with minor modification.  Briefly, a single E. coli DH5α colony was 
inoculated into 5 mL of Luria broth (LB) media in a 15 mL conical tube and incubated 
overnight at 37 °C in shaking water bath (GFL Shaking Water Baths-1086, Labsource, 
Manchester, UK) with a rotation speed of 150 rpm.  Then, 1 mL of the bacterial suspension 
was inoculated into 100 mL of pre-warmed LB broth medium in a 500 mL flask and 
continuously incubated under the same condition until the bacterial cells grew to log phase 
(OD600 = 0.35-0.5 in LB broth medium), which was determined by a Cecil 1000 series 
spectrophotometer (Cecil Instruments, Cambridge, UK).  Twenty milliliters of bacterial 
suspension was transferred to 50 mL conical tubes (20 mL/tubes).  Bacterial suspension in 
50 mL conical tubes were pelleted by centrifugation for 5 min at 1,500 x g at 4 °C, 
resuspended in 6 mL of sterile ice-cold 100 mM MgCl2 solution (6 mL/tubes), and then 
incubated for 10 min on ice.  The bacteria solution was pelleted by centrifugation at     
1,500 x g for 5 min at 4 °C, resuspended in 6 mL of sterile ice-cold 100 mM CaCl2 solution 
(6 mL/tubes), and incubated on ice for another 30 min.  All bacteria solutions were pooled 
into one 50 mL conical tube.  After another centrifugation step as above, the resulting cells 
pellet was ultimately resuspended in 5 mL ice cold 100 mM CaCl2 plus 15% glycerol.  The 
competent cell suspension was aliquoted into eppendorf tubes and stored at -80 °C until 
needed. 
   For transformation, the competent cell suspension and plasmid DNA 
of pGL2-basic and pmIL-6.Luc(-231) were thawed on ice.  Afterwards, 50 µL of the 
competent cell suspension and 1-3 µL (5-15 ng) of the plasmid DNA were directly loaded 
into the ice-chilled microcentrifuge tube and was allowed to incubate on ice for 30 min.  
The cell-DNA complex was then heat shocked at 42 °C for exactly 90 s.  The mixture was 
returned to ice for 3 min before 1 mL of fresh LB broth medium was added, and the mixture 
was incubated for 1 h at 37 °C in a shaking water bath with a rotation speed of 150 rpm.  At 
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this time, cultures were serially diluted and 200 µL aliquots were spread on agar-LB broth 
with and without ampicillin (100 µg/mL) to obtain the number of transformants and viable 
cells respectively.  After overnight incubation at 37 °C, a single colony was inoculated into 
5 mL of LB broth with ampicillin (100 µg/mL) in a 50 mL conical tube and continuously 
incubated under the same condition.  1 mL of bacteria solution was transferred to sterile 
cryo-storage tubes and 1 mL of sterile 100% glycerol was added.  After mixing, the 
glycerol stocks were stored at -80 °C until use.  Bacteria solution was then pelleted by 
centrifugation at 2,400 x g for 10 min at 4 °C and plasmid DNA was isolated from bacteria 
using the QIAprep Spin Miniprep Kit and a Microcentrifuge (Qiagen, Valencia, CA).  DNA 
concentration (pGL2-basic: 535.4 ng/µL, pmIL-6.Luc(-231): 692 ng/µL) in the extract was 
quantified using the NanoDrop ND-1000 Spectrophotometer and digested with HindIII-HF 
and BamHI (New England Biolabs Inc., Ipswich, MA).  DNA sequencing was performed 
for confirmation of the plasmid DNA. 
  5.3.11.2 Bacterial culture 
   Bacterial cells were streaked from glycerol stock, immediately 
transferred to 5 mL of LB broth with ampicillin (100 µg/mL) in a 50 mL conical tube, and 
incubated overnight at 37 °C in shaking water bath with a rotation speed of 150 rpm.  
Bacteria solution were harvested by centrifugation at 2,400 x g for 10 min at 4 °C, and 
plasmid DNA was isolated from bacteria using the QIAprep Spin Miniprep Kit and             
a Microcentrifuge.  Extracted DNA was then pooled into one microcentrifuge tube and 
concentrated using Savant DNA 110 Speed Vac (Global Medical Instrumentation, Inc., 
Ramsey, MN).  Consequently, the concentrated DNA (pGL2-basic: 578.2 ng/µL,        
pmIL-6.Luc(-231): 2,822.2 ng/µL) was quantified and stored at -20 °C until needed. 
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  5.3.11.3 Transfecting plasmid DNA into RAW264.7 cells using 
Lipofectamine 2000 
   RAW264.7 cells were transfected using Lipofectamine 2000 
(Invitrogen, Carlsbad, CA) according to manufacturer’s instructions.  Briefly, RAW264.7 
cells were preseeded in a 6-well plate at 5x10
5
 cells/well in high glucose DMEM medium 
with 10% FBS followed by overnight incubation.  Culture medium was then removed and 
replaced with fresh medium with 5% FBS.  After 24 h incubation, culture medium was 
removed, replaced with fresh medium without serum and antibiotics, and incubated 
overnight.  Before transfection, culture medium was removed and replaced with fresh 
medium without serum and antibiotics at 2 mL/well.  Cells were then incubated for 4 h with 
transfection mixture [8 µg of pGL2-basic in 16 µL of lipofectamine 2000 or 8 µg of    
pmIL-6.Luc(-231) (generously provided by Dr. Gail Bishop) in 16 µL of lipofectamine 
2000 per well].  The medium containing the transfection mixture was removed by 
centrifugation for 3 min at 700 rpm and replaced with fresh medium containing 2% FBS, 
and the cells were allowed to recover for 4 h.  Then, transfected cells were scraped and 
distributed to a 48-well plate at 4x10
5
 cells/1 mL/well.  After overnight incubation, culture 
medium was removed by centrifugation and replaced with fresh medium containing 2% 
FBS.  The transfected RAW264.7 cells were then pretreated with increasing concentrations 
of 95EE-FLP (50, 150, or 250 µg/mL) or vehicle for 1 h before stimulation with 700 ng/mL 
LPS.  Treatments were performed in 4 replicates.  Eighteen hours after stimulation, the 
medium was removed and cells were washed twice with 1X PBS by centrifugation for        
5 min at 300 x g at 4 °C.  Then, 40 µL of reporter lysis 1X buffer were added to wells of a 
48-well plate and the plate was kept at -80 °C overnight. 
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  5.3.11.4 Luciferase assay 
   Reporter gene system is a technology where a reporter gene is 
synthesized in response to activation of a specific signaling cascade of interests.  Thus, 
reporter protein expression of interest will be monitored by its enzymatic activities linked 
with a variety of colorimetric, fluorescent, or luminescent read-outs (Cheng et al., 2010). 
   Cell lysates in a 48-well plate were thawed at room temperature.  The 
plate was rocked and vortexed for several times to ensure the complete coverage of the cells 
with lysis buffer.  Lysed cells were then transferred to a 500 µL eppendorf tube on ice and 
vortexed.  Twenty microliter of lysed cells were added to a 96-luminometer plate and the 
luminometer was read with 100 µL luminescent substrate using Wallac Microbeta 1450 
Trilux Luminometer Liquid Scintillation Counter (Perkin Elmer Life Sciences, Turku, 
Finland).  Protein determinations were performed using the Bradford protein assay.  The 
luciferase activity was normalized to the determined amount of total protein.  Results of 
luciferase expression were expressed as a relative light units (RLU)/µg protein. 
 5.3.12 Statistical analysis 
  Statistical significance of all variables (GraphPad Prism 5, USA) was 
determined by performing a one-way analysis of variance (ANOVA) with a post-hoc 
Turkey’ s analysis to determine differences between treatments and control groups.  Values 
were considered statistically significant when p<0.05.  Data were presented as mean ± SEM 
(n=3 for ELISA and qRT-PCR analysis, n=4 for transient transfection analysis) and were 
representative of at least three independent experiments.  EMSA analysis experiments were 
repeated at least 2 times with similar results. 
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5.4 Results 
 5.4.1 Suppression by 95EE-FLP of TNF-α and IL-6 release in LPS-stimulated 
macrophages 
  To investigate the anti-inflammatory activity of 95EE-FLP, freshly isolated 
peritoneal macrophages were activated with LPS in the presence of 95EE-FLP.  ELISA was 
performed to quantify secreted proinflammatory cytokines TNF-α and IL-6.  95EE-FLP at 
150 and 250 µg/mL significantly decreased TNF-α production induced by LPS when 
compared to the vehicle control (Figure 5.4A).  Likewise, at the same concentrations,  
95EE-FLP also significantly suppressed LPS-induced IL-6 production (Figure 5.4B).  The 
suppressive effect of 95EE-FLP on TNF- and IL-6 was not due to direct cytotoxicity as 
cell viability of peritoneal murine macrophages was ≥ 80%, and there was no difference in 
cell viability among naïve (NA), vehicle (VH), and all 95EE-FLP treatment groups as 
assessed by trypan blue exclusion staining (data not shown).  Thus, 95EE-FLP suppressed 
both LPS-induced TNF-α and IL-6 secretions by mouse peritoneal macrophages with IL-6 
exhibiting more sensitivity to suppression.  Reduced TNF-α and IL-6 production by    
95EE-FLP treatment was also observed in the LPS-activated mouse macrophage cell line 
RAW264.7 (Figure 5.5A and B).  Cellular viability of RAW264.7 cells was ≥ 85% for all 
treatment groups and no differences in cell viability were observed among NA, VH, and 
95EE-FLP (data not shown).  Thus, 95EE-FLP was capable of impairing proinflammatory 
cytokine levels of TNF-α and IL-6 produced by both peritoneal macrophages and 
RAW264.7 macrophage cell line. 
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Figure 5.4 95EE-FLP suppressed TNF-α (A) and IL-6 (B) release in LPS-activated mouse 
peritoneal macrophages.  Mouse peritoneal macrophages (2.5x10
5 
cells/well) were 
pretreated with various concentrations of 95EE-FLP (50, 150, or 250 µg/mL) or vehicle 
control for 1 h.  Cells were then activated with 100 ng/mL LPS for 8 h.  The supernatants 
were harvested and measured for TNF-α and IL-6 production by ELISA.  Values shown are 
the mean ± SEM (n=3) and are representative for three independent experiments.  Bars 
marked with different letters are significantly different at p<0.05. 
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Figure 5.5 95EE-FLP suppressed TNF-α (A) and IL-6 (B) release in LPS-activated 
RAW264.7 cells.  RAW264.7 cells (2x10
6 
cells/well) were pretreated with various 
concentrations of 95EE-FLP (50, 150, or 250 µg/mL) or vehicle control for 1 h prior to 
activation with 100 ng/mL LPS for 8 h.  The supernatants were harvested, and TNF-α and 
IL-6 production were quantified by ELISA.  Data presented as mean ± SEM (n=3) and are 
representative for three independent experiments.  Bars marked with different letters are 
significantly different at p<0.05. 
 
 5.4.2 95EE-FLP suppressed TNF-α and IL-6 proinflammatory cytokines 
mRNA levels in LPS-stimulated RAW264.7 cells 
  To determine if suppression of TNF-α and IL-6 production by 95EE-FLP was 
related to changes in mRNA levels for both inflammatory cytokines, qRT-PCR was 
performed.  Increasing concentrations of 95EE-FLP produced a concomitant decrease in 
mRNA levels for both TNF-α and IL-6 in LPS-activated RAW264.7 cells (Figure 5.6A    
and B).  The profile of TNF-α and IL-6 suppression by 95EE-FLP at both the protein and 
mRNA levels was remarkably similar with 95EE-FLP exerting more pronounced effect on 
IL-6 than TNF-α.  In order to gain further insight into the molecular mechanisms of     
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95EE-FLP-mediated suppression of LPS-induced TNF-α and IL-6 production, EMSAs 
were conducted to examine 95EE-FLP modulation of transcription factor DNA binding 
activity of NF-ҡB, C/EBP, and AP-1. 
 
 
 
 
 
 
 
 
 
Figure 5.6 95EE-FLP suppressed TNF-α (A) and IL-6 (B) proinflammatory cytokine gene 
expression in LPS-activated RAW264.7 cells.  RAW264.7 cells (2x10
6 
cells/well) were 
pretreated with various concentrations of 95EE-FLP (50, 150, or 250 µg/mL) or vehicle 
control for 1 h followed by activation with 100 ng/mL LPS.  Cells were then incubated for  
8 h after-activation, at which time total RNA was isolated.  TNF-α and IL-6 mRNA levels 
were determined by qRT-PCR using Taqman primers and probe.  Endogenous 18S rRNA 
was used as a control and fold changes were obtained using 2
-∆∆Ct
 method.  Data are 
presented as mean ± SEM (n=3) and are representative of three independent experiments.  
Bars marked with different letters are significantly different at p<0.05. 
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 5.4.3 95EE-FLP suppressed LPS-induced NF-ҡB DNA binding activity in the 
TNF-α and the IL-6 promoters 
  As previously reported (Kuprash et al., 1999), the mouse TNF-α promoter 
contains several key NF-ҡB elements that are critically involved in regulating transcription 
(-860, -660, -630, and -510).  Of these four ҡB sites, the ҡB element located at -510 was 
reported to exhibit the strongest DNA binding activity.  Based on these prior findings, the 
effect of 95EE-FLP on LPS-induced NF-ҡB DNA-binding activity was investigated by 
EMSA using nuclear extracts from RAW264.7 cells.  Initially, kinetic studies were 
conducted to identify the peak time of ҡB binding after LPS activation of RAW264.7 cells.  
As shown in Figure 5.7A and 5.8A, NF-ҡB DNA binding activity in the mouse TNF-α and 
mouse IL-6 promoter was similarly induced with 100 ng/mL of LPS within 30 min and 
remained elevated throughout the 4 h time period.  Increasing concentrations of 95EE-FLP 
(50, 150, or 250 µg/mL) for 1 h prior to LPS (100 ng/mL) activation suppressed the 
increased NF-ҡB binding activity observed at 30 min post activation, in a concentration-
dependent manner (Figure 5.7B and 5.8B). 
 5.4.4 95EE-FLP suppressed LPS-induced C/EBP DNA binding activity in IL-6 
promoter 
  To further investigate transcription factor responses modulated by 95EE-FLP, 
gel shift assays of C/EBP binding to the IL-6 promoter was performed on RAW264.7 cell 
extracts.  The present study first examined the peak time of C/EBP DNA binding activity in 
100 ng/mL of LPS-stimulated RAW264.7 cells.  As presented in Figure 5.9A, C/EBP DNA 
binding activity in the mIL-6 promoter was induced by LPS within 30 min, reaching a peak 
at 2 h, decreased thereafter and almost returned to basal level by 4 h.  Exposure to 
increasing 95EE-FLP concentrations (50, 150, or 250 µg/mL) produced a concentration-
dependent suppression of C/EBP DNA binding activity in mIL-6 promoter (Figure 5.9B). 
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Figure 5.7 Electrophoretic mobility shift assay (EMSA) of NF-B DNA binding activity in 
mouse TNF-α promoter.  (A) Time course for LPS-induced NF-B DNA binding activity in 
RAW264.7 cells.  (B) The effect of 95EE-FLP on NF-ҡB binding activity in LPS-activated 
RAW264.7 cells.  Cells were pretreated with increasing concentrations of 95EE-FLP      
(50, 150, or 250 µg/mL) for 1 h and then activated with 100 ng/mL LPS for 30 min.  The 
nuclear protein (0.5 µg) was resolved by EMSA as described in the materials and methods.  
25-fold excess of unlabeled probe was used to compete with the labeled oligonucleotide and 
their NF-ҡB binding activity was compared at 30 min time point.  The data shown is 
representative of three independent experiments. 
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Figure 5.8 Electrophoretic mobility shift assay (EMSA) of NF-B DNA binding activity in 
mouse IL-6 promoter.  (A) Time course for LPS-induced NF-B DNA binding activity in 
RAW264.7 cells.  (B) The effect of 95EE-FLP on NF-ҡB binding activity in RAW264.7 
cells.  RAW264.7 cells were pretreated with increasing concentrations of 95EE-FLP       
(50, 150, or 250 µg/mL) for 1 h and then activated with 100 ng/mL LPS for 30 min.  The 
nuclear protein (1 µg) was resolved by EMSA as described in the materials and methods.  
The binding specificity was determined using an unlabeled probe (10 - 250 fold in excess) 
to compete with the labeled oligonucleotide and their NF-ҡB binding activity was compared 
at 30 min time point.  The data shown is representative of three independent experiments. 
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Figure 5.9 Electrophoretic mobility shift assay (EMSA) of C/EBP DNA binding activity in 
mouse IL-6 promoter.  (A) Time course for LPS-induced C/EBP DNA binding activity in 
RAW264.7 cells.  (B) The effect of 95EE-FLP on C/EBP binding activity in LPS-activated 
RAW264.7 cells.  RAW264.7 cells were pretreated with increasing concentrations of 95EE-FLP 
(50, 150, or 250 µg/mL) for 1 h and then activated with 100 ng/mL LPS for 2 h.  The nuclear 
protein (1 µg) was resolved by EMSA as described in the materials and methods.  The 
binding specificity was determined using an unlabeled probe (10 – 250 fold in excess) to 
compete with the labeled oligonucleotide and their C/EBP binding activity was compared at 
30 min time point.  The data shown is representative of three independent experiments. 
 
 5.4.5 95EE-FLP suppressed LPS-induced AP-1 DNA binding activity in IL-6 
promoter 
  Gel shift analysis was conducted to determine whether 95EE-FLP alters AP-1 
DNA binding activity in LPS-activated RAW264.7 cells.  Kinetic analysis revealed the 
peak time of AP-1 DNA binding activity was at 30 min (Figure 5.10A).  The potency of      
95EE-FLP on AP-1 DNA binding activity in activated RAW264.7 cells was evidenced by a 
Free probe 
C/EBP 
Time (h) 
LPS (100 ng/mL) 
Relative 
intensity 
10 25 50 100 250 Pr
o
b
e 
al
o
n
e 
0  1/2   1    2   3   4 
Cold 
competitors 
  -    +    +   +   +    +   
1
 0
0
 
1
.2
5
 
1
.6
1
 
1
.7
4
 
1
.2
9
 
1
.0
3
 
0
.4
3
 
0
.1
5
 
0
.1
3
 
0
.0
5
 
0
.0
2
 
A B 
C/EBP 
95EE-FLP (µg/mL) 
LPS (100 ng/mL) 
Free probe 
Relative 
intensity 
1
.0
0
 
0
.8
7
 
1
.4
2
 
1
.5
7
 
1
.2
4
 
1
.1
7
 
0
.9
9
 
0
.6
0
 
C
o
ld
 c
o
m
p
et
it
o
r 
 -    -    +   +    +   +   + 
N
A
 
2
5
0
 
N
A
 
V
H
 
5
0
 
1
5
0
 
2
5
0
 
P
ro
b
e 
al
o
n
e 
  
 
 
 
 
 
 
 
130 
concentration-dependent decrease of both upper and lower bands of AP-1 DNA binding 
activity (Figure 5.10B). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 Electrophoretic mobility shift assay (EMSA) of AP-1 DNA binding activity in 
mouse IL-6 promoter.  (A) Time course for LPS-activated AP-1 DNA binding activity in 
RAW264.7 cells.  (B) The effect of 95EE-FLP on AP-1 binding activity in LPS-activated 
RAW264.7 cells.  RAW264.7 cells were pretreated with increasing concentrations of  
95EE-FLP (50, 150, or 250 µg/mL) for 1 h and then activated with 100 ng/mL LPS for     
30 min.  The nuclear protein (1 µg) was resolved by EMSA as described in the materials 
and methods.  The binding specificity was determined using an unlabeled probe (10-100 
fold in excess) to compete with the labeled oligonucleotide and their AP-1 binding activity 
was compared to VH control.  The data shown is representative of three independent 
experiments. 
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 5.4.6 95EE-FLP-mediate suppression of pmIL-6.Luc(-231) reporter activity in 
LPS-activated RAW264.7 cells 
  To further investigate whether the impairment of NF-ҡB, C/EBP, and AP-1 
DNA binding activity in LPS activated RAW264.7 cells by 95EE-FLP resulted in 
suppression of IL-6 transcription, transient transfection experiments were performed using 
IL-6 promoter reporter.  Previously, Baccam and coworkers showed the activation of 
5’truncation mutants of the mIL-6 [pmIL-6.Luc(-231), pmIL-6.Luc(-161), pmIL-6.Luc      
(-84)] promoter/luciferase reporter with CD40 in CD154.CH12.LX B cells resulted in 
strongest luciferase activity with pmIL-6.Luc(-231).  In fact, pmIL-6.Luc(-231) exhibited 
comparable activity to the original full length mIL-6 promoter pmIL-6.Luc(-1277) (Baccam 
et al., 2003).  Based on these prior findings, we investigated whether 95EE-FLP 
suppression on proinflammatory IL-6 induction in LPS-stimulated RAW264.7 cells was at 
the level of transcription by using the IL-6 promoter-reporter possessing the 5’ truncation,             
pmIL-6.Luc(-231) (Figure 5.11A) (Baccam et al., 2003).  As presented in Figure 5.11B, 
pmIL-6.Luc(-231)-transfected RAW264.7 cells expressed higher luciferase activity upon 
LPS induction for 18 h, suggesting that the LPS regulatory elements present within the    
231 bp upstream of transcription start site were functionally active.  However, preliminary 
LPS concentration-response range finding studies using 100 to 1,000 ng/mL did not 
produce significant differences in luciferase activity in RAW264.7 cells.  Figure 5.11C 
shows that 95EE-FLP treatment of transiently transfected RAW264.7 cells with pmIL-6 
followed by activation with increasing concentrations of LPS demonstrated a dependent 
decrease in luciferase activity.  It is noteworthy that pmIL-6.Luc(-231) activity was greatly 
reduced with 95EE-FLP treatment (150 and 250 µg/mL). 
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Figure 5.11 IL-6 promoter reporter luciferase activity in transient transfected RAW264.7 
cells.  (A) a schematic diagram of -231 IL-6 promoter reporter construct.  Transcriptional 
response elements of AP-1, NF-ҡB, and C/EBP.  (B) IL-6 promoter reporter activity in 
RAW264.7 cells transiently transfected with pmIL-6.Luc(-231) construct and treated with 
or without LPS at indicated concentrations for 18 h.  (C) pmIL-6.Luc(-231) reporter activity 
in RAW264.7 cells treated with 95EE-FLP.  RAW264.7 cells (5x10
5
 cells/well) were 
preseeded in a 6-well plate and then transiently transfected with pGL2-basic and pmIL-6. 
Luc(-231).  Transfected cells were scraped, distributed to a 48-well plate (4x10
5
 cells/well) 
and incubated overnight.  Cells were then pretreated with indicated concentrations of  
95EE-FLP or vehicle for 1 h, followed by addition of 700 ng/mL LPS.  Eighteen hours after 
LPS treatment, luciferase activity was quantified in relative light units (RLU) by 
chemiluminescence assay.  The luciferase activity was then normalized to the determined 
amount of total protein.  Results of luciferase expression are expressed as a RLU/µg 
protein.  The results are presented as mean ± SEM (n=4) and are representative of three 
independent experiments.  Bars marked with different letters are significantly different at 
p<0.05. 
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5.5 Discussion and conclusion 
 Natural products derived from plants have long been used as potentially important 
sources of anti-inflammatory drugs (Gautan and Jachak, 2009).  The present study reports 
on the immune modulatory activity of 95EE-FLP as evidenced by suppression of 
proinflammatory cytokines, TNF-α and IL-6, in LPS-activated peritoneal murine 
macrophages and RAW264.7 cells.  Because high levels of TNF-α and IL-6 play a critical 
role in acute and chronic inflammatory diseases, both cytokines are prime targets for 
intervention by anti-inflammatory therapeutic agents.  Thus, suppression of elevated TNF-α 
and IL-6 induced by LPS has served as a biological model for evaluating anti-inflammatory 
drug candidates (Hüll et al., 1996; Wang et al., 2007; Zhiyuan and Wu, 2009).  
Phytochemicals, especially flavonoids have been shown to possess immune suppressive 
activity against these two inflammatory mediators.  Pretreatment of RAW264.7 cells with 
flavonoids such as luteolin, luteolin-7-glucoside, quercetin, and the isoflavonoid genistein 
suppressed LPS-stimulated TNF-α and IL-6 production (Xagorari et al., 2001).  Likewise, 
pretreatment of RAW264.7 cells with 7-O-methylnaringenin extract (flavonone class of 
polyphenols) from Rhododendron speciferum suppressed LPS-induced TNF-α and IL-6 
production (Soromou et al., 2012).  Analytical analyses in a previous study (Chapter III) 
identified considerable levels of flavonoids in ethanol extracts from PP leaves.  It is 
possible that flavonoids in 95EE-FLP represent one of the active constituents responsible 
for anti-inflammatory activity by down regulating TNF-α and IL-6 released from myeloid 
lineage cells.  Interestingly, PP belongs to the Acanthaceae plant family like Andrographis 
paniculata (AP) whose extracts displayed a wide spectrum of bioactivities, including anti-
inflammation.  Indeed, TNF-α and IL-6 mRNA expression were down regulated by 
andrograpanin isolated from AP (Liu, Wang, and Ge, 2008), mirroring the profile of 
suppression by 95EE-FLP in LPS-activated macrophages observed in the present study. 
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 To further gain insight into the molecular mechanisms by which 95EE-FLP impairs 
TNF-α and IL-6, the effects of 95EE-FLP on the activation of key transcription factors 
involved in TNF-α and mIL-6 regulation, principally NF-ҡB, C/EBP, and AP-1, were 
examined.  The present study demonstrated that 95EE-FLP decreased activation of NF-ҡB 
DNA binding activity in both mTNF-α and mIL-6 promoters occurred in a concentration- 
dependent manner.  The decreased NF-ҡB DNA binding activity to its cognate DNA 
response element in both the mTNF-α and mIL-6 promoters was consistent with the 
decreased TNF-α and IL-6 protein synthesis and mRNA expression in LPS-stimulated 
RAW264.7 cells.  In addition, the cis-acting element identified within the promoter region 
of murine IL-6 also contains C/EBP and AP-1 response elements (Baccam et al., 2003).  
The result shown here suggested that C/EBP and AP-1 are required for IL-6 induction in 
LPS-stimulated RAW26.7 macrophages as evidenced by dominant-positive suppression of 
C/EBP and AP-1 in the mIL-6 promoters by 95EE-FLP.  It is important to emphasize that 
although many studies have shown that various natural products can impair LPS-induced 
DNA binding activity of AP-1 and C/EBP to probes containing consensus sequences (Cho, 
Lee, and Kim, 2003; Lee, Sung, Kim, and Kim, 2003; Cho, Jang, Kim, and Kim, 2004), the 
results here have demonstrated decreased DNA binding activity to bona fided NF-ҡB 
binding sites present in mTNF-α promoter and NF-ҡB, C/EBP, and AP-1 binding sites 
present in mIL-6 promoters.  In the absence of LPS, 95EE-FLP-exposed RAW264.7 cells 
also displayed lower background mRNA levels of both mTNF-α and mIL-6 when compared 
to naïve resting cells (Figure 5.7B, 5.9B, and 5.10B).  These results suggested that       
95EE-FLP may have therapeutic utility by decreasing transcription of proinflammatory 
cytokines.  Furthermore, the present study also showed that 95EE-FLP suppressed LPS-
induced pmIL-6.Luc(-231) luciferase expression in a concentration-dependent manner 
suggesting the suppression of IL-6 occurred at the transcription level.  As the activation of 
NF-ҡB, C/EBP, and AP-1 results in the expression of gene encoding mediator IL-6 
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(Baccam et al., 2003), the suppression of IL-6 mRNA expression by 95EE-FLP could result 
from decreased transcriptional activity of NF-ҡB, C/EBP, and AP-1.  The effect of 
medicinal plants on suppressing transcriptional activity with consequent reduction of 
proinflammatory cytokines has been shown previously.  The ethyl acetate extract from AP 
significantly suppressed NF-ҡB luciferase activity resulting in reduction of TNF-α and IL-6 
production in LPS/IFN-γ stimulated RAW264.7 macrophages (Chao, Kuo, Hsieh, and Lin, 
2011).  In addition, a mixture of β-sitosterol and stigmasterol isolated from AP significantly 
suppressed NF-ҡB luciferase activity and TNF-α and IL-6 productions in LPS/IFN-γ 
stimulated RAW264.7 macrophages (Chao, Kuo, and Lin, 2010).  PP contains β-sitosterol, 
stigmasterol, and apigenin 7-O-β-glucoside (Phan et al., 2003) and other flavonoid 
compounds (Phan et al., 2005; Nguyen and Eun, 2011).  All these constituents have known 
or putative anti-inflammatory activity.  Apigenin-7-O-β-glucoside can metabolize into 
apigenin which also has antioxidant and anti-inflammatory activity.  Apigenin suppressed 
both protein and mRNA expression of COX-2 and iNOS and blocks NF-ҡB activation in 
LPS-activated RAW264.7 macrophages through suppression of inhibitory kappaB (IҡB) 
and NF-ҡB luciferase activity (Liang et al., 1999).  Another study also demonstrated that 
apigenin suppressed the production of proinflammatory cytokines IL-1β, IL-6 and TNF-α 
and NF-ҡB luciferase activity in LPS stimulated RAW264.7 macrophages (Nicholas et al., 
2007). 
 In conclusion, this study demonstrates that 95EE-FLP-mediated suppression of LPS-
induced TNF-α and IL-6 protein synthesis and mRNA expression in murine macrophages 
occurs, at least in part, through suppression of NF-ҡB(-510) in the mTNF-α and NF-ҡB, 
C/EBP and AP-1 activation, and DNA binding in the mIL-6 promoters.  Furthermore, the 
LPS activation of pmIL-6.Luc(-231) promoter/luciferase reporter gene in transfected 
RAW264.7 cells was also suppressed by 95EE-FLP.  Collectively, the partial mechanism of 
95EE-FLP-mediated suppression of proinflammatory cytokines in LPS-induced 
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macrophages was summarized in Figure 5.12.  Though anti-inflammatory leaves of PP, as 
well as various herbal medicine, have been anecdotal in nature rather than scientifically 
validated, PP leaves have long been traditionally used by Thai and Vietnamese people for 
prevention and treatment of various inflammatory diseases.  Considering the long historical 
use in folk medicine, its potential bioactive constituents, and the anti-inflammatory 
evidence provided by this study, PP leaves possess high potential to be developed as a new 
medicinal drug for the prevention or treatment of acute or chronic inflammatory diseases. 
 
 
Figure 5.12 Partial mechanism of 95EE-FLP on suppression of proinflammatory cytokines 
TNF-α and IL-6 in LPS-induced macrophages.  In unstimulated macrophages, C/EBP, NF-ҡB, 
and AP-1 are presented in the cytoplasm.  After TLR4 binds with LPS on the surface of 
macrophage, adaptor molecules associate with TLR4 in the cytoplasm.  These trigger 
phosphorylation or activations of C/EBP, NF-ҡB, or AP-1 transcription factor proteins to 
enter the nucleus and bind to their response elements in the mTNF-α and mIL-6 promoters.  
The DNA/CEBP, NF-ҡB, or AP-1 complexes then recruit other proteins to transcribe 
downstream DNA into mRNA, which inturn, is translated into high levels of TNF-α or IL-6 
protein.  Then, TNF-α and IL-6 proteins bind to their receptors, initiate their signal and 
cellular functions.  Pretreatment of 95EE-FLP down regulated TNF-α and IL-6 mRNA and 
protein expressions by decreasing binding activity of NF-ҡB to the response element in 
mTNF-α promoter, and the binding activities of NF-ҡB, C/EBP, and AP-1 in the mIL-6 
promoters.  The LPS activation of plasmid mIL-6.Luc(-231) was also suppressed by 95EE-FLP 
treatment. 
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CHAPTER VI 
CONCLUSIONS 
 
 The present study demonstrated that various extracts of Pseuderanthemum 
palatiferum (PP) leaves (95EE-FLP, 80EE-FLP, 80EE-DLP, WE-FLP, and WE-DLP) had 
phenolic and flavonoid compounds as well as antioxidant properties as evaluated by 
chemical antioxidant assays (DPPH and FRAP).  However, the extracts from PP fresh 
leaves (95EE-FLP, 80EE-FLP, and WE-FLP) displayed higher contents of phenolic and 
flavonoids as well as antioxidant activities than that of extracts from dried leaves       
(80EE-DLP and WE-DLP).  No significantly different levels of phenolic and flavonoids as 
well as ferric reducing antioxidant power between 95EE-FLP and 80EE-FLP was observed.  
Having highest contents of phenolic and flavonoids and strongest antioxidant activity, 
95EE-FLP and WE-FLP were selected for further determination of cellular antioxidant 
activity in macrophage RAW264.7 cells.  The range-finding study suggested that the 
concentration range of 0-250 µg/mL of both 95EE-FLP and WE-FLP did not affect cell 
viability of RAW264.7, as assessed by three different cell viability tests.  At non-cytotoxic 
concentration (50-250 µg/mL), 95EE-FLP and WE-FLP effectively diminished intracellular 
both in cellular antioxidant and anti-inflammatory activity. ROS generation in tBuOOH 
induced oxidative stress in RAW264.7 cells, which monitored by DCFH-DA fluorescent 
probe.  The cytoprotective effect of both extracts against oxidative damage induced by 
tBuOOH was observed as early as 30 min and throughout the incubation period.  This 
cytoprotective effect of both extracts was dose- and time-dependent and the profile of 
scavenging activity were similar to other antioxidant positive controls (250 µM catechin,  
20 µM resveratrol, and 10 µM quercetin).  The present study suggested that both 95EE-FLP 
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and WE-FLP possess anti-inflammatory property.  Increasing concentrations (50, 100, 150, 
200, or 250 µg/mL) of both 95EE-FLP and WE-FLP as well as various reference 
antioxidants positive controls [500 µM vitamin C (for NO, iNOS and COX-2) or 50 µg/mL 
trolox (for iNOS and COX-2)], significantly lowered the production of NO (p<0.05), iNOS, 
and COX-2, in LPS (1 µg/mL) plus IFN-γ (25 U/mL)-stimulated RAW264.7 cells.  This 
suppressive effect was, however, more pronounced with 95EE-FLP than with WE-FLP. 
 95EE-FLP, the most potent suppressor of inflammatory factors was selected for 
further investigation of its immune modulation of two most prominent proinflammatory 
cytokines, TNF-α and IL-6.  The present study demonstrated that 95EE-FLP dose-
dependently suppressed LPS (100 ng/mL)-induced TNF-α and IL-6 secretion in mouse 
(C57BL/6) peritoneal macrophages.  The similar suppression of LPS-induced up regulation 
of TNF-α and IL-6 protein synthesis and mRNA expression by 95EE-FLP was also 
observed in RAW264.7 cells.  To investigate the molecular mechanisms of 95EE-FLP-
mediated impairment of LPS-induced TNF-α and IL-6, gel shift assays were conducted to 
examine the modulation of transcription factor DNA binding activity of NF-ҡB, C/EBP, 
and AP-1.  95EE-FLP exhibited a concentration-dependent suppression of NF-ҡB binding 
activity within both the mTNF-α and mIL-6 promoters, when RAW264.7 cells were 
activated with LPS for 30 min.  95EE-FLP also exhibited a concentration-dependent 
suppression of C/EBP and AP-1 DNA binding activity within the mIL-6 promoters after 
activation of RAW264.7 cells with LPS for 30 min and 2 h, respectively.  The transient 
transfection of RAW264.7 cells with IL-6 promoter-luciferase reporter plasmid was 
performed to confirm that suppression of IL-6 transcription by 95EE-FLP was actually 
caused by impairment of NF-ҡB, C/EBP, and AP-1 DNA binding activity in LPS-activated 
RAW264.7 cells.  The result clearly indicated that 95EE-FLP reduced IL-6 luciferase 
promoter reporter activity in a concentration-dependent manner in transiently transfected 
RAW264.7 cells, upon LPS activation.  Therefore, the potent anti-inflammatory effects of 
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95EE-FLP are mediated, at least in part, by modulating TNF-α and IL-6 expression through 
down regulation of NF-ҡB, C/EBP, and AP-1 activity. 
 Collectively, these results suggest that extracts of PP leaves contain an abundance of 
phenolic compounds, especially flavonoids, and possess significant antioxidant and anti-
inflammatory activities.  However, further research in animal models and identification of 
PP therapeutic components are still required for the successful development of PP as new 
therapeutic agent against diseases with overproduction of ROSs and inflammatory 
disorders. 
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APPENDIX A 
PREPARATION OF REAGENTS 
 
A.1 Nitrite assay 
 Griess reagent 
- Phosphoric acid         3.5     mL 
- Sulfanilamide                     1        g 
- N-(1-napthyl)-ethylenediamine (NED)               0.1        g 
Adjust volume to 100 mL with DI water, and filter (store at 4 °C). 
A.2 Western blot 
 RIPA buffer 
- PBS (1X)                  100     mL 
- NP-40                      1     mL 
- Sodium dodecyl sulfate (SDS)     0.1        g 
(Store at 4 °C) 
 Lysis buffer 
- RIPA buffer                      1     mL 
- Phenylmethanesulfonyl fluoride (PMSF, 200 mM)   10      µL 
- Leupeptin (2 mM)          1      µL 
- E-64 (1 mM)          1      µL 
   (Freshly prepared) 
 Lowry reagents 
- Reagent A (2% Na2CO3 in 0.1 N NaOH) 
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 Na2CO3          5        g 
 NaOH (0.1 N)                250     mL 
 (Store at 4 °C) 
- Reagent B (0.5% CuSO45H2O in 1% sodium citrate) 
 CuSO45H2O                0.05        g 
 Sodium citrate      0.1        g 
 DI water                   10     mL 
- Reagent C (1 N Folin phenol reagent) 
 2 N Folin phenol reagent diluted with DI water (1:1, v/v) 
 (Freshly prepared) 
- Reagent D 
 Reagent A : Reagent B (50 : 1) (Freshly prepared) 
 Sample buffer (6X) 
- Tris-base                 0.59        g 
- DI water        8.5     mL 
- SDS         1.5        g 
- 2-Mercaptoethanol (2ME)       0.6     mL 
- Glycerol        7.5     mL 
- Bromophenol blue       7.5     mg 
(Store at 4 °C) 
 SDS (10%, w/v) 
- SDS          10        g 
- DI water                  100    mL 
(Store at RT) 
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 Ammonium persulfate (Aps) solution (10%, w/v) 
- Aps         0.1        g 
- DI water           1     mL 
 Acrylamide (30%, w/v) 
- Acrylamide         30        g 
- Bis-acrylamide       0.8        g 
- DI water                  100     mL 
(Filtrate, store at 4 °C) 
 Tris-Cl (1.5 M, pH 8.8) 
- Tris-base             18.165        g 
- DI water                    80     mL 
Adjust pH to 8.8 with HCl and bring to 100 mL with DI water. 
(Filtrate, store at 4 °C) 
 Tris-Cl (0.5 M, pH 6.8) 
- Tris-base                      6        g 
- DI water         80     mL 
Adjust pH to 6.8 with HCl and bring to 100 mL with DI water. 
(Filtrate, store at 4 °C) 
 Running buffer (10X) 
- Tris-base         30        g 
- Glycine                 14.4        g 
- SDS          10        g 
- DI water           1        L 
(Filtrate, store at 4 °C) 
 Running buffer (1X) 
- Running buffer (10X)                100     mL 
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- DI water                  900     mL 
 Blotting buffer (1X) 
- Tris-base           3        g 
- Glycine                 14.4        g 
- Methanol                  200     mL 
Adjust volume to 1 L with DI water, and filter (store at 4 °C). 
 TPBS 0.1% Tween 20 
- PBS (1X)                1000     mL 
- Tween 20           1     mL 
(Filtrate, store at 4 °C) 
 Nonfat milk (5%, w/v) 
- Nonfat milk                 0.75        g 
- TPBS 0.1% Tween 20                  15     mL 
(Freshly prepared) 
 Coomassie blue solution 
- Coomassie blue                0.05        g 
- Methanol                    80     mL 
- Glacial acetic acid                   14     mL 
Adjust volume to 100 mL with DI water (store at RT). 
 Destaining solution 
- Methanol           5     mL 
- Glacial acetic acid          7     mL 
Adjust volume to 100 mL with DI water (store at RT). 
 Resolving gel (7.5%) (for 2 gels) 
- DI water                 4.84     mL 
- 1.5 M Tris-Cl (pH 8.8)      2.5     mL 
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- Acrylamide (30%, w/v)      2.5     mL 
- SDS (10%, w/v)                 100      µL 
- Aps (10%, w/v)        50      µL 
- Tetramethylethylenediamine (TEMED)      10      µL 
 Resolving gel (10%) (for 2 gels) 
- DI water           4     mL 
- Tris-Cl (1.5 M, pH 8.8)      2.5     mL 
- Acrylamide (30%, w/v)      3.3     mL 
- SDS (10%, w/v)                 100      µL 
- Aps (10%, w/v)        50      µL 
- TEMED         10      µL 
 Stacking gel (4%) (for 2 gels) 
- DI water           3     mL 
- Tris-Cl (0.5 M, pH 6.8)               1.25     mL 
- Acrylamide (30%, w/v)                665      µL 
- SDS (10%, w/v)        50      µL 
- Aps (10%, w/v)        25      µL 
- TEMED         10      µL 
A.3 ELISA 
 Citric-phosphate buffer ( pH 5.0) 
- Diabasic sodium phosphate (0.2 M)             25.7     mL 
- Ctric acid (0.1 M)                24.3     mL 
- DI water         50     mL 
(Adjust pH to 5.0) 
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 3, 3’, 5, 5’-tetramethyl-benzidine stock solution (6 mg/mL) 
- 3, 3’, 5, 5’-tetramethyl-benzidine (TMB)     30     mg 
- DMSO           5     mL 
(Stock solution can be store up to 1 month at RT) 
 H2O2 (1%) 
- H2O2 (30%)        0.1     mL 
- DI water        2.9     mL 
 TMB substrate 
- Citric-phosphate buffer pH 5.0              12.5     mL 
- TMB stock solution (6 mg/mL)               200      µL 
- H2O2  (1%)         50      µL 
(Freshly prepared) 
 H2SO4 (6 N) 
- H2SO4 (18 M)            166.67     mL 
Adjust volume to 1 L with DI water 
A.4 EMSA 
 DNA annealing solution 
- Prepared stock DNA solution in nuclease free water (5 pmoles/μL). 
- Stock DNA in eppendorf tube are heated 2 min at 88 °C (usually use heat 
block). 
- Stand at RT and wait until it is at RT. 
- Aliquot 5 μL/tubes. 
(Store at -20 °C) 
 Protease inhibitors 
- DTT (1 M)         10      µL 
  
 
 
 
 
 
 
 
154 
- Aprotinin (0.5 mg/mL)         4      µL 
- Leupeptin (0.5 mg/mL)         4      µL 
- PMSF (200 mM)          5      µL 
(In 10 mL hypotonic buffer and in 10 mL buffer C) 
 Hypotonic buffer (HB buffer) 
- HEPES (0.5 M)          1     mL 
- MgCl2 (1 M)        75      µL 
Adjust volume to 50 mL with MQ water 
 Buffer C 
- HEPES (0.5 M)       1.5     mL 
- MgCl2 (1 M)                37.5      µL 
- EDTA (0.5 M)        15      µL 
- Glycerol        2.5     mL 
- NaCl (5 M)                 2.25     mL 
- Igepal         25      µL 
Adjust volume to 25 mL with MQ water 
 Buffer D 
- HEPES (0.5 M)       1.5     mL 
- MgCl2 (1 M)                37.5      µL 
- EDTA (0.5 M)        15      µL 
- Glycerol        2.5     mL 
Adjust volume to 25 mL with MQ water 
 Poly[d(I-C)] 
- Poly[d(I-C)] 1 bottom          10A260    units 
- HEPES (30 mM)          1     mL 
Measure absorbance (ng/mL) 
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 Polyacrylamide gel (5%)  in TBE buffer (0.5X) 
- MQ water               40.75     mL 
- Acrylamide : Bis-Acrylamide solution (29:1)            6.25     mL 
- TBE (10X)        2.5     mL 
- Aps (10%)        0.5     mL 
- TEMED                    50      µL 
 TBE buffer (10X) 
- Tris (890 mM)        54        g 
- Boric acid (890 mM)               27.5        g 
- EDTA (0.5 M)        20     mL 
Adjust volume to 500 mL with MQ water 
 Running buffer (TBE buffer, 0.5X) 
- TBE buffer (10X)                   25     mL 
Adjust volume to 500 mL with DI water 
A.5 Transfection and luciferase 
 LB broth 
- NaCl          10        g 
- Yeast extract          5        g 
- Tryptone         10        g 
Adjust volume to 1 L with DI water 
(Adjust pH 7.0 ± 0.2 and the medium was autoclaved at 121 °C for 15 min) 
 LB broth agar 
- LB broth                  200     mL 
- Bacto agar           4        g 
- Melt agar into LB broth in the microwave 
- Wait until the solution is cool enough to be held in the hands 
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- Ampicillin (100 mg/mL)                200      µL 
- Pour the LB broth agar onto the plate 
 Bradford’s reagent 
- Coomassie Blue-G                0.01        g 
- phosphoric acid (85%)       10     mL 
- Ethyl alcohol          5     mL 
- Adjust volume to 100 mL with DI water 
- Filtrate with Whatman No. 1 (5-6 times) 
- Keep in dark bottom in 4 °C 
 Bradford protein assay 
- Add 20 µL of BSA standard or sample to each well of a 96-well plate (2 µL 
sample + 18 µL DI water). 
- Add 180 µL of Bradford’s reagent to each well of a 96-well plate and 
gently mix. 
- Incubate for 5 min at RT. 
- Measure the absorbance at 595 nm on a microplate reader. 
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APPENDIX B 
REAGENTS FOR CELL CULTURE 
 
B.1 Phosphate buffered saline (PBS) 
 PBS (1X) 
- KH2PO4                 0.21         g 
- NaCl            9        g 
- Na2HPO4                 0.38         g 
- DI water           1        L 
Adjust pH to 7.2 ± 0.1, and filter sterile (store at 4 °C). 
B.2 Trypsin/EDTA preparation 
 Trypsin/EDTA 
- Trypsin                 0.25        g 
- EDTA                 0.04        g 
- PBS (1X)                  100     mL 
(Filter sterile, aliquot and store at -20 °C) 
B.3 Culture media preparation 
 FBS (inactivated) 
- Slowly thaw the frozen FBS in a beaker filled with water. 
- Put in water bath at 37 °C till completely thaw. 
- Heat inactivate (56 °C, 20 min), gentle mix every 5-10 min. 
- Aliquot 50 mL into conical tubes. 
(Store at -20 °C) 
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 HEPES buffer (1 M) 
- HEPES               23.83        g 
- DI water                  100     mL 
(Filter sterile, aliquot and store at -20 °C) 
 Penicillin/Streptomycin (100X) 
- Penicillin        0.6        g 
- Streptomycin                1.34        g 
- PBS (1X)                  100     mL 
(Filter sterile, aliquot and store at -20 °C) 
 RPMI 1640, 1X (incomplete medium) 
- RPMI-1640 (1X) with L-glutamine, and phenol red     1   pack 
- NaHCO3                      2         g 
- DI water           1        L 
Adjust pH to 7.2-7.4 (Filter sterile, store at 4 °C) 
 RPMI 1640, 1X (complete medium) 
- Inactivated FBS        20     mL 
- Penicillin/Streptomycin         2     mL 
- HEPES buffer (1 M)         3     mL 
Adjust volume to 200 mL with RPMI-1640, 1X, incomplete medium. 
(Store at 4 °C) 
 DMEM, high glucose, 1X (incomplete medium) 
- DMEM, high glucose, 1X with L-glutamine, with phenol red    1   pack 
- NaHCO3        3.7        g 
- DI water           1        L 
Adjust pH to 7.0-7.4 (Filter sterile, store at 4 °C) 
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 DMEM, high glucose, 1X (complete medium) 
- Inactivated FBS        20     mL 
- Penicillin/Streptomycin         2     mL 
- HEPES buffer (1 M)         3     mL 
Adjust volume to 200 mL with DMEM, high glucose, 1X, incomplete 
medium (store at 4 °C) 
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APPENDIX C 
DETECTION KITS 
 
C.1 mRNA analysis (qRT-PCR) 
 RNA isolation using SV Total RNA Isolation kits (Promega, Madison, WI) 
- Remove supernatant (collect supernatant and freeze at -80 °C for ELISA 
analysis) and wash the cells with ice-cold, sterile 1X PBS. 
- Add 175 µL of RNA Lysis Buffer (RLA) to the washed cells in a 6-well 
plate, disperse the pellet and mix well by vortexing and/or pipetting. 
- Transfer to 1.5 mL microcentrifuge tubes (or freeze at -80 °C until 
needed). 
- Add 350 µL of RNA Dilution Buffer (blue) to 175 µL of lysate.  Mix by 
inverting the tube 3-4 times.  Place in a water bath or heating block at 70 °C 
for 3 min.  Incubation longer than 3 minutes may compromise the integrity 
of the RNA. 
- Centrifuge at 12,000-14,000 x g for 10 min at 20-25 °C. 
- Transfer the cleared lysate solution to a fresh microcentrifuge tube by 
pipetting.  Avoid disturbing the pellet debris. 
- Add 200 µL 95% ethanol to the cleared lysate, and mix by pipetting 3-4 
times.  Transfer this mixture to the spin column assembly.  Centrifuge at 
12,000-14,000 x g for 1 min. 
- Take the spin basket from the spin column assembly, and discard the liquid 
in the collection tube.  Put the spin basket back into the collection tube.  
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Add 600 µL of RNA Wash Solution to the spin column assembly.  
Centrifuge at 12,000-14,000 x g for 1 minute. 
- Empty the collection tube as before and place it in a rack.  For each 
isolation to be performed, prepare the DNase incubation mix by 
combining 40 µL Yellow Core Buffer, 5 µL 0.09 M MnCl2 and 5 µL of 
DNase I enzyme per sample in a sterile tube (in this order).  Prepare only 
the amount of DNase incubation mix required and pipet carefully.  Mix by 
gentle pipetting; do not vortex.  Keep the DNase I on ice while it is 
thawed.  Apply 50 µL of this freshly prepared DNase incubation mix 
directly to the membrane inside the spin basket.  Make sure that the 
solution is in contact with and thoroughly covering the membrane.  The 
incubation solution is yellow to make this easier to visualize. 
- Incubate for 15 minutes at 20-25 °C.  After this incubation, add 200 µL of 
DNase Stop Solution to spin basket, and centrifuge at 12,000-14,000 x g 
for 1 minute.  There is no need to empty the collection tube before the next 
step. 
- Add 600 µL RNA Wash Solution (with ethanol added) and centrifuge at 
12,000-14,000 x g for 1 minute. 
- Empty the collection tube, and add 250 µL RNA Wash Solution (with 
ethanol added); centrifuge at high speed (20,000 x g) for 2 min. 
- If you have not already done so, remove the cap from the spin basket by 
using a twisting motion. 
- For each sample, remove one capped 1.5 mL elution tube.  Transfer the 
spin basket from the collection tube to the elution tube, and add 100 µL 
nuclease-free water to the membrane.  Be sure to completely cover the 
surface of the membrane with the water.  Place the spin basket assemblies 
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in the centrifuge with the lids of elution tube facing out.  Centrifuge at 
12,000-14,000 x g for 1 minute.  Remove the spin basket and discard.  Cap 
the elution tube containing the purified RNA and store at -70 °C to convert 
RNA into cDNA.  (If you want to determine purified RNA).  After that 
remove the spin basket and discard.  Cap the elution tube and put on ice to 
determine RNA using NanoDrop ND-1000 spectrophotometer. 
 Reverse transcription (RT) of mRNA to cDNA using High Capacity cDNA 
Reverse Transcription kit (AB Applied Biosystems, Foster City, CA) 
- Prepare the 2X Reverse Transcription Master Mix on ice. 
 
Components 
 
Volume/Reaction (µL) 
10X RT Buffer 2.5 
25X dNTP Mix 1 
10X RT Random 
Primers 
2.5 
MultiScribe Reverse 
Transcriptase (50U/µL) 
1.25 
RNase-free H2O 5.25 
Final Volume 12.5 
 
- Pipette 12.5 µL of 2X RT master mix into each well. 
- Pipette 12.5 µL of RNA sample into each well, pipette up and down two 
times to mix. 
- Seal the plate and incubate at 25 °C for 10 min, 37 °C for 2 h, and 85 °C 
for 5 min. 
- Store at 4 °C for 24 h before use. 
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C.2 EMSA 
 EMSA probe preparation using illustra ProbeQuant G-50 Micro Column (GE 
Healthcare, Piscataway, NJ) 
- Use 10 pmole annealed DNA in total volume of 46 µL 1X buffer. 
- Add 2 µL 32P-ATP (stock 10 μCi/μL) and mix gently. 
- Add 2 µL T4 kinase and mix gently. 
- Incubate 30 min at 37 °C (usually use water bath). 
- Proceed with column purification using GE Healthcare Illustra ProbeQuant 
G50 microcolumns. 
- Vortex column to suspend resin. 
- Snap off bottom and place column in a 2 mL eppendorf tube. 
- Spin at 735 x g, 1 min at RT.  Discard eppendorf. 
- Place column in fresh collection tube from GE ProbeQuant kit. 
- Apply 50 µL sample to resin without disturbing it. 
- Spin at 735 x g, 2 min at RT.  Discard column and retain flow-through. 
- Acess CPM with Liquid Scintillation Counter (LSC).  Place 2 μL sample 
on filter paper and read in 10 mL scintillation fluid. 
C.3 Transfection and luciferase 
 Plasmid DNA purification using the QIAprep Spin Miniprep kit and a 
Microcentrifuge (Qiagen, Valencia, CA) 
- Resuspend pelleted bacterial cells in 250 µL Buffer P1 and 
transfer to a microcentrifuge tube. 
- Add 250 µL Buffer P2 and mix thoroughly by inverting the tube 4-6 times. 
- Add 350 µL Buffer N3 and mix immediately and thoroughly by inverting 
the tube 4-6 times. 
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- Centrifuge for 10 min at 13,000 rpm (  17,900 x g) in a table-top 
microcentrifuge. 
- Apply the supernatants from step 4 to the QIAprep spin column by 
decanting or pipetting. 
- Centrifuge for 30-60 s.  Discard the flow-through. 
- Recommended: Wash the QIAprep spin column by adding 0.5 mL Buffer 
PB and centrifugation for 30-60 s.  Discard the flow-through. 
- Wash QIAprep spin column by adding 0.75 mL Buffer PE and 
centrifuging for 30-60 s. 
- Discard the flow-through, and centrifuge for an additional 1 min to remove 
residual wash buffer. 
- Place the QIAprep column in a clean 1.5 mL microcentrifuge tube.  To 
elute DNA, add 50 µL Buffer EB (10 mM Tris·Cl, pH 8.5) or water to the 
center of each QIAprep spin, let stand for 1 min, and centrifuge for 1 min. 
 Preparation of transfection mixture using Lipofectamine 2000 (Invitrogen, Carlsbad, 
CA) 
- Dilute DNA in 250 µL of Opti-MEM reduced serum medium 1X and mix 
gently. 
- Dilute Lipofectamine 2000 in 250 µL of Opti-MEM reduced serum 
medium, mix gently, and incubate for 5 min at RT. 
- After 5 min incubation, combine the diluted DNA with Lipofectamine 
2000, mix gently, and incubate for 20 min at RT. 
- Add 500 µL complexes to each well (6-well plate) in a drop wise fashion 
and mix gently. 
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 Preparation reporter lysis 1X buffer from Reporter Lysis 5X Buffer (Promega) 
- Add 4 volumes of water to 1 volumes of Reporter Lysis 5X Buffer.  
Equilibrate 1X lysis buffer to room temperature before use. 
- Carefully remove the growth medium from cells to be assayed.  Rinse the 
cells twice with PBS, being careful not to dislodge attached cells.  Remove 
as much of the final PBS rinse as possible. 
- Add enough 1X reporter lysis buffer to cover the cells.  Freeze-thaw once 
to ensure complete lysis. 
- Rock culture dishes several times to ensure complete coverage of the cells 
with lysis buffer.  Transfer the cell lysates to a microcentrifuge tube.  
Place the tube on ice. 
- Vortex the microcentrifuge tube and transfer cell lysates to 96 luminator 
plate. 
- The cell lysates may be assayed directly or store at-70 °C. 
 Luciferase assay reagent preparation (Luciferase Assay System 10-Pack, 
Promega) 
- To prepare the luciferase assay reagent, add 10 mL of Luciferase Assay 
Buffer to the vial containing the lyophilized Luciferase Assay Substrate. 
- Avoid exposure of the luciferase assay reagent to multiple freeze-thaw 
cycles by dispensing the reconstituted reagent into working aliquots.  
- Store any unused luciferase assay reagent at -70 °C. 
- Equilibrate luciferase assay reagent to RT before each used. 
- Each reaction requires 100 µL of reagent to initiate enzyme activity. 
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APPENDIX D 
RESTRICTION DIGESTION OF DNA 
 
D.1 Mapping of pmIL6.1-Luc (6877 bps or full length mIL-6 prompter) 
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D.2 The amount of DNA for using in restriction digestion of DNA 
 pGL2 (535.4 ng/µL), need 500 ng/lane             0.93 µL (  0.  µL) 
 pmIL-6.Luc(-231) (692 ng/µL), need 500 ng/lane                      0. 2 µL (  0.  µL) 
 The table shows working reaction of DNA restriction enzyme digestion 
Samples 
pGL2 (0.5 µg/Lane) pmIL-6.Luc(-231) 
(0.5 µg/Lane) 
Uncut 
(µL) 
1 cut 
(µL) 
2 cut 
(µL) 
Uncut 
(µL) 
1 cut 
(µL) 
2 cut 
(µL) 
Template (DNA) 
10X NEB Buffer3 
10X NEB Buffer4 
10X BSA 
BamHI 
HindIII-HF 
DI water 
0.9 
- 
- 
- 
- 
- 
19.1 
0.9 
2 
- 
2 
2 
- 
13.1 
0.9 
- 
2 
2 
2 
2 
11.1 
0.7 
- 
- 
- 
- 
- 
19.3 
0.7 
2 
- 
2 
2 
- 
13.3 
0.7 
- 
2 
2 
2 
2 
11.3 
Total volume 20 µL 20 µL 20 µL 20 µL 20 µL 20 µL 
 
D.3 Expected size 
The table shows expected size of interested plasmid DNA 
Plasmid DNA Size (bp) BamHI HindIII-HF 
pGL2-basic 5598 5598 2906 and 2692 
pmIL-6.Luc(-231) 5789 5789 3097 and 2692 
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D.4 Result of DNA restriction analysis 
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